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A B S T R A C T
The presented thesis describes the historical evolution of growth
and laboratory reference values and the methods for their cre-
ation – leading finally to a family of methods applied in the
WHO Multicentre Growth Reference Study (MGRS) [6]. The fol-
lowing part describes these methods, their assumptions, and
model diagnostics. The original article at the beginning of part
III combines these methods with resampling to be able to use
LMS-type methods on data containing different dependencies
like follow-up measures and family relationships. This method
has been applied in the estimation of reference values of sev-
eral laboratory values in the context of the LIFE child study
[52]. Three papers are already published and are also presented
in part III. The next section concentrates on the accompanying
R package childsds [76]. A short summary and outlook con-
cludes the work.
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Ziel: Die vorliegende Arbeit soll die Entwicklung und Bedeu-
tung von Referenzwerten im pädiatrischen Kontext beschrei-
ben. Der zugehörige Artikel beschreibt die Kombination der
von der WHO empfohlene Methode und Resampling, um die
Herleitung von Referenzwerten auch im Fall von Messwieder-
holungen und anderen Abhängigkeiten zu ermöglichen. Drei
weitere Artikel, in denen die Methode angewendet wurde und
eine kurze Vorstellung des zugehörigen, begleitend entwickel-
ten R Pakets (statistische Software) bilden Teil III der Arbeit.

We have seen that computer programming is an art,
because it applies accumulated knowledge to the world,
because it requires skill and ingenuity, and especially
because it produces objects of beauty.
— Donald E. Knuth [42]
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Part I
I N T R O D U C T I O N

1
I N T R O D U C T I O N
1.1 standardization and reference values
In anthropometry as well as in laboratory medicine, a numeric
measurement value represents a natural trait or feature of a
particular subject. The meaning of an isolated measurement re-
mains unclear. Its interpretation is only possible in comparison
to the distribution of the respective value in the corresponding
population. This allows a (somewhat statistical) definition of
normality. In pediatrics, this comparison is even more challeng-
ing. A child’s development, starting during pregnancy, com-
prises changes in anthropometric measures, e.g. height, weight,
or head circumference, laboratory parameters, e.g. hormones
especially during puberty, changes in abilities, e.g. cognitive or
motoric skills, and changes in behavior, e.g. sleep and activ-
ity. To describe development in the context of age (as well as
sex), one has to understand the age-value relationship as well
as the age-dependent non-pathological and pathological vari-
ability. To understand the meaning of a measured value, it has
to be considered in the context of age and sex. Therefore, it
is useful to standardize the measured value x conditional on
age and sex. In the case of normally distributed measures, the
standardization is carried out in the following way: standardization
1. for each sex and age, the expected value µ is calculated
2. for each sex and age, the standard deviation σ is calcu-
lated
3. the standardized value z is calculated as z = x−µ(age, sex)
σ(age, sex)
Because this standardized value is measured in standard de-
viations, it is also called standard deviation score (SDS). Nega-
tive values indicate values below the expected value, whereas
positive values indicate values above the expected value. Val-
ues between -1 and +1 are considered as average scores, val-
ues below -2 SDS/above +2 SDS are considered as extremely
low/high. SDS can directly be transformed into centiles or per-
centiles, where an SDS value of 0 corresponds to the 50th centile centiles
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Figure 1: The same value of height is different in the context of differ-
ent ages: an exceptionally high value at the age of three is a
normal value at the age of five and an extremely low value
at the age of seven.
(the median). The 100 · pth centile of a continuous variable Y is
defined as the value yp such that
Prob(Y 6 yp) = p.
In a less mathematical speech: the 100 · pth centile of a contin-
uous variable Y is the value where 100 · p percent of the val-
ues are less than the respective values, and 100 · (1 − p) per-
cent are greater than this value. In the table below you find
typically used SDS values and the corresponding centiles or per-
centiles. The transformations between SDS and percentile valuesSDS and percentiles
and vice versa are straightforward and can be carried out us-
ing MSExcel, LibreOffice, or any comprehensive statistical soft-
ware.1
Besides the direct transformation of measurements into SDS,reference range
sometimes, only cut-offs are given, so-called reference limits.
The measurement value is compared to these limits. Values out-
side the limits may indicate abnormality. The use of reference
limits or reference ranges are standard in the laboratory con-
text. These limits are often the 97th (+1.881 SDS) or 97.5th per-
centile (+1.960 SDS) and, if applicable, the 3rd (-1.881) or 2.5th
percentile (-1.960 SDS).
1 For example, in Excel, NORM.S.INV(perc) and NORM.S.DIST(SDS, TRUE),
R: pnorm() and qnorm(), SAS: PROBNORM() and PROBIT()
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sds percentile sds percentile
-2.000 2.3 +2.000 97.8
-1.960 2.5 +1.960 97.5
-1.881 3.0 +1.881 97.0
-1.280 10.0 +1.280 90.0
-1.000 16.0 +1.000 84.0
0.000 50.0
Table 1: Standard deviation scores and the respective percentiles for
selected values.
1.2 the scope of this thesis
The presented thesis describes the historical evolution of growth
and laboratory reference values and the methods for their cre-
ation – leading finally to a family of methods applied in the
MGRS. The following part describes these methods, their as-
sumptions, and model diagnostics. The original article at the be-
ginning of part III combines these methods with resampling to
be able to use it on data containing different dependency struc-
tures like follow-up measures and family relationships. This
method has been applied in the estimation of reference values
of several laboratory values in the context of the LIFE child
study [52]. Three papers are already published and are also
presented in part III. The next section concentrates on the ac-
companying R package childsds [76].A short summary and
outlook concludes the work.

2
H I S T O R I C A L A S P E C T S
2.1 development of basic concepts
The measuring of human characteristics goes back to ancient
times. Before 1900, the main purpose of anthropometry was ad-
ministrative: it was, for example, used to determine the value of
slaves. Due to an increasing awareness of social inequalities dur-
ing the 19th century, anthropometric measurements became a
means to search for and later to define suboptimal conditions of
health [74]. In the context of children, the monitoring of growth
has been an important instrument for assessing the state of de-
velopment and a child’s health. The first documented and pub- a first growth curve
lished growth curve was generated by Montbeillard who deter-
mined the height of his son in six-month intervals from birth
to the age of 18 years. George-Louis Leclerc, Comte de Buffon
published the curve in his Histoire Naturelle, général et particulère
[8, 74, 17]. Since the 18th century, the use of growth charts has
expanded to visualize the growth pattern of a group of children.
It became the important tool of today.
Figure 2: The first documented growth curve: height measurements
of Montbeillard’s son. Age was reported in years, months,
and days. Data taken from Hauspie, Cameron, and Molinari
[35, page 30, Table 2.1]
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At the end of the 18th and the beginning of the 19th century,
the concept of the normal distribution arises. First developed
by DeMoivre as an approximation to the binomial distributionA DeMoivre
(1733, the earliest version of the most important Central Limit
Theorem), it was used by Pierre Simon Laplace to describe thePS Laplace
distribution of errors [79]. In 1812, Laplace published the first
edition of the groundbreaking work, Theorie Analytique des Prob-
abilités [46].
Adolphe Quetelet, a Belgian statistician, applied the idea toA Quetelet
anthropometry. He introduced the concept of l’homme moyen
(the average person) as a representative of a group of subjects
[53, 54]1.
Figure 3: Average growth of men. Taken from Anthropométrie ou
mesure des différentes facultés de l’homme [55].
Francis Galton, well aware of both concepts, the concept ofF Galton
normality and the concept of the l’homme moyen, was also aware
of deviations from normality in a lot of measures. He intro-
duced the notion of percentiles as a cumulative (non-parametric)
function. When any large group of statistical cases is sorted into a
hundred classes equal in number, and progressively increasing value,
the dividing values between the classes are called Percentiles; or, if
1 La nécessité de faire abstraction des individus pour ne m’occuper que de
ce qui rapporte aux masses m’a conduit, comme je l’ai dit, à admettre
l’homme moyen, que, par rapport au système social, peut être considéré
comme l’analogue du centre de gravité dans les corps. Quetelet [54]
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into ten classes, they are called Deciles; or if into four classes, they are
called Quartiles. The fiftieth percentile, the fifth decile, and the second
quartile are consequently the same as the median. All other deciles,
&c, are calculated on the same principle as the median[. . . ] [29]. In London 1884
1884/5, on the occasion of the International Health Exhibition
in London, he founded his Anthropometric Laboratory, where
he took 17 measures from 9,337 individuals until late 1884 [27].
By 1885, when the exhibition closed, 10,000 individuals were
measured with more than 150,000 measurements2.
The individuals were happy to pay for being measured. Gal-
ton himself stated in [28] that if there had been more accommoda-
tion there would have been a large increase in number measured. The
following measures were taken:
• keenness of sight
• color sense
• judgment of eye in estimating length and squareness
• hearing: its keenness, highest audible note
• touch
• breathing capacity
• swiftness of blow with fist
• strength of pull and squeeze
• height, sitting and standing (including measurement of
the thickness of the heel of the shoe)
• span of arms
• weight
2 Source: The Galton Institute.
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Figure 4: Photograph of Francis Galton’s Laboratory with kind ap-
proval of the UCL Galton Collection at University College
London.
In addition, the age at last birthday; the birthplace; the state
(married, unmarried, or widowed); residence, whether urban,
suburban, or country, and occupation of each tested subject was
recorded. No names were asked for [28].
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(a) Galton’s standard form used within the Anthropometric Laboratory
for capturing the measures.
(b) Galton’s standard form used within the Anthropometric Laboratory
for capturing the personal data.
Figure 5: Galton’s forms used within the Anthropometric Laboratory
taken from [28].
In January 1885, Galton published the first percentile tables a Nature paper
in his article Anthropometric per-centiles containing the 5th, 10th,
20th, 30th, 40th, 50th, 60th, 70th, 80th, 90th, and 95th percentiles
of height, sitting height, and span of arms of men and women
aged 23–51 years. Percentiles of weight, breathing capacity, swift-
ness of blow, strength of pull, strength of squeeze, and keenness
of sight were given for men and women aged 23–26 years.
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Figure 6: Galton’s percentile table published in January 1885 in Na-
ture [27]
Galton stresses the importance of systematic measurement of
especially children with the object of keeping an adequate oversight
upon their physical well-being by a judicious series of measurements.
[. . . ] The use of periodical measurements is two-fold, personal and
statistical. The one shows the progress of the individual; the other
that of portions of the nation, or of the nation as a whole. [28]
2.2 growth references and growth charts
Combining growth curves, the concept of percentiles, and vi-
sualization results in growth charts. The evolution of growthHP Bowditch
charts has started 1891 when Henry Pickering Bowditch pub-
lished his work The growth of children, studied by Galton’s method
of percentile grades [7]. It was the last of three books on the
growth of children and presented three alternative layouts to
visualize the relationships between height, age, and percentiles:growth charts
(a) height plotted against the percentiles for each age group
(b) age plotted against the percentiles for different height cat-
egories
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(c) height plotted against age for different percentiles
(a) height vs percentiles, grouped
by age
(b) age vs percentiles, grouped by
height
(c) height vs age, grouped by percentiles
Figure 7: The three different types of growth charts designed by
Henry Bowditch. The example growth charts were gener-
ated from height data of boys in Flandern [63].
The third alternative has become the standard format of growth
charts and is still a standard instrument in pediatrics.
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2.3 laboratory reference values
Beginning during the 1950s and 1960s, laboratory automation
went mainstream.[49] Laboratories have started to produce a
large amount of data facilitating the study of biological variabil-
ity (intra-, inter-individual, short- and long-term). The concept
of reference values replaced a very unclear notion of normality
[68]. In addition, Gräsbeck and Saris [32] suggest to substitute
the term reference values for the ambiguous term of normal and
its emotionally charged counterpart abnormal values [73]. The
first book on laboratory reference values was published in 1973
[67, 68]. After 1980, various recommendations were published;
In the late ’90s, the concept of reference values was applied
in routine by all kinds of health professionals [68, 30]. Its use
is recommended by the ISO 15189 standard and the European
Directive 98/79 EC. Reference values, first introduced as philos-
ophy, had become one of the most powerful tools in laboratory
medicine [30].
Part II
M E T H O D S

3
M E T H O D S E L E C T I O N
3.1 nomenclature
Whereas the concept and the application of standard deviation reference population
scores and reference ranges are straightforward, the generation
of reliable reference values is a complex process [40]. First, the
reference population has to be chosen. In general, the aim of
reference ranges (in pediatrics) is to describe the age dependent
distribution of values in the general population. In this case,
the reference population is equal to the general population. By
convention, the general population is understood as the body of
all healthy subjects of a population. However, health is relative
and lacks a precise definition [30], its meaning may depend
on the measure of interest. Gräsbeck stated in [31] that absolute
health does not exist. Some pathology is present in every individual
like entropy in a chemical system. Therefore, exact inclusion and
exclusion criteria have to be defined: a broken finger should
have no influence on the body height but maybe on laboratory
measurements related to the bone metabolism.
The reference population may also consist of patients suf-
fering from a certain disease. Isojima et al. [37] Karlberg et al.
[41] Sempe, Bondallaz, and Limoni [66], for example, published
height reference values for girls with the Turner syndrome. The
members of the reference population are called reference in-
dividuals. From the reference population the reference sample reference individual
group is randomly chosen. It should consist of a sufficient num-
ber of individuals from which the reference values can be ob-
tained. The ethnic composition of the reference population, sea-
sonal variations, diet preferences, and lifestyle factors also have
to be taken into account and might influence the sampling pro-
cess. In addition, especially laboratory measurements are af-
fected by differences in the analytical methods [40].
The latest definitions listed in the approved guidelines [36,
paragraph 4.2], published by the Clinical and Laboratory Stan-
dard Institute (CLSI) as CLSI document EP28-A3c (formerly C28-
A3) are listed below. The recommendations are directed to lab-
oratory reference values but are in essential parts also applica-
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ble in anthropometry. They are used throughout the following
work.
definitions
observed value : the value of a particular type of quantity,
obtained by observation or measurement of a test subject, to
be compared with reference values, reference distribution, ref-
erence limits, or reference intervals.
reference distribution : the distribution of reference val-
ues; note: Hypotheses regarding the distribution of a reference
population may be tested using the reference distribution of the
reference sample group and adequate statistical methods. The
parameters of the hypothetical distribution of the reference pop-
ulation may be estimated using the reference distribution of the
reference sample group and adequate statistical methods.
reference individual : a person selected for testing on
the basis of well-defined criteria; note: It is usually important
to define the person’s state of health.
reference interval : the interval between, and including,
two reference limits; note: It is designated as the interval of val-
ues from the lower reference limit to the upper reference limit.
In some cases only one reference limit is important, usually an
upper limit, x. The corresponding reference interval is 0 to x.
Most frequently reference interval comprises the central 95% of
the distribution of reference values.
reference limit : a value derived from the reference distri-
bution and used for descriptive purposes; note: It is common
practice to define a reference limit in a way that a stated fraction
of the reference values is less than or equal, or greater than or
equal, to the respective upper or lower limit; the reference limit
is descriptive of the reference values and may be distinguished
from various other types of decision limits.
reference population : a group consisting of all poten-
tial reference individuals.
reference sample group : an adequate number of sub-
jects selected to represent to reference population.
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reference value : the value (test result) obtained by the
observation or measurement of a particular type of quantity
on a reference individual; note: Reference values are obtained
from a reference sample group.
Figure 8: From reference indivuals to reference values and reference
limits. Adapted from Horowitz et al. [36]
Reference limits are not to be mistaken for decision limits decision limits
which are used to classify subjects as diseased or non-diseased.
From the definition of the reference interval, it follows that 5%
of the reference values (assumed to originate from a healthy
population) are above or below its limits. Hence, a value ly-
ing outside the reference interval can be a completely normal
but rare value. Notwithstanding, because of this infrequency
in healthy individuals it may indicate an underlying disease or
adverse condition.
3.2 the choice of statistical method
After the collection of measurements, the statistical method
has to be chosen. We can distinguish between two approaches
when it comes to the consideration of age: The first group of
methods is based on the partition of age into subclasses or
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age intervals. Subsequently, parametric or non-parametric pro-age subclasses
cedures are applied to identify the respective reference limits
(in most cases the 2.5th and the 97.5th centile). The second
group comprises methods which estimate the required refer-
ence curves dependent on age as continuous parameter. The
former approach is recommended by the guidelines from the
Clinical and Laboratory Standards Institute [36] but critized for
example by Haeckel et al. [34], Loh et al. [47], and Yang et al.
[81]. The choice of age-intervals are often arbitrary or rather
subordinated to the number of cases than to biological reason-
ing. It also remains unclear how to deal with jumps between
age classes [34]. Therefore, in the case of an age dependency, acontinuous
approach continuous approach seems to be more appropriate because it
reflects the natural development. Again, there are two groups
of methods:
• methods without distributional assumption
• methods relying on distributional assumption
Quantile regression is an example of the first group. Each
quantile – in the case of centiles each centile – is estimated
separately. Therefore, it is an appropriate method to estimate
specific quantiles [14]. It does not assume any underlying dis-
tribution. The relationship between the outcome variable (i.e.,
the specific quantile of the outcome variable) and age can be
modeled parametric or non-parametric. To capture the predom-
inantly non-linear relationships between the outcome variables
and age natural polynomials, fractional polynomials or splines
can be used.
LMS-type methods, on the other hand, are an example of adistributional
assumption method presuming an underlying distribution. In other words,
for every fixed age, the outcome variable follows a paramet-
ric distribution. The distribution family is assumed to be fixed,
only the distribution parameters vary with age. Whereas the
distribution is described by parameters, the relationship be-
tween the distribution parameters and the age variable is not
assumed to follow a predefined parametric model. It is mod-
eled to change smoothly as the covariate changes; the smooth-
ing method is based on the maximum penalized likelihood [18].
The LMS-type models themselves can be understood as a sub-
group of generalized additive models for location, shape, and
scale (GAMLSS) [60, 70, 71, 72, 1, 58].
Within the context of the MGRS (1997–2003), the World Health WHO MGRS
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Organization (WHO) compared 30 methods of centile estima-
tion. The advisory group stated main and secondary criteria as
guides for model selection [6]:
Main criteria: method comparison
• Outer centiles can not be estimated with sufficient preci-
sion without relying on an underlying distribution, given
the scarce information at the tails.
• The crossing of centiles must be avoided. Therefore, the
simultaneous calculation of centiles is necessary.
• Only methods that allow back-transformations should be
considered so that direct calculation of centiles and z-
scores is enabled.
• Because the MGRS data set is composed of both a longi-
tudinal component, sampled at target ages, and a cross-
sectional component (where data were collected contin-
uously across the age range), its design does not favour
the use of age-grouping methods for estimating centiles.
Interpolation to an age-group midpoint, followed by vari-
ability correction, could be applied to cross-sectional data,
but treating age as a continuous variable likely will avoid
problems associated with variability and arbitrary choices
of age groupings.
• Methods that are able to address kurtosis, in addition to
skewness, are preferable; genuine kurtosis can occur for
some measurements and, if data are not modelled cor-
rectly, resulting fitted centiles can be distorted.
Secondary criteria:
• There should be tools to assess fit of the model.
• It should be easy to explain and well documented.
• It should applicable to different anthropometric measures
so that the WHO growth curves would rely on a single
approach.
The LMSP method was found as the most flexible and, there- and the winner is
fore, an appropriate method to estimate centile charts in the
context of anthropometric measurements [6]. However, finally
the original LMS method implemented in GAMLSS was applied
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within the MGRS [22, 50, 48]. Methods based on distributional
assumptions were identified to be better suited to produce more
accurate Z- or SD-scores at the extremes of the distribution [6].
However, it requires a fitting choice of the distribution.
3.3 generalized additive models for location,
shape & scale
3.3.1 Distribution Parameters
Continuous distributions are usually described by parameters
defining the central tendency or location (1st moment), the dis-
persion or scale (2nd moment), and shape of the distributed
values. The most used shape parameter is skewness (3rd mo-skewness
ment) which measures the degree of asymmetry. The coefficient
of kurtosis (4th moment) describes the degree of flatness of thekurtosis
distribution [43]. In ordinary regression models, only the mean
µ, dependent on the covariates, is estimated. The variance σ2is
assumed to be constant (the assumption of homoscedasticity)
and the residuals (or errors) are assumed to be normally dis-
tributed. In GAMLSS, not only the mean µ can be modeled but,
dependent of the chosen distribution, also the remaining distri-
bution parameters.
The normal distribution as a two-parameter distributions isnormal distribution
fully described by the mean µ and the variance σ2. The skew-
ness ν and the kurtosis τ are fixed (ν = 0, τ = 3). Figure 9
shows the age-dependent distribution of simulated, normal dis-
tributed values (a) in the case of constant variance (homoscedas-
ticity) and (b) in the case of increasing variance. Only (a) could
be validly modeled using ordinary regression; (b) would vio-
late the assumption of homoscedasticity.
The Box Cox Cole and Green distribution (BCCG), for exam-3-parameter dists.
ple, is a three parameter distribution family described by the
location parameter µ, the scale parameter σ, and the shape pa-
rameter λ (or in GAMLSS parlance ν)1. Let Y be a randomly
distributed variable then
1 In the context of the original articles concerning the LMS methods λ is used
to indicate the parameter. The three parameters add up to the name of the
method: LMS. In the context of GAMLSS, λ is replaced by ν for consistency
reasons.
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(a) constant variance (homoscedasticity)
(b) increasing variance for increasing age
Figure 9: Hypothetical values increasing with age and normally dis-
tributed conditional on age. In (a) the variance is constant,
whereas in (b) the variance increases with age.
Z =

1
σν
[(
Y
µ
)ν
− 1
]
if ν 6= 0 (1a)
1
σ
log
(
Y
µ
)
if ν = 0 (1b)
is normally distributed. Therefore, ν is a measure of the skew-
ness of the distribution [18]. Figure 10 shows three examples of
density curves where µ and σ are equal for all of the curves but
ν differs.
Figure 11 shows the the age-dependent distribution of simu-
lated, BCCG distributed values. For 2.5 years of age the distribu-
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Figure 10: Examples of the BCCG distribution with varying ν (or in
LMS parlance λ).
tion is left-skewed (ν = −7). With increasing age the skewness
parameter increases reaching 1 (in the context of BCCG symme-
try) at an age of 12.5. For higher ages the distribution becomes
again more skewed, in that case to the right.
Figure 11: BCCG distribution with varying paramaters for µ, σ, and
ν (or in LMS parlance λ). The histograms as well as the
density curves are plotted conditional on age.
GAMLSS models can estimate up to four parameters. The 4th4-parameter dists
parameter, as stated above, would characterize the kurtosis or
flatness of the distribution. An example of such a distribution
is the BCPE distribution. To demonstrate the influence of the
coefficient of kurtosis, in Figure 12, the density curves for dif-
ferent values of tau are presented. The respective density curve
of the normal distribution is added as dashed gray line. As we
can see, the curve of a BCPE distribution with ν = 1 (symmet-
ric) and τ = 2 corresponds to the normal distribution. Lower
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values of τ result in more slender, leptokurtic curves; higher
values result in flatter, platykurtic curves.
Figure 12: Examples of the BCPE distribution with varying τ and fixed
σ and ν.
In most distributions the resulting skewness and kurtosis
does depend rather on the combination of the parameters than
on one isolated parameter alone. However, in most cases, a
dominating parameter can by identified. Because there is a wide
range of possible distribution families, the approach is very flex-
ible. A selection of available distribution is listed in Table 2
3.3.2 Distributions Selection
One of the most important modeling decisions for a GAMLSS
model is the choice of the distribution for the response vari- distribution families
able [71]. The WHO statistical advisory group recommends ex-
amining the sample mean/median, standard deviation, skew-
ness, and kurtosis for all measurements across age. Kurtosis
should only be included if the fit of the more complex model
is significantly improved compared to the methods adjusting
only for the first three moments [6]. Nonetheless, the fourth
moment is increasingly seen as possibly important in estimat-
ing extreme centiles [6]. As a first example, the BMI of Dutch
boys is modeled assuming a normal distribution (two parame-
ters), a BCCG distribution (three parameters), and a BCPE distri-
bution (four parameters). The data originates from the Dutch
growth study [25, 26] and is provided as part of the AGD pack-
age [75]. In Figure 13, the use of the three different fitting distri-
butions are compared. In very young boys, the density curves
are nearly congruent. With increasing age, the empirical dis-
tribution of the values becomes more and more right-skewed,
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a quality which cannot be covered by the normal distribution.
The curves modeled assuming the more flexible three- or four-
parameter distribution are similar for all ages. Therefore, the
inclusion of kurtosis does not seem to be indicated. A more for-
mal approach to assess and compare the quality of fits will be
expounded in a later chapter (4).
(a) assuming a normal distribution
(2 parameters)
(b) assuming a BCCG distribution (3
parameters)
(c) assuming a BCPE distribution (4
parameters)
(d) comparison of the three fits
Figure 13: Example 1: Modeling body mass index (BMI) from the com-
plete sample of the Dutch growth data [25, 26, 75] using
GAMLSS assuming different age-dependent distributions.
The parameters of this distribution vary with age. (a) the
model is fitted assuming a normal distribution, therefore
the two parameters µ and σ are modeled dependent on
age. The BCCG distribution (b) has an additional parameter
ν, and allows for modeling skewness in addition. BCPE (c)
is a four-parameter distribution and also allows to adjust
for age-varying kurtosis (τ). (d) shows the four fits on top
of each other.
The second example (Figure 14) uses data on triceps skin-
folds of more than 13,000 boys aged 2 months to 20 years of
age from the National Health and Nutrition Examination Sur-
vey (NHANES) 1999–2010. Again, the normal distribution does
not meet the requirements of the skewed distribution of the
data. In (d), the resulting violet centile curves are ostensibly
not appropriate. The effect is strongest for the 5th percentile
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which is noticeably too low for almost all ages. The centile
curves resulting from using the BCCG and the BCT distribution
are apparently identical for the 5th percentile and very similar
for the 50th percentile. The 95th centile curves differ between
10 and 18 years of age. In Figure 15 the change of the differ-
ent distribution parameters is explicitly visualized for the three
distributions. The three curves for µ show similar pattern, but
the assumption of normally distributed values results in signif-
icantly higher estimates. The estimated dispersion parameter σ
is also overestimated using the normal distribution. The reason
is the incapability of taking the strong skewness into account.
(a) assuming a normal distribution
(2 parameters)
(b) assuming a BCCG distribution (3
parameters)
(c) assuming a BCT distribution (4 pa-
rameters)
(d) comparison of the resulting cen-
tile curves
Figure 14: Example 2: Modeling triceps skinfold from the NHANES
data 1999–2010. 13,504 measurements from boys aged 2
months to 20 years were available. Again, GAMLSS is ap-
plied and different age-dependent distributions are as-
sumed: (a) normal distribution does not met the skewness
inherent to the data, (b) BCCG distribution, and (c) BCT dis-
tribution, (d) shows the resulting 5th, 50th, and 95th centile
curves.
Distributions family num. of range skew- kurt-
params ness osis
Box-Cox Cole & Green BCCG 3 (0,∞) both -
Box-Cox power exp. BCPE 4 (0,∞) both both
continue next page
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Distributions family num. of range skew- kurt-
params ness osis
Box-Cox t BCT 4 (0,∞) both lepto
beta BE 2 (0, 1) (both) -
beta original BEo 2 (0, 1) (both) -
exp. gen. beta type 2 EGB2 4 (−∞,∞) both lepto
exp. EXP 1 (0,∞) (positive) -
gamma GA 2 (0,∞) (positive) -
gen. beta type 1 GB1 4 (0, 1) (both) (both)
gen. beta type 2 GB2 4 (0,∞) both both
gen. Gamma GG 3 (0,∞) positive -
gen. inv. Gaussian GIG 3 (0,∞) positive -
gen. t GT 4 (−∞,∞) (symm.) lepto
Gumbel GU 2 (−∞,∞) (negative) -
inv. Gaussian IG 2 (0,∞) (positive) -
inv. Gamma IGAMMA 2 (0,∞) (positive) -
Johnson’s SU JSU 4 (−∞,∞) both lepto
log normal family LNO 2 (+ 1) (0,∞) positive
logistic LO 2 (−∞,∞) (symm.) (lepto)
log normal LOGNO-
LOGNO2
2 (0,∞) (positive) -
log normal Box-Cox LNO 2 (+ 1) (0,∞) (positive) -
normal-exp.-t NET 2 (+ 2) (−∞,∞) (symm.) lepto
normal NO-
NO2
2 (−∞,∞) (symm.)
normal family NOF 3 (−∞,∞) (symm.) (meso)
pareto type 2 PARETO2 2 (0,∞) positive
power exp. PE- 3 (−∞,∞) (symm.) both
PE2
reverse Gumbel RG 2 (−∞,∞) positive -
reverse gen. extreme RGE 3 (0,∞) positive -
skew power exp. SEP1- 4 (−∞,∞) both both
(type 1 to 4) SEP4
sinh arcsinh SHASH-
SHASHo,
4 (−∞,∞) both both
skew normal SN1- 3 (−∞,∞) both -
(type 1 to 2) SN2
skew t ST1- 4 (−∞,∞) both lepto
(type 1 to 5) ST5
t family TF 3 (−∞,∞) (symm.) lepto
Weibull WEI-
WEI3
2 (0,∞) (positive) -
continue next page
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Distributions family num. of range skew- kurt-
params ness osis
exp. Gaussian exGAUS 3 (−∞,∞) positive -
Table 2: Selection of continuous distributions implemented in
GAMLSS. For presentational reasons exponential, generalized,
inverse, and symmetric are abbreviated to exp., gen., inv., and
symm.
3.3.3 Smoothing Methods
The second important choice to be made is the choice of the
smoothing function. As seen above, the distribution parame- smoothing
ters change over time. This change is presumed to be smooth,
i.e., there are no jumps in location, dispersion, skewness, or
kurtosis across age; the change is seamless and continuous.
Overfitting has to be avoided but age intervals subject to rapid
changes should meet the true trend. The smoothing technique
combined with the estimated distribution should be able to re-
flect the age specific aspects of the measurement pattern [6].
Parametric (linear and non-linear regression, natural and frac-
tional polynomials) as well as non-parametric (P-splines, cubic
splines, loess, or neural networks) models can be used to model
each of the distribution parameters µ, σ, ν, and τ. A parametric
approach assumes a functional relationship between the covari-parametric approach
ate (here: age) and the outcome variable. The basic form (e.g.
linear, polynomial, etc.) is given as an assumption, the best pa-
rameters (best in terms of maximum likelihood or respective
approaches) are estimated. The parametric approach is quite
flexible because it is not constrained to linear predictors. Some
examples of different functional relationships are given below.
In Figure 16, for each of the formulas and different values of
the βi example curves are visualized.
y = f(age) = β0 +β1 · age (2)
y = f(age) = β0 +β1 · age +β2 · age2 (3)
y = f(age) = β0 +β1 · ageβ2 (4)
y = f(age) = β0 · exp (β1 · age) (5)
Non-parametric approaches do not assume a predefined func-non-parametric
approach tional relationship, thereby, there is no formulaic way of de-
scribing the respective association. Consequently, it is more dif-
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(a) µ changing with age for different
distributions
(b) σ changing with age for different
distributions
(c) ν changing with age for different
distributions
(d) τ changing with age for different
distributions
Figure 15: Changing parameters for three different distribution fami-
lies.
ficult to communicate non-parametric models. The most com-
mon non-parametric regression estimators are kernel estima-
tors, splines (smoothing splines, regression splines), local poly-
nomials, and wavelets [24]. The ultimate aim is to remove side
effects of sampling variability or outliers to detect the underly-
ing, true pattern [6]. In Figure 17, three parametric approaches
and one non-parametric approache are visualized. Once more,
the BMI data from the Dutch growth study are used [25, 26, 75].
3.3.4 Link Functions
A link function g(·) relates the mean value of the response y
to the linear predictor. Using a link function (other than iden-
tity) while modeling continuous responses can be understood
as transformation of the response while fitting the model.
In GAMLSS, each parameter comes with its own link function.
If the si(·) are the selected smoothing functions and the distri-
bution of the response variable Y is given by Y ∼ D(µ,σ,ν, τ)
the model is given as:
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Figure 16: Four examples of parametric families available for fitting
the relationship between a continuous response variable
and age.
g1(µ) = s1(age) (6)
g2(σ) = s2(age) (7)
g3(ν) = s3(age) (8)
g4(τ) = s4(age) (9)
Usually, the link functions are chosen to ensure that the pa-
rameters are well-defined [71]. For example, while modeling σ
or τ a log link is chosen to ensure σ resp. τ remain positive for
all values of age. An identity link is suitable while modeling ν
since ν is well defined on (−∞,∞).
3.3.5 Fitting Algorithms
There are two fitting algorithms implemented in the GAMLSS
software: the RS algorithm and the GC algorithm. Both lead
to maximum penalized log-likelihood estimates for the coeffi-
cients [71]. The RS algorithm does not need accurate starting
values for the distribution parameters. It is more stable in the
initial state. On the other hand, the GC algorithm is more ap-
propriate when fitting highly correlated parameter estimates.
Therefore, a mixture of the two algorithm might be applied.
3.4 lms-type methods
The original LMS method was developed by Cole in 1988 [16].Cole 1988
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(a) fitting a simple linear model (b) fitting a 3rd grad natural poly-
nomial model
(c) fitting a fractional polynomial
model
(d) fitting a P-spline model
Figure 17: Modeling body mass index (BMI) from the complete sam-
ple of the Dutch growth data [25, 26, 75] using GAMLSS. The
BCCG distribution was assumed as age-dependent distribu-
tion of the BMI. The first model (a) was fitted assuming a
linear relationship, the second (b) assuming a relationship
described by a third order polynomial. Model (c) shows
the fit using fractional polynomials and (d) one is fitted
using P-splines.
In this first version, age was divided into age groups. For each
group a Box-Cox distribution was assumed and, hence, the dis-
tribution parameters were estimated. The L, the M, and the S
making up the name of the method stand for the parameters λ
(skewness), µ (location), and σ (dispersion). Subsequently, they
were separately smoothed across age using whatever method is
convenient [16]. In 1992, Cole and Green [18] removed the sub-
jective step of grouping and used maximum penalized likeli-
hood to model the parameter curves non-parametrically. Three
smoothing parameters controlling the degree of smoothing for
each of the parameters must be chosen.
An LMS model can be modeled as GAMLSS assuming the Box
Cox Cole and Green distribution (BCCG) for the response vari-
able. As already mentioned above, ν is used instead of λ in
GAMLSS parlance. The original three parameter method was
enhanced during the following years. The resulting LMST and
LMSP methods assume the Box Cox t distribution (BCT) [61] and
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Figure 18: The effect of the degree of smoothing. All for models (only
µ is visualized) are fitted applying penalized P-splines.
the Box Cox Power Exponential distribution (BCPE) [59], respec-
tively. Both distributions have four parameters, where the kur-
tosis of the BCT distribution is restrained to leptokurtosis. In
addition, a power transformation of age u = ageξ can be ap-
plied to age to improve the model’s ability of capturing fast
changes in the response variable. The original version of the
LMS method uses an identity link (no transformation) for all of
the parameters. The default link functions for σ, ν, and τ as
implemented in the gamlss package [72] are log, identity, and
log, respectively.
Given the distribution, the power transformation, and the
link functions, the effective degrees of freedom have to be deter- degree of smoothing
mined. In [71] three methods of automatic selection procedures
are described. Method 1 is based on minimizing the generalized
Akaike information criterion (GAIC), method 2 on minimizing
the validation global deviance (VDEV), and method 3 is a two-
step approach featuring a power transformation of age and a lo-
cal maximum likelihood (ML) procedure while fitting a model.
The methods are as well implemented in the gamlss package
[72, 62].
In [80], Wright and Royston compare three different meth-
ods for the generation of age-related reference values. The LMS
method turned out to be extremely flexible and widely applica-
ble. The problem of significant kurtosis in the residuals while
applying the original LMS method was addressed by introduc-
ing distributions which are able to model kurtosis as well [61,
59]. Therefore, the resulting family of methods as implemented
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in GAMLSS is even more flexible than the original one. Further-
more, additional covariates can be included. A formula for com-
puting centiles and Z-scores can be provided [6]. Therefore the
LMS-type methods fits all of the main criteria proposed by the
WHO:
• It relies on an underlying distribution.
• Therefore, crossing of centiles is not possible.
• Back-transformation is available.
• Age is considered continuously.
• It is possible to address skewness and kurtosis if neces-
sary.
The secondary criteria are also met. There are different meth-
ods to assess the model fit, the method is well documented
and easy to explain, and it is flexible enough to be applied in
multiple settings. Different tools to assess the model fit are in-
troduced in the next section.
4
M O D E L D I A G N O S T I C S
In the following chapter the four already used models estimat-
ing the age-dependent distribution of the triceps skin fold are
used as an example to demonstrate each technique in turn.
4.1 normalized quantile residuals
In ordinary regression, the residuals are defined as the differ-
ence between the observed and the fitted value:
ˆi = yi − yˆi
These residuals are assumed to be normally distributed. Ipso
facto, the residuals can be used to investigate the goodness
of the fit: pattern in the residuals (i.e. non-normal distributed
residuals) indicate problems concerning the model assumptions
or the model fit. In non-normal regression, e.g., in situations
with underlying skewed distributions, the residuals might be
far from normality. In [23], Dunn and Smyth propose a general
definition of residuals for a broad range of regression models
which guarantees normally distributed residuals whenever the
assumed model is appropriate1. Model checking techniques via
the normality of residuals are well established. Therefore, nor-
malized quantile residuals allow the application of common
and broadly available model diagnostic methods.
The generation of normalized quantile residuals is described
following an example assuming a BCCG distribution. Let
f(y;µ(age0 = 4),σ(age0 = 3),ν(age0 = 6))
and
F(y;µ(age0 = 4),σ(age0 = 3),ν(age0 = 6))
be the probability density function (pdf) and cumulative dis-
tribution function (cdf) of a hypothetical measure at a given
value of age (age0). And let y0 = 7 be a randomly chosen mea-
surement value. Since the area under a density curve equals 1
the definite integral
∫y0
−∞ f(y)dy = F(y0) is a value between 0
1 The proposed method also comprises discrete models which are ignored
here completely
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Figure 19: The curve of the pdf and the curve of the corresponding cdf
of a BCCG distribution. The observed value y0 and the asso-
ciated probability Pr(y 6 y0) are indicated as blue shaded
area under the pdf (upper chart) and as value F0(y0) (bot-
tom chart).
and 1 and corresponds to the cumulative probability of y0, de-
picted as blue shaded area in Figure 19. F(y0) corresponds to
the 100 · F(y0) centile of the distribution defined by F(y).
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Figure 20: The cumulative probability is mapped to the correspond-
ing value of a standard normal distribution using the in-
verse cdf of the standard normal distribution Φ−1 (upper
chart). The associated pdf and the associated definite inte-
gral are depicted in the bottom chart. The area of the blue
shaded area is equal to the blue shaded area in Figure 19.
In our example is y0 = 7 and F(7) = 0.882. Therefore, 7 corre-
sponds approximately to the 88th centile of a BCCG distribution
with the given parameters. Now let Φ be the cdf of the stan-
dard normal distribution. To calculate the respective residual
r0 we have to find the 100 · F(y0)th centile of a standard nor-
mal distribution which is equivalent to the standard deviation
score of y0. It is given by Φ−1(F(y0)) (Figure 20). In our exam-
ple we have Φ−1(F(y0)) = Φ−1(0.882) = 1.18. The normalized
quantile residuals are standard normal distributed by defini-
tion (when the choice of model is appropriate). Throughout the
remaining sections residual refers to the normalized quantile
residuals. The resulting residuals should be plotted against
• the fitted values to detect violations against the homoscedas-
ticity assumption
• age to detect age spans suffering from insufficient fit
• the sequence of data collection to detect temporal correla-
tion
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• standard normal quantiles to detect deviations from nor-
mality.
4.2 diagnostic plots
4.2.1 Residuals versus Fitted
(a) residuals vs. fitted values assum-
ing a normal distribution
(b) residuals vs. fitted values assum-
ing a BCCG distribution
(c) residuals vs. fitted values assum-
ing a BCT distribution
(d) residuals vs. fitted values as-
suming a BCPE distribution
Figure 21: Residuals plotted vs.fitted values for four assumed under-
lying distributions. Note also the different ranges of the
fitted values.
Plotting the model residuals ri should show no pattern. They
should be symmetric to the x-axis conditional on fitted val-
ues, (standard) normally distributed around 0. Figure 21 shows
residuals vs. fitted plots for four assumed distributions: nor-
mal, BCCG, BCT, and BCPE. The residuals of the normal model
are clearly not symmetric with respect to zero. They exhibit
an irrefutable tendency towards higher positive residuals, i.e. a
prominent skewness (subplot (a)) which is caused by the inabil-
ity to account for the innate skewness of the data. The variance
seems to be acceptably stable for the whole range of fitted val-
ues. Only for fitted values between 9 and 11 there is an indica-
tion of heteroscedasticity.
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4.2.2 Residuals versus Age
(a) residuals vs. age assuming a nor-
mal distribution
(b) residuals vs. age assuming a
BCCG distribution
(c) residuals vs. age assuming a BCT
distribution
(d) residuals vs. age assuming a
BCPE distribution
Figure 22: Residuals plotted vs. age for four assumed underlying dis-
tributions.
The residuals plotted against age show no pattern if the as-
sumptions are met. Figure 22 shows the respective plots. The
fit with the presumption of an underlying normal distribution
shows again remarkable skewness indicating the inadequacy
of presumed normality. No age-dependent patterns are seen.
Therefore, the value-age relationship seems to be modeled ade-
quately.
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4.2.3 Kernel Density Plots
(a) kernel density of the residuals
assuming a normal distribution
(b) kernel density of the residuals
assuming a BCCG distribution
(c) kernel density of the residuals
assuming a BCT distribution
(d) kernel density of the residuals
assuming a BCPE distribution
Figure 23: Density plots of the residuals for the four assumed under-
lying distributions and the respective empirical parame-
ters. The dashed line depicts the pdf of the standard normal
distribution.
The empirical density of the residuals is plotted in Figure 23
in comparison with the density of the standard normal distri-
bution. In addition, the empirical mean, the empirical variance,
and the empirical coefficients of skewness and kurtosis can be
compared with the respective parameters of the standard nor-
mal distributions (mean:0, variance:1, skewness:0, kurtosis:3).
The mean and the variance of the residuals are around 0 and 1
resp. for all of the distributions. The skewness differs seriously
from 0 in subplot (a). This becomes evident in the plot as well
as in the parameter estimate. Again, this is caused by the inabil-
ity of the model to adapt for the innate skewness in the data.
The kurtosis is estimated best assuming a BCPE distribution.
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4.2.4 Quantile-Quantile Plots
(a) normal quantile-quantile plot as-
suming a normal distribution
(b) normal quantile-quantile plot
assuming a BCCG distribution
(c) normal quantile-quantile plot as-
suming a BCT distribution
(d) normal quantile-quantile plot
assuming a BCPE distribution
Figure 24: Normal quantile-quantile plots for the four assumed un-
derlying distributions. Substantial deviations from normal-
ity are seen in subplot (a).
A further plot for comparing the distribution of the residuals
with a standard normal distribution is the normal quantile-
quantile plot (QQ-plot) or normal probability plot. The quantiles
of the empirical distributions are plotted against the theoretical
quantiles of a standard normal distribution (unit normal quan-
tiles). In the case of approximately normally distributed residu-
als the points are near the line. Figure 24 shows the respective
plots for the different models fitted to triceps data. In Figure
25, nine examples of normal quantile-quantile plots are shown.
The data are randomly sampled from a normal distribution.
We see that deviations especially in the tails are not necessarily
compelling reasons to reject the normal assumption. Therefore,
with an exception of the first model (underlying normal distri-
bution – subplot (a)) all QQ-plots show acceptable characteristics.
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Figure 25: Examples of normal QQ-plots for nine different random
samples from a normal distribution.
4.2.5 Worm Plots
A worm plot is a detrended QQ-plot. Instead of plotting the em-
pirical quantiles against the unit normal quantiles the differ-
ence [empirical quantiles - the unit normal quantiles] is plotted
against the unit normal quantiles. Therefore, the vertical dis-
tance of a residual to the x-axis is the difference between the
empirical and the respective theoretical quantile. The plot was
introduced 2001 by Buuren and Fredriks and it is called worm
plot because the points plotted form a wormlike string [11]. The
shape of the worm indicates how well the model fits the data.
In Table 3, the interpretation of different patterns are given. In
addition, the plot contains the 95% confidence interval of the
unit normal quantiles as two elliptic curves symmetric to the
x-axis. An appropriate model fit results in about 95% between
and about 5% of the points outside the two elliptic curves. Fig-
ure 26 shows the worm plots of the four different models. The
worm plot depicting the fit assuming an underlying normal dis-
tribution indicates a mean fitted too high (worm passes below
the origin) and a skewness fitted too low (worm has a U-shape).
The worm plots regarding the BCCG and the BCT distribution
show clear S-shaped patterns with the left bent up. Therefore,
the tails of the fitted distribution seem to be too heavy. The fit
assuming an underlying BCPE appears to be the most appropri-
ate but also shows a mean fitted slightly too high. There might
also be some problems with the tails. Worm plots can be plot-
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ted stratified by age intervals to evaluate the fit dependent on
age. Figure 27 shows nine worm plots for nine different age in-
tervals of the model fitted assuming an underlying normal dis-
tribution. The fitting problems are present for all age categories.
The BCCG based model fit the data very well in low ages but is
not able to model the changing kurtosis in higher ages. This is
also true for the BCT based model: the residuals are platykurtic
(i.e. the resulting coefficient of kurtosis < 3, see also 23). Again,
the model based on the BCPE distribution appears to fit the data
best.
Figure 26: Worm plots of the normalized quantile residuals for the
four assumed underlying distributions.
Shape of worm Residuals Fitted distribution
worm above the origin mean too low location to low
worm below the origin mean too high location too high
worm has a positive slope variance too high scale too low
worm has a negative slope variance too low scale too high
worm U-shaped positive skewed skewness too low
worm inverted U-shaped negative skewed skewness too high
worm S-shaped left bent down leptokurtosis tails too light
worm S-shaped left bent up platykurtosis tails too heavy
Table 3: Different shapes of a worm plot indicate different problems
of model fit. Adapted from [11] and [71]
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Figure 27: Multiple worm plot of the normalized quantile residuals
for the model fitted assuming an underlying normal distri-
bution.
Figure 28: Multiple worm plot of the normalized quantile residuals
for the model fitted assuming an underlying BCCG distri-
bution.
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Figure 29: Multiple worm plot of the normalized quantile residuals
for the model fitted assuming an underlying BCT distribu-
tion.
Figure 30: Multiple worm plot of the normalized quantile residuals
for the model fitted assuming an underlying BCPE distribu-
tion.
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4.3 numerical statistics
4.3.1 Observed and Expected
The appropriateness of the model can also be described by
comparing the expected proportion below a particular quantile
curve with the observed proportion. The observed proportions
for selected centiles are given in Table 4. The observed propor-
tions regarding the 1st centile range between 0.0005 (normal
distribution) and 0.0095 (BCPE distribution). Compared to the
expected value of 0.01 we find the BCPE based model to have
the best fit. The estimates of the 1st percentile resulting from
the model based on the normal assumption are too low result-
ing in too small a proportion of values below the 1st percentile.
The same is true for the 5th percentile. The 10th percentile is
fitted well but the fitted median is slightly too high for the
BCCG, BCT, and BCPE based models. The observed proportions
are rather high for the normal based model, indicating an over-
estimation of the percentile curves. The remaining percentiles
show an acceptable fit for all distributions, but in the model
based on the normal assumption an increasing tendency to un-
derestimate the outer percentile curves becomes apparent. Al-
together, the fits of the three models using the BCCG, BCT, and
BCPE distributions are acceptable. The BCCG and the BCT mod-
els show slightly inferior estimates of the extreme percentile
curves.
dist P01 P05 P10 P50 P90 P95 P99
NO 0.0005 0.0043 0.0170 0.6067 0.8814 0.9211 0.9676
BCCG 0.0058 0.0401 0.0945 0.5176 0.8821 0.9507 0.9960
BCT 0.0056 0.0417 0.0969 0.5155 0.8808 0.9511 0.9970
BCPE 0.0095 0.0436 0.0901 0.5254 0.8914 0.9462 0.9922
Table 4: The observed proportions of values below the 1st, 5th, 10th,
50th, 90th, 95th, and 99th percentiles can be compared to
evaluate the fit. This is again done using the models for
the NHANES triceps data assuming the four different distri-
butions.
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This comparison can also be done for separate age ranges to
evaluate the fit dependent on age (Table 5). We find some age-
dependent patterns in the fit. The tendency to underestimate
the 1st and 10th percentile curve in the normal based model in-
creases with age. For higher ages, there is a tendency to under-
estimate the 1st percentile curve also present for the BCCG and
the BCPE model. The weakness of these two models in the esti-
mation of the extreme percentile curves becomes more promi-
nent in higher age groups.
age intervals
perc distribution (0.147,5.1] (5.1,10] (10,15] (15,19.9]
P01 NO 0.0017 0.0000 0.0000 0.0000
BCCG 0.0076 0.0086 0.0035 0.0036
BCT 0.0068 0.0090 0.0035 0.0036
BCPE 0.0066 0.0105 0.0098 0.0118
P10 NO 0.0463 0.0064 0.0063 0.0006
BCCG 0.0880 0.1027 0.0920 0.0980
BCT 0.0948 0.1042 0.0920 0.0980
BCPE 0.0890 0.0990 0.0854 0.0890
P50 NO 0.5747 0.6399 0.5944 0.6294
BCCG 0.5106 0.5297 0.5106 0.5225
BCT 0.5045 0.5282 0.5106 0.5228
BCPE 0.5067 0.5387 0.5224 0.5396
P90 NO 0.9001 0.8857 0.8594 0.8763
BCCG 0.9018 0.8812 0.8651 0.8752
BCT 0.8974 0.8808 0.8654 0.8752
BCPE 0.8979 0.8857 0.8867 0.8922
P99 NO 0.9747 0.9623 0.9692 0.9619
BCCG 0.9895 0.9963 0.9997 1.0000
BCT 0.9932 0.9959 0.9997 1.0000
BCPE 0.9907 0.9914 0.9917 0.9950
Table 5: The observed proportion of values below the 1st, 10th, 50th,
90th, and 99th percentiles per age group.
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4.3.2 Q-Statistics
If the model fits the data, the normalized quantile residuals
are normally distributed. The Q-test procedure investigates the
distribution of residuals in several age ranges including tests
for location, scale, skewness and kurtosis (Z1, . . . ,Z4) and is de-
scribed in detail, for example, in [65, 71, 51]. The Q.stats()
function implemented in the gamlss package [72] provides a
convenient interface for the inspection of the Q-Statistics. The
results are presented as a table as well as a chart. Z-values be-
low -2 or above 2 indicate deviation from normality. The Q-
statistics are sensitive to age dependencies of the first four mo-
ments of the distributions of the residuals and to non-normality
of the resulting Z-scores. The D’Agostini K2 statistic given by
K2 = Z23 + Z
2
4 tests the deviation from a skewness of 0 and a
kurtosis of 3 simultaneously.
As an example, the resulting tables for the normal and the
BCPE model (the worst and best model so far) are displayed in
Table 6. In the case of the normal-based model, the deviation
of the empirical from the theoretical 3rd moment (skewness) is
striking. In the case of the BCPE model, the mean differs signifi-
cantly from 0 in 5 of 12 age groups. The low p-values of the re-
spective Q-statistics indicate deviation from the assumption of
age-independent, normally distributed residuals for both mod-
els.
dist age Z1 Z2 Z3 Z4 Agost- N
ino K2
NO 0.13 to 1.04 1.31 3.8 8.78 3.93 92.49 1169
1.04 to 2.29 -1.66 -2.21 12.05 8.35 214.86 1110
2.29 to 3.96 0.54 -4.31 14.66 10.75 330.52 1110
3.96 to 5.96 0.19 0.87 20.76 14.29 635.11 1141
5.96 to 7.96 -1.9 -0.71 16.46 9.46 360.29 1115
7.96 to 10.04 0.24 1.54 13.6 5.59 216.17 1135
10.04 to 12.12 2.42 1.52 10.94 0.76 120.19 1153
12.12 to 13.62 1.07 -0.19 10.88 1.04 119.56 1088
13.62 to 15.29 -0.82 -0.7 12.61 2.47 165.19 1152
15.29 to 16.79 -1.54 -0.99 13.68 4.78 209.94 1085
16.79 to 18.38 0.31 0.15 13.73 4.69 210.57 1153
18.38 to 19.96 0.19 0.22 14.59 6.32 252.73 1093
TOTAL Q 18.65 45.41 2309.45 618.17 2927.62 13504
df for Q 5 9 12 12 24 0
continue next page
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dist age Z1 Z2 Z3 Z4 Agost- N
ino K2
p-val for Q 0 0 0 0 0 0
BCPE 0.13 to 1.04 1.67 1.79 -0.13 -1.09 1.2 1169
1.04 to 2.29 -1.75 -0.84 1.88 1.17 4.92 1110
2.29 to 3.96 0.47 -1.91 -1.89 7.14 54.54 1110
3.96 to 5.96 -0.28 -2.06 1.21 2.07 5.73 1141
5.96 to 7.96 -2.52 0.89 -0.07 -0.19 0.04 1115
7.96 to 10.04 0.07 1.86 0.18 -3.01 9.12 1135
10.04 to 12.12 2.25 0.61 -0.81 -0.53 0.93 1153
12.12 to 13.62 0.39 -0.17 -0.94 1.03 1.94 1088
13.62 to 15.29 -2.06 -0.91 1.61 0.14 2.62 1152
15.29 to 16.79 -2.79 -0.42 1.77 0.98 4.1 1085
16.79 to 18.38 -0.92 0.98 -0.74 1.75 3.61 1153
18.38 to 19.96 -0.6 -0.57 0.49 -1.12 1.5 1093
TOTAL Q 30.92 18.75 16.71 73.55 90.26 13504
df for Q 5 9 2.59 8 10.59 0
p-val for Q 0 0.03 0 0 0 0
Table 6: The Q-statistics for different age groups for the BCPE and the
normal model.
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The following part contains the original article. It
was published in the
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2017, Volume 30.
Furthermore, up till now, three articles were pub-
lished using the proposed method.
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O R I G I N A L A RT I C L E
The LMS-type methods described above do not adjust for mul-
tiple measurements or other dependency structures within the
data. Therefore, we combined the method with resampling. The
resulting method is described in the following article.
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Abstract
Background: The interpretation of individual  laboratory 
test results requires the availability of population-
based reference intervals. In children, reference interval 
 estimation has to consider frequently the strong age-
dependency. Generally, for the construction of reference 
intervals, a sufficiently large number of independent 
measurement values is required. Data selections from 
hospitals or cohort studies often comprise dependencies 
violating the independence assumption.
Methods: In this article, we propose a combination of 
LMS-like (mean, M; coefficient of variation, S; skewness, 
λ or L) and resampling methods to overcome this draw-
back. The former is recommended by the World Health 
Organization (WHO) for the construction of continuous 
reference intervals of anthropometric measurements in 
children. The approach allows the inclusion of dependent 
measurements, for example, repeated measurements per 
subject. It also provides pointwise confidence envelopes 
as a measure of reliability.
Results and conclusions: The combination of LMS-type 
methods and resampling provides a feasible approach to 
estimate age-dependent percentiles and reference inter-
vals using unbalanced longitudinal data.
Keywords: biological variation; epidemiology; LMS 
method; reference intervals, reference limits.
Introduction
Laboratory measurement data have to be assessed and 
interpreted using up-to-date and reliable reference 
limits. To determine and to validate reference intervals 
for biomarkers, data have to be collected in large healthy 
or disease-free populations of reference individuals [1]. 
Dependent upon the effect of age and sex as confounding 
variables, reference intervals are estimated for males and 
females and often for discrete age intervals separately. 
Instead of partitioning into subclasses as suggested by 
the guidelines from the Clinical and Laboratory Standards 
Institute [1] a continuous trend can be modeled on age as 
a covariate. Such a modeled trend has to be described as 
age-dependent distribution specified by location, scale 
and shape parameters. Accordingly, reference intervals 
can be determined as quantiles of the underlying distri-
bution. Because of the strong age-dependency of many 
of the laboratory parameters during childhood and ado-
lescence, it is common to express a child’s measurement 
value as standard deviation score (SDS) or Z-scores. By 
this approach, a measured value is described as its differ-
ence from the age-typical expected value (i.e. the center 
of the distribution). The latter distance is measured in 
multiples of one SD. In the context of anthropometric 
measurements, the World Health Organization (WHO) 
recommends SDS values as the best way to assess the 
expression of a measurement value in the context of age 
and sex [2].
In the late 80s/early 90s, the LMS method was intro-
duced by Cole [3] to describe age-dependent distributions 
for different measures. Among others, height [4], weight, 
lung function [5], etc. were modeled through the distribu-
tion parameters for location (mean, M), scale (coefficient 
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of variation, S) and shape (skewness, λ or L). The name 
of the method is derived from the short form of these 
parameters. Each of these parameters is allowed to vary 
smoothly with age: not only the mean might change with 
age, but also the variance and the skewness of the values. 
Provided with this information about the distribution, the 
transformation to normal distributed SDS and therefore 
the calculation of age-independent SDS values is possi-
ble. During the following decades, the LMS method was 
further developed to be able to model even more complex 
distributions including an additional shape parameter for 
kurtosis [6]. The generalization – LMS-type methods – as 
a subgroup of generalized additive models for location, 
shape and scale (GAMLSS) is a semi-parametric univari-
ate regression model where all defining parameters of 
the assumed distribution of the response variable can be 
modeled as additive functions of the explanatory vari-
ables [7]. The method is one of the most widely applied 
approaches in practice [8].
Epidemiological studies are a very interesting data 
source for the establishment of reference values, but their 
data structure is often complex because several relation-
ships between participants or longitudinal series of meas-
urements may be included. LIFE Child is such a study, 
and as part of the Leipzig Research Center for Civilization 
Diseases, it collects data on children from the prenatal 
period to the age of 18 years. The study started in 2011 and 
is ongoing [9]. Blood and urine samples are taken at each 
visit. Anthropometric measures are also obtained at each 
visit. Multiple siblings were and are also included. There-
fore the data contains a complex dependency structure. 
The violation of the independence assumption for the 
subjects causes difficulties in several statistical estimation 
processes like in the aforementioned LMS-type methods. 
On the other hand, the large volume of data, taken from a 
non-diseased and deeply phenotyped population is rare 
and a valuable and suitable source to estimate reference 
intervals. To be able to use all data generated in the LIFE 
Child study we address the problem by a combination of 
LMS-type methods and resampling. Thus we propose a 
new approach for the estimation of reference values using 
unbalanced (i.e. different subjects may contribute differ-
ent numbers of measurements) longitudinal data.
Materials and methods
Subjects
The LIFE child study as part of the Leipzig Research Center for Civi-
lization Diseases is a prospective longitudinal population-based 
cohort study collecting detailed information from pregnancy to ado-
lescence [9]. Blood samples are collected for the measurement of 
basic clinical chemistry, endocrinological and hematological para-
meters at each visit starting at the age of 3, 6 and 12 months followed 
by yearly follow-up visits. Multiple anthropometric measurements 
are obtained in conventional standardized procedures at each visit 
and, in addition, starting at the age of 6 years, via the 3D body scan-
ner [10]. The cohort consists of non-diseased children living in and 
around the city of Leipzig, Germany. They further pass an extensive 
investigation program including family and clinical history and a 
wide range of questionnaires assessing issues of lifestyle, behavior 
and development [11–14]. The LIFE Child study has been registered 
with the trial number: NCT02550236 and was approved by the Ethics 
Committee of the University of Leipzig (Reg. No. 264-10-19042010) [9]. 
All procedures performed were in accordance with the ethical stand-
ards of the institutional research committee and with the 1964 Hel-
sinki declaration and its later amendments. Informed consent was 
obtained from all individual participants (or their parents) included 
in the study.
Laboratory methods
Measurement of serum high-density lipoproteins (HDL) from sub-
jects of the LIFE-cohort (nmeas = 5734, age ± SD [age]: 9.33 ± 4.9 years, 
BMI-SDS ± SD [BMI-SDS]: 0.16 ± 1.1, here SD is the sample standard 
deviation) was carried out by Cobas 8000 clinical chemistry analyzer 
with test kits from Roche Diagnostics GmbH, Mannheim, Germany.
Generalized additive models for location, shape and scale 
(GAMLSS): Modeling a measurement value along with varying age 
as a continuous variable was chosen because it reflects the natural 
development better than an artificial partitioning into age intervals. 
This approach is recommended by the WHO for anthropometric 
measurements but is also applied in the context of laboratory meas-
urements [15]. Also, the widths of the age intervals are arbitrarily cho-
sen and vary from author to author; therefore a continuous approach 
has to be considered as optimal as proposed by the German Society 
for Clinical Chemistry and Laboratory Medicine (DGKL-WG) and oth-
ers [16, 17].
To describe the change in a variable over time, different kinds 
of models – dependent on the nature of the underlying relation-
ships – are applicable. GAMLSS do not only model a mean trend but 
additional parameters to characterize the age-dependent distribu-
tion. The aforementioned LMS-type methods belong to this family of 
models. By the estimation of mean/median, variation, skewness and 
kurtosis over time it provides a description of the desired distribution 
and its change over time.
In the original LMS method, the Box-Cox Cole and Green (BCCG) 
distribution for the response variable is assumed [3]. It can model the 
location (median: μ), a scale parameter (σ) and the skewness (λ) as 
functions of age. In an extended version of the LMS method, a Box-
Cox t distribution (BCT) with age-dependent parameters is assumed 
for the response variable (LMS-T method) [18]. In addition to skew-
ness, kurtosis as a shape parameter is taken into account. However, 
it is only possible to model leptokurtosis (lepto means slender). The 
Box-Cox power exponential (BCPE) distribution [19] facilitates to 
model also meso- and platykurtic distributions – where platy means 
broad and mesokurtic means a kurtosis comparable to the normal 
distribution (LMS-P method). In the latter two distributions, the 
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parameters are usually named as follows: μ (location), σ (scale), 
ν (shape: skewness) and τ (shape: kurtosis). Therefore, the age-
dependent distribution D (age) is described by the tuple of functions
D(age) { (age), (age), (age), (age)}.= µ σ ν τ
Provided with this information, the measurement values can be 
transformed into the respective SDS which are expected to be nor-
mally distributed [1, 7]. Therefore SDS values can immediately be 
transformed into quantiles or percentiles. In [2] the Box-Cox power 
exponential and therefore the LMS-P method is proposed because it 
can model lepto-, platy- and mesokurtic distributions and is, there-
fore, the most flexible of the LMS-type methods. However, sometimes 
choosing the simpler BCCG or the BCT distribution seem to be more 
appropriate, e.g. when convergence problems occur or if the empiri-
cal distribution justifies the choice. The estimation of the distribu-
tion parameters allows for normalizing according to age which is a 
pre-condition for the construction of reference intervals based on the 
normal distribution (i.e. it allows the calculation of SDS).
GAMLSS is a semiparametric method, i.e. whereas one assumes 
a predefined distribution described by varying parameters with vary-
ing age, the effect of the explanatory variable (i.e. age) is estimated 
using non-parametric procedures. Accordingly, we do not assume 
any predefined functional relationship between age and the meas-
urement value.
Resampling
The estimation of distribution parameters for location, shape and 
scale according to age using GAM requires the independence of 
measurements. In the LIFE Child study, this independence assump-
tion would be violated by the longitudinal character of the study and 
furthermore by the family relationships (genetics and environment) 
of siblings. The exclusion of all dependent measurements would 
result in a tremendous loss in subjects and measurements and thus 
information. We address this problem by a resampling technique: we 
repeat the estimation process 1000 times, each time using a different 
subsample.
Each time 75% of the families were sampled; in a second step, 
one measurement from all available measurements of each family 
was sampled. We put sampling weights on families and measure-
ments in a way that each person had the same probability to be 
selected. The restriction to only a part of the families is necessary 
because there are families comprising only one measurement and we 
did not want to include these measurements with a probability of one 
(certain event). It is also possible to choose different weights. One can 
choose weights on families and persons in a way that each measure-
ment has the same probability to be selected (instead of each person) 
or to downweigh over-represented subgroups.
The LMS-P method was applied to both genders using a log link. 
For estimation the lms() function from the R [20] package GAMLSS 
[6] was applied. The degrees of freedom for μ were restricted to five 
and for σ to four. For the other parameters, automatic selection of 
smoothing parameters were used [21]. For each estimation during the 
loop, the parameter values were recorded for monthly grid points. 
The final estimates were taken as the mean values of the thousand 
single estimated values. As an additional result, we gained informa-
tion about the precision of our estimates in the form of confidence 
intervals which is essential to judge the validity of the deduced ref-
erence limits [22]. These confidence intervals were available for the 
parameters as well as for the percentile estimates. The confidence 
intervals are calculated as pointwise envelopes simply by calculating 
the quantiles of the replicates at each point.
To assess the stability of the estimates, the percentile estimates 
were compared to the estimates in [23] which arise from the same 
population at an earlier time point (and therefore fewer samples). 
Furthermore, a random subsample of 2000 children (1000 boys and 
girls) were taken as training data set, and the method was applied. 
The resulting reference values were used to transform the raw meas-
urement values of the test data set (composed of the remaining data) 
to SDS. Afterward, the proportions of data points below the 2.5th and 
above the 97.5th percentiles were compared to the expected value of 
2.5%. The same model was applied to (a) a random sample of one 
measurement per child (comprising all children) and (b) to the entire 
set of data points to examine differences in estimates. To assess the 
age-conditional normality of the transformed data resulting from the 
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Figure 1: Estimated percentile curves of HDL.
(A) Estimated percentile curves of HDL for the 2.5th, 10th, 50th, 90th 
and 97.5th percentiles for boys; dashed lines show the estimated 
curves using all data points at once for estimation, the dotted lines 
show the percentile estimates using one measurement per child, 
gray lines (background) show single estimated curves for each 
percentile, black lines show the mean estimated percentile curves. 
(B) Estimated percentile curves of HDL for the 2.5th, 10th, 50th, 90th 
and 97.5th percentiles for girls; dashed lines show the estimated 
curves using all data points at once for estimation, the dotted lines 
show the percentile estimates using one measurement per child, 
gray lines (background) show single estimated curves for each per-
centile, black lines show the mean estimated percentile curves.
Brought to you by | Universitaetsbibliothek Leipzig
Authenticated | mvogel@life.uni-leipzig.de author's copy
Download Date | 6/8/17 9:15 AM
56 original article
4      Vogel et al.: Laboratory reference intervals
final model, worm plots were applied [24]. Trends were verified using 
linear mixed models implemented and available in the lme4 package 
[25, 26].
Results and discussion
We applied the new approach to estimate reference 
values using unbalanced longitudinal data of HDL as an 
example. A total of 2926/2808  measurement values of 
1574/1511 boys/girls aged 0.25–18  years were available. 
The children belong to 1165/1117 families, respectively. 
The models were estimated for boys and girls separately. 
A Box-Cox power exponential distribution conditional on 
age was assumed for the response variable, i.e. the dis-
tribution could be described by parameters for location, 
variation, skewness and kurtosis. The lms() function con-
tained in the aforementioned GAMLSS package was used 
for model fitting. The 1000 time loop containing the mod-
eling for both sexes took about 4 h on a quad-core com-
puter with 16 GB of RAM.
Figure  1A and B shows the smoothed centile curves 
for selected percentiles. The light gray curves visual-
ize the single estimations whereas the dark black lines 
represent the mean estimated curves. The dashed lines 
show the resulting percentile curves using all data points 
at once in a single estimation process, for the estimation 
of the dotted percentile lines, only one measurement per 
child was included. The respective percentile curves are 
very close to each other. This holds as one would expect 
especially for the 50th percentile curves. The deviations 
become larger for the leftmost and the rightmost age 
groups (near 0 and 18 years of age). This is not surprising 
because these are the most unstable regions of estimation. 
For the same reason, the deviations become larger for the 
utmost percentile curves (i.e. the 2.5th and the 97.5th). 
This is more dominant for the estimates in girls. However, 
the effect is small. The effect may be larger for more het-
erogeneous data originating from a non-healthy or mixed 
population. Over-representation of peculiar values would 
cause a bias towards the extremes especially in the lowest 
and highest percentiles (persons having peculiar labora-
tory values tend to be checked more often than healthy 
individuals). Estimates and confidence intervals of the 
final estimates are stated in Tables 1 (boys) and 2 (girls).
The proportion below the 2.5th and above the 97.5th 
percentile in the test data is 2.25/3.69% and 2.97/2.71%, 
respectively, for boys/girls (expected 2.5%). Figure 2A 
Table 1: 2.5th, 10th, 50th, 90th, 97.5th percentile values for HDL in boys aged 0.5–17.5 including 95% confidence interval.
Age   P02.5  P02.5 CI  P10  P10 CI  P50  P50 CI  P90  P90 CI  P97.5  P97.5 CI
0.5   0.596  (0.540, 0.657)  0.758  (0.720, 0.799)  1.108  (1.073, 1.145)  1.565  (1.499, 1.631)  1.893  (1.770, 2.014)
1.0   0.624  (0.572, 0.677)  0.785  (0.750, 0.822)  1.135  (1.106, 1.166)  1.580  (1.528, 1.632)  1.884  (1.785, 1.981)
1.5   0.657  (0.605, 0.708)  0.819  (0.782, 0.856)  1.170  (1.141, 1.200)  1.607  (1.563, 1.655)  1.894  (1.810, 1.977)
2.0   0.697  (0.643, 0.751)  0.859  (0.820, 0.899)  1.214  (1.182, 1.247)  1.649  (1.603, 1.696)  1.923  (1.845, 1.997)
2.5   0.742  (0.689, 0.799)  0.906  (0.863, 0.949)  1.268  (1.233, 1.303)  1.705  (1.655, 1.752)  1.970  (1.889, 2.042)
3.0   0.791  (0.736, 0.850)  0.957  (0.911, 1.000)  1.327  (1.289, 1.364)  1.769  (1.715, 1.822)  2.029  (1.947, 2.102)
3.5   0.839  (0.783, 0.899)  1.007  (0.963, 1.052)  1.386  (1.348, 1.426)  1.836  (1.779, 1.892)  2.095  (2.008, 2.167)
4.0   0.884  (0.826, 0.943)  1.055  (1.012, 1.100)  1.442  (1.404, 1.483)  1.899  (1.840, 1.957)  2.158  (2.070, 2.229)
5.0   0.957  (0.900, 1.016)  1.134  (1.092, 1.176)  1.536  (1.500, 1.575)  2.008  (1.950, 2.064)  2.271  (2.187, 2.342)
6.0   1.006  (0.949, 1.065)  1.190  (1.150, 1.233)  1.606  (1.569, 1.646)  2.096  (2.042, 2.153)  2.372  (2.296, 2.446)
7.0   1.031  (0.977, 1.086)  1.225  (1.186, 1.265)  1.655  (1.619, 1.691)  2.167  (2.114, 2.220)  2.465  (2.387, 2.539)
8.0   1.032  (0.983, 1.081)  1.232  (1.196, 1.270)  1.678  (1.643, 1.713)  2.215  (2.154, 2.270)  2.540  (2.449, 2.620)
9.0   1.014  (0.971, 1.062)  1.216  (1.184, 1.252)  1.674  (1.639, 1.710)  2.239  (2.176, 2.299)  2.584  (2.486, 2.674)
10.0   0.992  (0.953, 1.037)  1.188  (1.156, 1.221)  1.649  (1.614, 1.684)  2.229  (2.165, 2.289)  2.582  (2.480, 2.683)
11.0   0.963  (0.928, 1.000)  1.149  (1.119, 1.180)  1.600  (1.568, 1.632)  2.180  (2.122, 2.240)  2.528  (2.431, 2.626)
12.0   0.924  (0.893, 0.959)  1.097  (1.069, 1.129)  1.534  (1.502, 1.568)  2.104  (2.045, 2.160)  2.441  (2.347, 2.527)
13.0   0.889  (0.859, 0.920)  1.049  (1.020, 1.078)  1.466  (1.433, 1.500)  2.021  (1.966, 2.077)  2.348  (2.266, 2.426)
14.0   0.871  (0.840, 0.910)  1.019  (0.991, 1.051)  1.414  (1.383, 1.451)  1.951  (1.898, 2.008)  2.267  (2.187, 2.346)
15.0   0.876  (0.839, 0.920)  1.013  (0.984, 1.045)  1.384  (1.350, 1.422)  1.896  (1.841, 1.956)  2.199  (2.119, 2.274)
15.5   0.885  (0.842, 0.936)  1.015  (0.984, 1.049)  1.373  (1.336, 1.412)  1.871  (1.809, 1.931)  2.165  (2.088, 2.238)
16.0   0.895  (0.845, 0.956)  1.019  (0.984, 1.058)  1.363  (1.323, 1.407)  1.845  (1.772, 1.913)  2.130  (2.052, 2.200)
16.5   0.906  (0.845, 0.973)  1.024  (0.984, 1.064)  1.354  (1.306, 1.405)  1.819  (1.726, 1.899)  2.094  (2.001, 2.167)
17.0   0.917  (0.839, 0.992)  1.030  (0.977, 1.076)  1.346  (1.282, 1.408)  1.794  (1.667, 1.897)  2.058  (1.942, 2.146)
17.5   0.928  (0.832, 1.008)  1.035  (0.965, 1.096)  1.338  (1.254, 1.420)  1.770  (1.607, 1.902)  2.024  (1.868, 2.134)
CI, confidence interval.
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Table 2: 2.5th, 10th, 50th, 90th, 97.5th percentile values for HDL in girls aged 0.5–17.5 including 95% confidence interval.
Age   P02.5  P02.5 CI  P10  P10 CI  P50  P50 CI  P90  P90 CI  P97.5  P97.5 CI
0.5   0.612  (0.487, 0.713)  0.775  (0.717, 0.824)  1.138  (1.097, 1.179)  1.614  (1.535, 1.689)  1.930  (1.810, 2.049)
1.0   0.638  (0.536, 0.724)  0.801  (0.754, 0.844)  1.152  (1.119, 1.187)  1.598  (1.539, 1.657)  1.890  (1.791, 1.987)
1.5   0.668  (0.581, 0.744)  0.831  (0.791, 0.872)  1.174  (1.142, 1.208)  1.598  (1.549, 1.647)  1.872  (1.786, 1.959)
2.0   0.703  (0.625, 0.773)  0.866  (0.826, 0.907)  1.205  (1.171, 1.239)  1.615  (1.567, 1.662)  1.878  (1.796, 1.962)
2.5   0.741  (0.669, 0.807)  0.906  (0.865, 0.949)  1.244  (1.206, 1.280)  1.648  (1.600, 1.697)  1.905  (1.823, 1.989)
3.0   0.782  (0.712, 0.849)  0.948  (0.905, 0.993)  1.290  (1.252, 1.328)  1.694  (1.641, 1.743)  1.948  (1.864, 2.031)
3.5   0.824  (0.748, 0.891)  0.992  (0.950, 1.036)  1.340  (1.302, 1.377)  1.748  (1.694, 1.800)  2.001  (1.919, 2.081)
4.0   0.865  (0.779, 0.931)  1.035  (0.993, 1.080)  1.389  (1.353, 1.427)  1.804  (1.749, 1.854)  2.058  (1.981, 2.135)
5.0   0.935  (0.828, 1.005)  1.109  (1.066, 1.151)  1.476  (1.442, 1.511)  1.908  (1.851, 1.956)  2.168  (2.093, 2.239)
6.0   0.981  (0.858, 1.054)  1.157  (1.107, 1.200)  1.534  (1.502, 1.568)  1.980  (1.926, 2.030)  2.247  (2.174, 2.313)
7.0   1.011  (0.883, 1.082)  1.187  (1.134, 1.226)  1.566  (1.537, 1.599)  2.017  (1.966, 2.068)  2.285  (2.213, 2.355)
8.0   1.031  (0.922, 1.090)  1.204  (1.158, 1.238)  1.580  (1.551, 1.610)  2.026  (1.980, 2.075)  2.289  (2.222, 2.352)
9.0   1.033  (0.952, 1.082)  1.201  (1.167, 1.230)  1.574  (1.548, 1.602)  2.014  (1.970, 2.058)  2.265  (2.197, 2.332)
10.0   1.011  (0.955, 1.053)  1.178  (1.149, 1.209)  1.557  (1.530, 1.584)  1.997  (1.956, 2.035)  2.240  (2.170, 2.308)
11.0   0.970  (0.933, 1.009)  1.140  (1.109, 1.171)  1.532  (1.504, 1.560)  1.982  (1.942, 2.022)  2.221  (2.149, 2.290)
12.0   0.926  (0.888, 0.967)  1.099  (1.067, 1.133)  1.508  (1.479, 1.536)  1.970  (1.926, 2.012)  2.207  (2.132, 2.280)
13.0   0.897  (0.861, 0.935)  1.074  (1.044, 1.105)  1.497  (1.468, 1.526)  1.972  (1.925, 2.014)  2.206  (2.131, 2.275)
14.0   0.891  (0.853, 0.931)  1.073  (1.043, 1.103)  1.507  (1.478, 1.537)  1.990  (1.949, 2.031)  2.227  (2.163, 2.290)
15.0   0.908  (0.870, 0.948)  1.098  (1.069, 1.130)  1.539  (1.509, 1.567)  2.027  (1.987, 2.069)  2.273  (2.212, 2.333)
15.5   0.924  (0.887, 0.966)  1.120  (1.088, 1.155)  1.561  (1.530, 1.591)  2.051  (2.009, 2.094)  2.305  (2.236, 2.370)
16.0   0.943  (0.905, 0.988)  1.145  (1.111, 1.184)  1.587  (1.554, 1.618)  2.077  (2.029, 2.124)  2.341  (2.253, 2.424)
16.5   0.965  (0.918, 1.017)  1.173  (1.134, 1.221)  1.613  (1.577, 1.650)  2.101  (2.039, 2.163)  2.376  (2.261, 2.490)
17.0   0.988  (0.930, 1.053)  1.203  (1.150, 1.260)  1.638  (1.593, 1.685)  2.122  (2.042, 2.209)  2.409  (2.264, 2.560)
17.5   1.012  (0.939, 1.100)  1.235  (1.169, 1.306)  1.663  (1.604, 1.722)  2.141  (2.042, 2.253)  2.439  (2.257, 2.643)
CI, confidence interval.
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Figure 2: Worm plots as detrended QQ plots.
(A) Worm plots as detrended QQ plots showing the fit of the final model for boys for four age groups: 0.15–4, 4–8, 8–12 and 12–18 years. 
(B) Worm plots as detrended QQ plots showing the fit of the final model for girls for four age groups: 0.15–4, 4–8, 8–12 and 12–18 years.
and B shows detrended QQ plots (worm plots) [22] for the 
final model for boys and girls for four age groups. The 
plots show the empirical quantiles of residuals plotted 
against the theoretical quantiles for each of the age groups 
0.16–4, 4–8, 8–12 and 12–18 years like conventional quan-
tile-quantile plots but rotated by 45 degrees. If the model 
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fits the data well the “points” are all near the horizontal, 
straight line at y = 0. Therefore, the residuals seem to be 
very well distributed. It is generally accepted that the con-
fidence intervals for each of the reference limits divided 
by the range of the concerned reference limit should be 
<0.2 [27]. With regard to the 97.5th percentile and ½ year 
steps this holds for all given points except the age of 17 
and 17.5 years in girls and 17.5 in boys. If we look in more 
detail at monthly age values (not shown) the critical 
region starts at the age of 17.25 years with values between 
0.2 and 0.3 for boys and 3 months earlier (17.00 years) for 
girls. As mentioned above this is due to less stable estima-
tion at the lower and upper age limits.
The comparisons with the estimates in [21] of the 10th, 
50th and 90th percentile show only small differences for 
means and confidence limits for all of the three percentiles 
in boys in all age ranges. This holds for the differences 
of the estimates as well as of the lower and upper con-
fidence limits: they were between −0.02 and 0.02  with a 
slight tendency to negative values (mean: −0.01). For girls 
results were similar for the 10th and 50th percentile but 
showed higher deviations for the 90th percentile, there 
we found differences between −0.2 and 0.2 with a mean 
difference around −0.04. The estimation of the upper per-
centiles in girls is more unstable than the estimation in 
boys. However, the magnitude of the fluctuations is still 
acceptable.
Necessary wrappers around the gamlss() and lms() 
functions [6] and functions for resampling, summarizing 
and calculation of the confidence intervals are provided 
as R package [28] and can be downloaded from https://
cran.r-project.org/web/packages/childsds. The package 
also contains functions to summarize the results and to 
create ready-to-use parameter (or LMS) tables. The sds() 
function facilitates the transformation of measurement 
values into SDS. The parameter tables necessary for cal-
culating these SDS values of all mentioned laboratory 
measures are also provided. The package also collects 
additional reference tables from different sources [29–34] 
and will be continuously updated.
Acknowledgments: We would like to thank David Petroff 
for his valuable comments during the writing process.
Author contributions: All the authors have accepted 
responsibility for the entire content of this submitted 
manuscript and approved submission.
Research funding: This publication is supported by 
the Leipzig Research Center for Civilization Diseases, 
University of Leipzig. LIFE is funded by means of the 
European Union, the European Regional Develop-
ment Fund (ERDF), (Grant/Award Number: ‘LIFE-013: 
100232872/713-3000634982’) and the Free State of Saxony 
within the framework of the excellence initiative.
Employment or leadership: None declared.
Honorarium: None declared.
Competing interests: The funding organization(s) played 
no role in the study design; in the collection, analysis and 
interpretation of data; in the writing of the report; or in the 
decision to submit the report for publication.
References
1. Horowitz GL, Altaee S, Boyd JC, Ceriotti F, Garg U, et al. Defining, 
establishing, and verifying reference intervals in the clinical 
laboratory; approved guideline. CLSI document EP28-A3c. 
Wayne, PA: Clinical and Laboratory Standards Institute, 2010.
2. Borghi E, de Onis M, Garza C, Van den Broeck J, Frongillo EA, 
et al. Construction of the World Health Organization child 
growth standards: selection of methods for attained growth 
curves. Stat Med 2006;25:247–65.
3. Cole TJ. The LMS method for constructing normalized growth 
standards. Eur J Clin Nutr 1990;44:45–60.
4. Fredriks AM. Nationwide age references for sitting height, leg 
length, and sitting height/height ratio, and their diagnostic 
value for disproportionate growth disorders. Arch Dis Child 
2005;90:807–12.
5. Quanjer PH, Stanojevic S, Cole TJ, Baur X, Hall GL, et al. Multi-
ethnic reference values for spirometry for the 3-95-yr age 
range: the global lung function 2012 equations. Eur Respir J 
2012;40:1324–43.
6. Stasinopoulos DM, Rigby BA, Akantziliotou C. gamlss: General-
ized additive models for location scale and shape. R Package 
Version 4.4-0. 2016.
7. Stasinopoulos DM, Rigby RA. Generalized additive models 
for location scale and shape (GAMLSS) in R. J Stat Softw 
2007;23:1–46.
8. Wright EM, Royston P. A comparison of statistical methods 
for age-related reference intervals. J R Stat Soc Ser A Stat Soc 
1997;160:47–69.
9. Poulain T, Baber R, Vogel M, Pietzner D, Kirsten T, et al. The LIFE 
Child study: a population-based perinatal and pediatric cohort 
in Germany. Eur J Epidemiol 2017;32:145–58.
10. Glock F, Vogel M, Naumann S, Kuehnapfel A, Scholz M, et al. 
Validity and intra-observer reliability of three-dimensional scan-
ning compared to conventional anthropometry for children and 
adolescents from a population-based cohort study. Pediatr Res 
2017;81:736–44.
11. Dathan-Stumpf A, Vogel M, Rieger K, Thiery J, Hiemisch A, et al. 
Serum lipid levels were related to socio-demographic character-
istics in a German population-based child cohort. Acta Paediatr 
2016;105:e360–7.
12. Rieger K, Vogel M, Engel C, Ceglarek U, Thiery J, et al. Refer-
ence intervals for iron-related blood parameters: results from a 
population-based cohort study (LIFE Child). LaboratoriumsMedi-
zin 2016;40:31–41.
13. Wallborn T, Grafe N, Quante M, Geserick M, Casprzig N, et al. 
Never plan a population based cohort study on a rainy Friday 
after a sunny Thursday. Eur J Epidemiol 2013;28:285.
Brought to you by | Universitaetsbibliothek Leipzig
Authenticated | mvogel@life.uni-leipzig.de author's copy
Download Date | 6/8/17 9:15 AM
original article 59
Vogel et al.: Laboratory reference intervals      7
14. Quante M, Bruckmann S, Wallborn T, Wolf N, Sergeyev E, et al. 
Managing incidental findings and disclosure of results in a pae-
diatric research cohort – the LIFE Child Study cohort. J Pediatr 
Endocrinol Metab 2015;28:75–82.
15. Dortschy R, Rosario AS, Scheidt-Nave C, Thierfelder W, Thamm 
M, et al. Bevölkerungsbezogene Verteilungswerte ausgewählter 
Laborparameter aus der Studie zur Gesundheit von Kindern und 
Jugendlichen in Deutschland (KiGGS). 2009.
16. Haeckel R, Wosniok W, Arzideh F, Zierk J, Gurr E, et al.  
Critical comments to a recent EFLM recommendation for  
the review of reference intervals. Clin Chem Lab Med 
2017;55:341–7.
17. Zierk J, Arzideh F, Haeckel R, Rascher W, Rauh M, et al. Indirect 
determination of pediatric blood count reference intervals. Clin 
Chem Lab Med 2013;51:863–72.
18. Rigby RA, Stasinopoulos DM. Using the Box-Cox t distribu-
tion in GAMLSS to model skewness and kurtosis. Stat Model 
2006;6:209–29.
19. Rigby RA, Stasinopoulos DM. Smooth centile curves for skew 
and kurtotic data modelled using the Box–Cox power exponen-
tial distribution. Stat Med 2004;23:3053–76.
20. R Core Team. R: A language and environment for statistical com-
puting. R Foundation for Statistical Computing, 2016.
21. Rigby RA, Stasinopoulos DM. Automatic smoothing parameter 
selection in GAMLSS with an application to centile estimation. 
Stat Methods Med Res 2013;23:318–32.
22. Solberg HE. Approved recommendation (1987) on the theory of 
reference values. Part 5. Statistical treatment of collected refer-
ence values. Determination of reference limits. Clin Chim Acta 
1987;170:S13–32.
23. Dathan-Stumpf A, Vogel M, Hiemisch A, Thiery J, Burkhardt R, 
et al. Pediatric reference data of serum lipids and prevalence 
of dyslipidemia: Results from a population-based cohort in 
Germany. Clin Biochem 2016;49:740–9.
24. Buuren S van, Fredriks M. Worm plot: a simple diagnostic  
device for modelling growth reference curves. Stat Med 
2001;20:1259–77.
25. Bates D, Mächler M, Bolker B, Walker S. Fitting linear mixed-
effects models using lme4. J Stat Softw 2015;67:1–48.
26. Pinheiro J, Bates D. Mixed-effects models in S and S-PLUS. 
Springer Science & Business Media, 2006.
27. Henny J, Vassault A, Boursier G, Vukasovic I, Mesko Brguljan 
P, et al. Recommendation for the review of biological refer-
ence intervals in medical laboratories. Clin Chem Lab Med 
2016;54:1893–1900.
28. Vogel M. childsds: Data and methods around reference values in 
pediatrics. R Package Version 0.6.1. 2017.
29. De Onis M, Onyango A, Borghi E, Siyam A, Blössner M, et al. 
Worldwide implementation of the WHO child growth standards. 
Public Health Nutr 2012;15:1603–10.
30. Wright CM, Williams AF, Elliman D, Bedford H, Birks E, 
et al. Using the new UK-WHO growth charts. Br Med J 
2010;340:c1140–c1140.
31. Flegal KM, Cole TJ. Construction of LMS parameters for 
the  centers for disease control and prevention 2000 growth 
charts. Natl Health Stat Rep 2013;63:1–4.
32. Neuhauser H, Schienkiewitz A, Rosario AS, Dortschy R, 
Kurth B-M. Referenzperzentile für anthropometrische Ma\s 
szahlen und Blutdruck aus der Studie zur Gesundheit von 
Kindern und Jugendlichen in Deutschland (KiGGS). 2013.
33. Kromeyer-Hauschild K, Wabitsch M, Kunze D, Geller F, Geiss 
HC, et al. Percentiles of body mass index in children and 
adolescents evaluated from different regional German studies. 
Monatsschr Kinderheilkd 2001;149:807–818.
34. Kromeyer-Hauschild K, Dortschy R, Stolzenberg H, Neuhauser 
H, Rosario AS. Nationally representative waist circumference 
percentiles in German adolescents aged 11.0-18.0 years. Int J 
Pediatr Obes 2011;6:e129–37.
Brought to you by | Universitaetsbibliothek Leipzig
Authenticated | mvogel@life.uni-leipzig.de author's copy
Download Date | 6/8/17 9:15 AM
60 original article
6
A RT I C L E S U S I N G T H E P R O P O S E D M E T H O D
At the following pages three articles are presented. The articles
evolved in the context of the LIFE Child study [52], a longitu-
dinal cohort study following children and their families from
pregnancy to adulthood. One of the main objectives is the de-
scription of normal development in terms of value-age rela-
tionships and the age-specific non-pathologic variability. The
dimensions taking into account range from anthropometry, lab-
oratory measurements to behavioral measures. The following
publications are the first of a series concentrating on this aim.
They investigate the age-dependent reference ranges of serum
lipids (total cholesterol, HDL cholesterol, LDL cholesterol, tri-
glycerides), iron related serum parameters (ferritin, hemoglobin,
reticulocytes, transferrin), and liver enzymes (alanine amino-
transferase, aspartate aminotransferase, γ-glutamyltransferase).
• Dathan-Stumpf et al. “Pediatric reference data of serum
lipids and prevalence of dyslipidemia” [20]
• Rieger et al. “Reference intervals for iron-related blood
parameters” [57]
• Bussler et al. “New pediatric percentiles of liver enzyme
serum levels (ALT, AST, GGT): effects of age, sex, BMI and
pubertal stage” [10]
Clinical
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Background: Serum lipid concentrations are thought to be risk factors for the development of cardiovascular
disease. The present study aims to investigate the prevalence of dyslipidemia and provide sex- and age-related
reference values for triglycerides, total cholesterol, LDL and HDL cholesterol as well as apolipoproteins A1 and
B by using modern analytical approaches.
Materials and methods: Venous blood and anthropometric data were collected from 2571 subjects of the
LIFE Child study, aged between 0.5 and 16 years. Age- and gender-related reference intervals (3rd and 97th per-
centiles) were established by using Cole's LMS method.
Results: Serum concentrations of TC, LDL-C, TG and ApoBwere higher in girls than in boys. In girls TC reached
peak levels two years earlier than in boys. Triglyceride levels initially declined until the school age. Until early ad-
olescence there was a steady increase. The LDL-C concentrations in girls and boys followed similar patterns to
that of TC. Up to the age of 8 years, a continuous increase inHDL levels for both sexeswas found. Due to the strong
correlation between HDL-C and ApoA1 (r = 0.87) or rather between LDL-C and ApoB (r = 0.93), the respective
percentiles showed very similar patterns. Dyslipidemia prevalence were as follows: increased TC 7.8%, increased
LDL 6.1%, increased TG 0–9 years 22.1%, increased TG 10–16 years 11.7%, and decreased HDL 8.0%.
Conclusion: Age- and sex-related trends for all parameters are similar to those of the German KIGGS study.
With the exception of HDL cholesterol, the prevalence of dyslipidemias in the German LIFE Child cohort are sim-
ilar to the US-American prevalence.
© 2016 The Canadian Society of Clinical Chemists. Published by Elsevier Inc. All rights reserved.
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1. Introduction
There are a lot of studies showing that overweight and obesity corre-
late with an increased risk for the occurrence of cardiovascular and/or
metabolic disease [1]. Unfortunately, some of thesemechanisms in chil-
dren have not been fully understood until now. Heart and circulatory
diseases are manifested after the fourth decade of life, whereas the for-
mation of atherosclerosis starts at a distinctly earlier age [2]. The serum
lipids are seen as crucial risk factors for the formation of the atheroscle-
rotic disease in later life [3]. Obese children exhibit signiﬁcantly in-
creased values for TG, TC, LDL, VLDL, and ApoB compared to patients
with normal weight [4]. In addition, a signiﬁcant correlation between
the cholesteryl ester transfer protein (CETP) and pediatric obesity
could be established [4]. Normal weight children have in general higher
HDL cholesterol levels than obese ones. The concentration of HDL de-
creases in prepubertal childrenwith progressiveweight gain and devel-
opmental stage [5]. Moreover, there is a positive relationship between
the particle size of LDL and triglycerides. TG are negatively associated
with the particle size of HDL [6]. Children with hypercholesterolemia
have increased oxidized LDL subfractions and higher concentrations in
several inﬂammatory factors such as tumor necrosis factor related mol-
ecules like TNF α. Inﬂammatory processes are thought to play a role in
the development of atherosclerosis [7]. In addition to the clinical labora-
tory assays of classical serum lipids, there are recommendations tomea-
sure apolipoproteins (APO's) [8]. Concentrations of proteins provide
additional information about a potential dyslipidemia. Thus, an in-
creased concentration of ApoB, despite normal values of total cholester-
ol and LDL, is associated with obesity, metabolic syndrome or diabetes,
type 2 [8]. The ApoB/ApoA1 ratio is correlatedwith an increased arterial
stiffness in patients withmetabolic syndrome, measured by pulse wave
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velocity [9]. The discussion illustrates the central importance of refer-
ence values in general and of their clinical interpretation. Age- and
gender-related references represent the basis for clinically diagnostic
and therapeutic decisions particularly in pediatrics. In recent years,
there have been national [10] and international [11] efforts to create ex-
pedient reference values for serum lipids. Unfortunately, the apolipo-
proteins A1 and B were largely excluded. The present study aims to
update reference ranges for TG, TC, LDL and HDL cholesterol usingmod-
ern and current laboratory methods and to determine reference inter-
vals for apolipoproteins A1 and B.
2. Study population and design
The LIFE-Child cohort is a longitudinal study, initiated in July 2011, of
the Leipzig Medical Faculty, Department for Child and Adolescent Med-
icine. The aim of this project is to collect data on growth and develop-
ment of subjects during the time between birth and adolescence as
well as on environmental health determinants [12]. The population, re-
cruited for this study consisted of 2571 children and adolescents of the
LIFE-Child Health cohort and the LIFE-Child Obesity cohort aged be-
tween 0 and 16 years, in the time between 2011 and August, 2015. A
representative cohort for the population of the city of Leipzig and
Caucasian/German population was created by the inclusion of the
Obesity cohort. There were 1345 boys and 1226 girls included in
this analysis. Probands who were treated with lipid-lowering medi-
cation were intended to be excluded. However, none of the subjects
fulﬁlled this criterion. Only healthy subject were included: children
with diseases such as diabetes mellitus, inherited metabolic dis-
eases, chromosomal aberrations and chronic kidney and liver dis-
ease as well as children with acute illnesses such as bronchitis or
otitis media were excluded.
In order to avoid a violation of the independence criteria in the sta-
tistical analysis, 75% of families were selected and from these in turn a
measured value was used. A weighting procedure was carried out de-
pending on the family size and the number of measured values. So
every measurement was drawn with equal probability. For the sample
thus obtained reference values were determined. This procedure was
repeated 1000 times to determine the average estimated values and
their conﬁdence limits. This procedure allows the inclusion of all
existingmeasurement data [13]. Fig. 1 shows the composition of the ref-
erence population. Fig. 2 illustrates the age and sex composition of the
reference population, with the example of ApoB. To underline the rele-
vance of the newly created reference values for clinical practice, the
prevalence of dyslipidemia in the LIFE-Child cohort, as a representative
example of Germany, was determined. Therefore, the cut-off values of
the S2k guideline [30], which are consistent with the American cut-off
values [31], have been taken as a basis.
The study was approved by the Ethical Committee of the University
of Leipzig (reference number: Reg. No. 264-10-19042010). LIFE-Child is
registered by the trial number: NCT02550236. Participants aged
12 years or older actively consent to every examination, while parents
always have to give their written consent in advance.
Fig. 1. Composition of the reference population from the LIFE-Child cohort. The ﬂowchart contains information about excluded subjects.
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3. Lipid measurements
Venous blood was taken from the fasting subjects of the LIFE
study. It was documented if adequate fasting times were not ob-
served. The measurement of laboratory parameters was carried out
at the Institute for Laboratory Medicine of the University Hospital.
The measurement of serum lipids was performed on a ‘Cobas 8000
Clinical Chemistry Analyzer’ with test kits of the company Roche Di-
agnostics GmbH. The determination of the total cholesterol, HDL
cholesterol, LDL cholesterol and triglycerides was performed using
a validated speciﬁc homozygous enzymatic color test. ApoA1 and
ApoB were determined by an immunological turbidity testing. A
conversion of the KiGGS values [mg/dl] to mmol/l was performed
by factor 0.026 in TC, LDL and HDL cholesterol for the comparative
charts (Figs. 4–6).
4. Questionnaires
Standardized questionnaires for fasting state as well as for
sociodemographic factors in families were used as previously de-
scribed [12].
5. Statistical analysis
The distributions of all laboratory parameters weremodeled contin-
uously dependent on age and stratiﬁed by gender. Data wrangling and
analyses were carried out using R [14]. No outliers were eliminated.
Plausibility for all values was tested and ascertained. Age-dependent
distributions and resulting reference intervals were estimated using
an LMS-type method [15], using the respective methods provided by
the gamlss package [16,17]. To avoid violations against the indepen-
dence assumption a resampling method on the entire sample was ap-
plied and the parameters were reestimated 1000 times and results in
ﬁnal estimates and respective conﬁdence intervals [13]. The 3rd (P3),
10th (P10), 50th (P50, median), 90th (P90) and 97th (P97) percentiles
were demonstrated (Figs. 3–8). The corresponding tables for reference
values of all serum lipids (Tables 1–6) and the tables for lambda, mu
and sigma (Tables 7–12) are shown in the Supplements section. The
model quality was checked using Wormplots [18] by the wp function
of the “gamlss” package. The 95%-conﬁdence intervals were calculated
as pointwise envelopes simply by calculating the quantiles of the repli-
cates at each point (Tables 1–6). To determine the correlation of two
laboratory parameters, a linear regression analysis was performed. To
identify the prevalence of mixed dyslipidemia Flat Contingency
Tables were created.
6. Results
Tables 1–6 summarize the reference intervals for the serum lipids
dependent on gender and age. In addition, the smoothened percentiles
(Fig. 3–8) were presented for girls and boys. All in all, 2571 measured
values per parameter were evaluated. Due to relatively low numbers
of subjects in each of the age groups the upper age limit was reduced
from 18 to 16 years.
Initially, the measured values of total cholesterol showed a similar
course for both sexes. First, the values increased continuously to ﬁnally
reach a plateau, only the values of the 90th and 97th percentiles of the
girls were an exception. Until entering school age they showed a steady
decrease. Based on themedian, the girls reached this plateau aged about
8 years, the boys two years later. Compared to the boys, girls reported
signiﬁcantly higher cholesterol values already in early childhood
(p b 0.01). With progressing age the levels of the males approach
those of the females. After reaching the plateau, a gender speciﬁc course
was observed.While the values of the boys fell continuously, the serum
concentrations of the girlswere only subject tominor ﬂuctuations. From
the 50th percentile onward therewas a rise in the curves of the 14-year-
old girls, so the values of the 90th and 97th percentiles recorded the
maximum at 16 years. Table 1 summarizes the gender references. Fig.
3a and b illustrate the corresponding percentiles.
The course of the low density lipoproteins (LDL) of the boys was
very similar to that of the total cholesterol. Based on the median,
serum concentrations remained constant from age 7 for almost
5 years and fell slightly afterwards. In the range of the 3rd and
10th percentiles this trend was less pronounced. Apart from the pe-
riod between 10 and 15 years, girls had signiﬁcantly higher serum
concentrations than boys (p b 0.01). This difference was mainly ob-
served in babyhood to infancy. In the upper percentiles the values
fell up to the age of 13 years in girls. Initially the concentrations of
the 3rd and 10th percentiles recorded slight increases. After age 9
downward trends were documented. Subsequently, the other curves
showed only small ﬂuctuations in the serum concentrations. Table 2
as well as Fig. 4a and b abstract this behavior.
The data of high density lipoproteins (HDL) showed higher concen-
trations in boys than in girls at the age of 2 to 12.5 years (p b 0.01). Up to
the age of 8 years continuous increases in HDL levels could be deter-
mined for both sexes with the particularity of the fall of values in the
90th and 97th percentiles up to the age of 1.5 years in girls. At the age
of 9 a stronger gender distribution was shown. While the values of
boys, especially in the upper percentiles, reached a plateau and fell con-
tinuously afterwards, the curves of the females ran wavy with increas-
ing upward trends from the age of about 14 years. The generated
reference values for age and sex are shown in Table 3. Fig. 5a and b illus-
trate the progression of the percentiles.
Fig. 2. Histogram for age and sex distribution of the reference population from the LIFE-Child cohort (total: n = 2571, males: n = 1345, females: n = 1226).
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The proﬁles of the triglycerides developed equally for both sexes,
only the serum concentrations in girls were signiﬁcantly higher
(p b 0.05). First, a sharp drop of the values could be observed up to
the age of 6 and 6.5 years. This reduction was much less pronounced
in the lower percentiles (P3, P10). Following, these curves showed a
constant course with a minimal upward trend with increasing age.
After the sharp drop in the values, a steady increase was recorded for
both sexes, and the maximum was observed at 12.5 years. Afterwards
the triglyceride levels fell slightly. The examined reference values of
the TG are summarized in Table 4. Fig. 6a and b illustrate the corre-
sponding percentiles.
From the 50th percentile the serum concentrations of ApoA1 in 6 to
12-year-old boys were signiﬁcantly higher compared to those of the fe-
male subjects (p b 0.05). In both sexes the concentrations fell down
until the age of 2 years. Thereafter, the values increased concurrently
until the age of 10. While the serum concentrations of the boys
remained constant from the age of 13, the values of the girls rose
again. Table 5 and Fig. 7a and b sum up this behavior.
With increasing age a slightly decreasing trend in the concentra-
tions for apolipoprotein B was observed, which was most clearly
seen in the ﬁrst 5 years of life. Negligible increases in the 3rd and
10th percentiles were detected for both sexes up to the age of
3 years. Above the 50th percentile, changes were hardly visible in
girls from the age of about 14 years. Serum concentrations of apoli-
poprotein B were higher in girls than in boys (p0–10 years b 0.01),
except for the lower limits from 12.5 years. The corresponding per-
centiles are shown in Fig. 8a and b. Table 6 exhibits their schedular
summary. Similarly to adulthood, a strong correlation between LDL
cholesterol and apolipoprotein B (r = 0.93) as well as HDL choles-
terol and ApoA1 (r = 0.87) was shown.
In addition, the prevalence of dyslipidemia in the LIFE-Child cohort
in Leipzig was regarded as a representative example of Germany and
was compared with the US-American prevalence (Table 13). As evi-
dence of the existence of familial hypercholesterolemia, LDL cholesterol
N4.9 mmol/l was used [32]. Six children had such high LDL concentra-
tions. With 22.1% the presence of a pure hypertriglyceridemia
Fig. 3. Smoothed percentile curves for total cholesterol (mmol/l) in a) males/b) females over the age (0 to 16 years) based on the reference population of the LIFE-Child Cohort (total: n=
2504, males: npers = 1311, nmeas = 2478; females: npers = 1193, nmeas = 2251). Shown are the 3rd (P3), 10th (P10), 50th (P50, median), 90th (P90) and 97th (P97) percentiles. The
dashed lines show the comparative values of the KiGGS study.
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(TG N 1.1mmol/l) in children between 0 and 9 years was recordedmost
frequently.
7. Discussion
It was documented by the investigators if adequate fasting times
were not observed, but it must be added that in children younger than
seven years sobriety cannot be assumed. Values presented for this age
group do not lose their validity, because also in clinical practice sobriety
cannot be guaranteed in very young children. However, for children
from the age of 5 to 6 years families have stated that the recommenda-
tion of fasting was adhered to. Nevertheless, this fact is only important
for triglycerides. A relevant inﬂuence on the other serum lipids is not as-
sumed. In the present study LDL cholesterol was directly determined
and not calculated using the Friedewald formula, which allowed to
avoid the inﬂuence of fasting periods and thus of falsely high calculated
LDL levels.
Obese children and adolescents have an increased risk for the oc-
currence of cardiovascular disease [1]. De Koning et al. show that
anthropometric parameters such as waist circumference or BMI are as-
sociatedwith an adverse lipid proﬁle in the pediatric population [36]. In
our study overweight and obesity are classiﬁed using the 90th and 97th
bodymass index (BMI) percentile cut-offs of Kromeyer–Hauschild [12].
By the purposeful inclusion of the OBESITY cohort in this investigation,
a population representative of the city of Leipzig was created. The prev-
alence of obesity in the LIFE-Child cohort is equal to the prevalence of
obesity in the German population (KiGGS) and the city of Leipzig [37].
When interpreting serum lipids and apolipoproteins in childhood
and adolescence, important aspects, such as gender-based courses and
greater concentration ﬂuctuations, compared to adulthood, are taken
into account. Generally, in healthy children up to 18 years increased
concentrations of lipids can be expected, particularly during the ﬁrst
3 years of life and at the end of puberty [29]. Based on these test results
the age and gender distributions of serum lipids show similar tenden-
cies to those described in previous studies. Possible variations of values
are due to differences in the composition and size of the reference pop-
ulation, the laboratory analytical methods or the statistical approaches
to determine the reference values. The method used in this study for
Fig. 4. Smoothed percentile curves for LDL cholesterol (mmol/l) in a)males/b) females over the age (0 to 16 years) based on the reference population of the LIFE-Child Cohort (total: n=
2503, npers = 1311, nmeas= 2478; females: npers= 1192, nmeas= 2249). Shown are the 3rd (P3), 10th (P10), 50th (P50, median), 90th (P90) and 97th (P97) percentiles. The dashed lines
show the comparative values of the KiGGS study.
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collecting the reference values continuously – rather than for artiﬁcially
created age groups – was only practiced in records of the KiGGS study
[10]. According to a recommendation of the IFCC (International Federa-
tion of Clinical Chemistry and LaboratoryMedicine) andNCCLS themin-
imum of a reference population should include 120 subjects in each age
group, providing that analyzed values are distributed symmetrically
[19]. These required sizes could not be realized in different age groups.
The guideline EP28-A3 of the CLSI (Clinical and Laboratory Standards In-
stitute) noted that quite lower numbers can be tolerated in special sub-
ject collectives, like here in pediatrics [20,21]. In this study, the
statistical approach does not necessarily require the minimum of 120
subjects for any age group: since the complete data set was smoothed
by statistical progressive ﬁtting of the percentiles. Therefore, for prepa-
ration of the reference values of serum lipids, age groups were not nec-
essary. Rather, a distribution over the corrected age was created.
Themeasured reference values in total cholesterol are well in agree-
ment with results of other studies [22–24]. In relation to KiGGS, which
provides a good equivalent regarding location, time frame and use of
statistical method of calculation by Cole, good matches of reference
intervals are largely shown in age and gender [10]. With the exception
of the values in the 97th percentile in girls up to the age of 3.5 years,
the serum concentrations collected in the LIFE-Child study are lower.
We determined peak deviation of 0.3 mmol/l at the age of 1.5 years. In
the 90th and 97th percentiles in boys we observed a maximum devia-
tion of 0.4 mmol/l up to the age of approximately 8 years.
At a glance, the percentile curves for LDL cholesterol in KiGGS al-
ready show greater ﬂuctuations in developing of values [10]. In KiGGS
the curves of boys describe an additional peak at about 4 years. Overall,
the collected values of the Robert Koch Institute were slightly higher up
to the age of 13.5 years. In the 97th percentile, smaller values of
0.3 mmol/l were recorded in LIFE in the range of the ﬁrst peak. In infan-
cy, the curves of LDL levels in girls exceed those of KiGGS. From the 50th
percentile differences of up to 0.3 mmol/l can be detected in this age. In
the range of the lower percentiles, themeasurement results conform to
KiGGS values. Compared to a study published in Washington in 2003,
the values of LIFE-Child are considerably higher for both sexes. This dif-
ference is pronounced much more among girls [25]. However, the
French LDL-reference data are still higher than ours [26].
Fig. 5. Smoothed percentile curves for HDL cholesterol (mmol/l) in a)males/b) females over the age (0 to 16 years) based on the reference population of the LIFE-Child Cohort (total: n=
2504, npers = 1311, nmeas= 2478; females: npers= 1193, nmeas= 2251). Shown are the 3rd (P3), 10th (P10), 50th (P50, median), 90th (P90) and 97th (P97) percentiles. The dashed lines
show the comparative values of the KiGGS study.
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Comparing the trends of the HDL levels of the two German studies,
no large deviations can be observed [10]. Only our readings were higher
in both sexes. Especially in the 90th and 97th percentiles of boys maxi-
mum deviations of 0.3 mmol/l are detected. In addition, the high points
of the percentiles in LIFE will be achieved earlier. Compared to interna-
tional results, the HDL levels in our project measured higher to some
0.4 mmol/l [23]. These differences are particularly clear in the range of
the upper reference intervals [24]. To illustrate the described compari-
sons between KiGGS and the LIFE-Child study visually, graphics (Figs.
4–6) have been created, and they show the respective 3rd, 10th, 50th,
90th and 97th percentiles of both sexes. The values of the KiGGS study
are shown in dashed lines.
Subsequently, we refer to international references because the fol-
lowing serum lipids are not discussed in KiGGS. In juxtaposition to a
study from Saudi Arabia, which included only children from 6 years,
boys in LIFE aged 9–13 years exhibit higher serum concentrations of tri-
glycerides (TG). In 8- to 9-year-old girls the values are below those of
the Arab comparative study. In early adolescence differences to
0.3 mmol/l are indicated for both sexes [23]. Compared to the French
population higher TG values can be noticed from the 90th percentile
in boys and girls [26]. The database of the Canadian Laboratory Initiative
on Pediatric Reference Interval (CALIPER) is a major project that is re-
peatedly referred to in literature [27]. Therein, the published reference
intervals for TG are not listed by gender, but the intervals are much
more generous in scope than in LIFE-Child. In a pilot study of CALIPER,
which also carried out the laboratory analyses using a Roche Cobas sys-
tem the reference data are 0.7 mmol/l higher in children N1 year than
those in our project [28].
In recent years, the apolipoproteins have become increasingly im-
portant [8,9]. In the pubescence the established values for ApoA1 in
Leipzig conﬁrm the results of CALIPER [27]. For boys and girls in the
younger age the Canadian reference intervals are deﬁned less up to
0.2 g/l. This perception is consistent with other studies [24,28]. The col-
lected reference intervals for ApoB are similar to values of the Canadian
Laboratory Initiative [27]. Comparatively, in other studies smaller serum
concentrations were measured [24,28].
In order to make a diagnosis of familial hypercholesterolemia, the
following criteria must be fulﬁlled: positive family history of hypercho-
lesterolemia and premature coronary artery disease or proof of
xanthomas [31]. Due to lack of anamnestic data, pathologically elevated
LDL values N4.9mmol/l in these 6 children are only seen as an indication
of the presence of familial hypercholesterolemia. In literature, the
Fig. 6. Smoothed percentile curves for triglycerides (mmol/l) in a) males/b) females over the age (0 to 16 years) based on the reference population of the LIFE-Child Cohort (total: n =
2504, npers = 1311, nmeas = 2478; females: npers = 1193, nmeas = 2251). Shown are the 3rd (P3), 10th (P10), 50th (P50, median), 90th (P90) and 97th (P97) percentiles.
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prevalence of familial hypercholesterolemia is reported at least 1:500
(=0.2%) [31]. This information coincides with our result.
In other sources higher prevalence of up to 1:137 are referred [32,
33]. Comparing the prevalence of dyslipidemias between Leipzig and
the United States, according to data from the NHANES [30], similar per-
centage frequencies were found (Table 13). The prevalence at LIFE-
Childwere lower by less than 1% than theAmerican comparative values.
Only the frequency of HDL cholesterol b1mmol/lwas found 5–7% lower
than that in the US. In comparison to China the prevalence in Leipzig
was continuously higher by 2–3% for each dyslipidemia [34]. The most
frequently represented pure hypertriglyceridemia (TG N 1.1 mmol/l)
in children between 0 and 9 years should be evaluated critically, be-
cause most of the children in the age range of 0–6 years were often
not sober due to lack of practicality. The composition of the reference
population of this study represents a distortion that stands out, especial-
ly compared to the social distribution in the city of Leipzig [35]. As it
turned out, children from socially disadvantaged families were general-
ly underrepresented in the LIFE-Child study, possibly due to a less pro-
nounced health awareness. In comparison to well-off peers, these
children show unfavorable distributions of serum lipids and their con-
centrations, and, therefore, they might run a higher risk of developing
cardiovascular disease [35]. Consequently, it can be assumed that the
prevalence of non-hereditary dyslipidemias in the population is greater
as determined in this study.
8. Conclusion
By these investigations, current reference values for total cholester-
ol, triglycerides, LDL cholesterol, HDL cholesterol, ApoA1 and ApoB in
children and young peoplewere established, deﬁned bymodern analyt-
ical and statistical methods. In relation to previous (German) studies,
data were completed and presented more speciﬁc about the age by
means of a new methodological approach. With the exception of HDL
cholesterol values b1mmol/l, the prevalence of dyslipidemia in Leipzig,
representative of Germany, showed similar distributions as in the US.
This study corroborates age, gender and puberty-related courses of
the parameters and underlines the need for current reference intervals.
Fig. 7. Smoothed percentile curves for ApoA1 (g/l) in a)males/b) females over the age (0 to 16 years) based on the reference population of the LIFE-Child Cohort (total: n= 2569, npers =
1345, nmeas = 2546; females: npers = 1224, nmeas = 2327). Shown are the 3rd (P3), 10th (P10), 50th (P50, median), 90th (P90) and 97th (P97) percentiles.
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Fig. 8. Smoothed percentile curves for ApoB (g/l) in a) males/b) females over the age (0 to 16 years) based on the reference population of the LIFE-Child Cohort (total: n = 2571, npers =
1345, nmeas = 2546; females: npers = 1226, nmeas = 2329). Shown are the 3rd (P3), 10th (P10), 50th (P50, median), 90th (P90) and 97th (P97) percentiles.
Table 13
Prevalence of dyslipidemia and familial hypercholesterolemia (LDL cholesterol N4.9
mmol/l) in the LIFE-Child cohort (n = 2571), as a representative example of Germany.
Compared to the occurrence of dyslipidemia in the US similar prevalence are shown, with
the exception of HDL cholesterol.
Number of
children
Prevalence Prevalence in
the USb
Total cholesterol N5.2 mmol/l 202 7.8% 8%
LDL cholesterol N3.4 mmol/l 158 6.1% 7%
HDL cholesterol b1 mmol/l 206 8.0% 13–15%
Triglycerides
Children 0–9 years N1.1 mmol/l 583 22.1%
Children 10–19 years N1.5 mmol/l 309 11.7% 12%
LDL N 3.4 mmol/l and TG N 1.5 mmol/l 32 1.2%
LDL N 3.4 mmol/l and TC N 5.2 mmol/l 124 4.8%
LDL cholesterol N4.9 mmol/la 6 0.23% (1:500)
a One of the criteria of familial hypercholesterolemia.
b Prevalence in the United States, according to the data from the National Health and
Nutrition Examination Survey (NHANES) [31].
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Abstract
Background: Pediatric reference intervals for iron-related 
parameters are determined continuously over time from 
a highly standardized sample collection by application of 
the R-package generalized additive models for location, 
scale and shape (GAMLSS), which is little known in labo-
ratory medicine.
Methods: Two thousand seven hundred and seventy-eight 
samples from Leipzig research center for civilization dis-
eases (LIFE) Child participants at the age of 2.5–19 years 
were analyzed on a Sysmex XN-9000 for hemoglobin 
and reticulocytes and on a Roche Cobas 8000 for trans-
ferrin and ferritin. Reference intervals were established 
by repeated model calculation by use of the LMS (λ-μ-σ) 
method from Cole with specifically weighted subsamples.
Results: Continuous and gender-specific reference 
intervals as well as smoothed percentile curves were 
established for hemoglobin, ferritin, reticulocytes and 
transferrin. In the case of repeated model calculations, 
single curves and averaged percentile curves were shown. 
The single curves outlined potential variations of the dif-
ferent parameter trends. The averaged percentile curves 
submitted a stable assessment of curve trends over time 
for iron-related parameters in childhood and adolescence.
Conclusions: For the first time current age- and gender- 
specific reference intervals are available by application 
of the R-package GAMLSS and the laboratory techniques 
applied here. Compared to earlier studies, previous find-
ings can be completed and discrepancies related to differ-
ent methodical approaches, can be pointed out. Relevant 
findings for the diagnosis of iron deficiency anemia, such 
as gender-dependent assessment of hemoglobin starting 
at the age of 11 instead of 15 [according to the World Health 
Organization (WHO)], are presented.
Keywords: child cohort; ferritin; hemoglobin; iron meta-
bolism; LIFE Child; reticulocytes; reference intervals; 
transferrin.
Introduction
Iron represents in quantitative terms the most abundant 
essential trace element in people, and with enzymes 
dependent on it, is involved in important metabolic 
processes, such as oxygen binding and distribution via 
hemoglobin and myoglobin, transmitter production or 
cytokine induction. Inadequate iron intake can have 
many causes and manifests itself in a lack of iron, or 
even iron deficiency anemia, which is the most common 
form of anemia [1]. Clinically, it manifests itself in chil-
dren early, unlike in adults, due to increased demand 
during growth. The symptoms are wide-ranging and may 
even include inhibition of physical, cognitive, mental 
and motor development [2, 3]. Contrary to outdated 
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assumptions, iron deficiency anemia is detected not on 
the basis of a lowering of iron levels, but on the basis 
of a decrease in hemoglobin and ferritin concentrations, 
which are below the age-appropriate mean values by 
more than two standard deviations [4]. Latent iron defi-
ciency may already be detected through a decrease in 
ferritin and an increase in transferrin levels while hemo-
globin remains normal. A decreased reticulocyte count 
in addition to a drop in hemoglobin levels indicates a 
manifest iron deficiency [5, 6].
Reference intervals are used for the clinical inter-
pretation of laboratory results and are thus the basis for 
clinical decisions. Particularly in pediatrics, age-related 
reference intervals are required to take adequate account 
of physical development, nutrition, growth, organ matu-
rity, hormone and immune responses as well as diseases 
during specific age segments. After reference intervals 
had been used for iron-dependent parameters for a long 
time, which had been determined either several decades 
ago or on the basis of hospitalized test subjects, there 
have been a growing number of efforts in recent years 
to devise current reference intervals [7, 8]. These efforts 
have been informed by population-based data on chil-
dren of different ages in the USA (NHANES, 1994; AACC, 
2007) [9–11], Ireland (1997) [12], Canada (CALIPER, 
2009/10/12) [13–15], Germany (KiGGS, 2009 [16]; Zierk 
et al., 2013 [17]), Denmark (2012) [18] and Sweden (2013) 
[19]. Among the total of eight studies mentioned, refer-
ence intervals were specified for hemoglobin in six, for 
ferritin in four, for reticulocytes in two, and for transfer-
rin in four of the studies. Furthermore, only the German 
studies have so far determined reference intervals for 
hemoglobin and ferritin in a continuous manner on 
the basis of age, including reference percentiles, rather 
than using age categories. There are still no continu-
ous reference intervals for transferrin and reticulocytes. 
However, these parameters have until now been con-
sidered parameters with poorly confirmed information 
regarding reference intervals, a situation due to stand-
ardization deficits in measurement procedures as well as 
due to a lack of or poorly verified basic data, particularly 
with respect to children [20]. As a result of these gaps 
described, it is the objective of this paper to determine 
age- and gender- dependent reference intervals, includ-
ing percentile curves, for the parameters hemoglobin, 
reticulocytes, ferritin and transferrin. This is done on 
the basis of a large study population by means of current 
and highly standardized laboratory methods as well as 
in applying the Generalized Additive Models for Loca-
tion, Scale and Shape-R (GAMLSS-R) package, which is 
still relatively unknown in laboratory medicine.
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Figure 1: Histogram for age and gender distribution of the reference 
population from the LIFE Child cohort regarding the first visit (total: 
n = 1779, boys: n = 903, girls: n = 876).
Materials and methods
Study design and participants
The data of participants in the LIFE Child study, aged 2.5–
19 years and from the region of Leipzig, have been used. 
LIFE Child is a sub-project of the “Leipzig Research Center 
for Civilization Diseases” of the University of Leipzig with 
a longitudinal/cross-sectional study design. The study 
received a positive assessment from the competent ethics 
commission (Reg. No. 264-10-19042010). At the beginning 
of each visit, the test subjects and their parents received 
information from a study physician before they had to 
sign a consent form, which was a requirement for par-
ticipating in the study. The data of the test subjects were 
pseudonymized to prevent any conclusions about the indi-
viduals [21]. The participants were not part of a clinical 
cohort, in other words, the computation of reference inter-
vals was primarily based on healthy children and adoles-
cents. Only those measurement time points have been 
factored into the data analysis at which full readings were 
available for hemoglobin, ferritin, reticulocytes and trans-
ferrin. This yielded 2778 measurement time points of 1779 
test subjects representing 1346 families. Figure  1 shows 
the age and gender composition of the random sample 
at each first measurement time point. As regards weight 
distribution, the majority of children (78%) had a normal 
weight, while 7% were underweight, 7% overweight, and 
8% were considered obese. The average age-adjusted BMI 
was 0.1, with a minimum value of –4.6 and a maximum 
value of 4.8. As the age adjustment is based on references 
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according to Kromeyer-Hauschild [22], the minor increase 
in the mean value can be attributed to the increasing trend 
of recent years that has seen children become more over-
weight. It was impossible to rule out that the parameters 
ferritin and transferrin were affected by potential infec-
tions, which is why the same calculations were done for 
this with the measurement time points of a simultane-
ous increase in CRP of  ≥ 5 mg/L (n = 84) being excluded. 
In general, the CRP increase was  ≥ 2.8 to 5.0 mg/L in 5%, 
and  ≥ 5.0 mg/L in 3% of the study participants. For 92% 
of the participants, the CRP level was within the refer-
ence interval. Furthermore, a medication-based iron 
uptake was documented at 0.4% of the measurement time 
points (n = 10). These were not excluded due to their small 
number.
Pre-analysis and analysis
Venous blood samples were taken at the beginning of a 
study day using EDTA whole blood and serum monovettes 
(Sarstedt AG & Co, Nümbrecht, Germany). The samples 
were then sent directly for instant analysis to the central 
laboratory in the same building. Observance of fasting 
times was attempted, but did not constitute an exclusion 
criterion if a participant did not comply. This decision was 
based on the fact that this was not required under either the 
German AWMF [23] guidelines on iron deficiency anemia 
or the World Health Organization (WHO) reports on assess-
ing the iron status [24]. There was no indication of icteric, 
lipemic or hemolytic samples among the available study 
population. For the laboratory analysis of the full blood 
count (including reticulocytes), an automated XN series 
hematology analyzer for in-vitro diagnostics at the clini-
cal laboratory of Sysmex Corporation (Sysmex XN-9000, 
Sysmex Deutschland GmbH, Norderstedt, Germany) was 
used. This device allows for the quantitative determina-
tion and analysis of the status quo and marks the detect-
able blood and body fluid components, especially for 
hemoglobin, using the sodium-lauryl-sulfate-hemoglobin 
method, and for reticulocytes, using fluorescence flow 
cytometry with semiconductor laser technology. Trans-
ferrin was analyzed by means of immunological turbid-
ity tests using a cobas 8000 (c module), and ferritin by 
means of electrochemiluminescence immunoassays using 
a cobas 8000 (e module) (each one from Roche Diagnos-
tics GmbH, Mannheim, Germany). The analytical test pro-
cedures were performed according to the manufacturer’s 
specifications. Only CE-IVD-certified tests approved for 
patients were used. By way of an example, the results of 
the daily quality control measurements of February 2014 
were used to determine the interassay coefficients of vari-
ation. Relative to devices and target values, the interassay 
coefficient of variation for hemoglobin measurements was 
between 0.5% and 1.3% (target values 3.8/7.4/10.3 mmol/L, 
n = 28–37, measured on three modules), for reticulocyte 
measurements between 2.3% and 5% (target values 
50.4/23.4/8.9‰, n = 28–37, measured on two modules), for 
ferritin measurements at 2.7% resp. 1.7% (target values 
23.7 resp. 184 ng/mL, n = 50 resp. 44), as well as for trans-
ferrin measurements at 2.4% (target values 2.01 resp. 
3.28 g/L, n = 47 resp. 40). The respective values were repre-
sentatives of the other measurement periods; intra-assay 
coefficients of variations were not determined in the event 
of low interassay coefficients of variation.
Statistical analyses
The choice of statistical methodology was based on the 
IFCC guideline for establishing reference intervals [25] 
and on the WHO recommendations on the estimation of 
percentiles [26], which were worked out for anthropomet-
ric parameters, but are also increasingly used for other 
parameters. As recommended by the IFCC, the lower and 
upper reference values were the percentiles 2.5 and 97.5 
[25]. A modified LMS (λ-μ-σ) method according to Cole, 
Rigby and Stasinopoulos taken from the WHO recommen-
dations was used [27, 28], which is also implemented in 
the GAMLSS package of the statistics R software [29–31]. 
This was used on the assumption of a Box-Cox power 
exponential distribution (BCPE), which can map normal 
distributions as well as steep and flat peaks, making it 
highly flexible. This way, it was possible to achieve a 
normalization of the age-based distribution, which is a 
requirement for determining reference intervals. These 
distributions are characterized by the parameters median 
(location parameter, μ, M), coefficient of variation (scale 
parameter, σ, S), skew (λ, L) and curvature (shape param-
eters) as a function of age [32, 33]. The approach of esti-
mating the parameters as a continuous function of age 
was preferred, because it provided a better model for 
physiological development than a step-by-step consid-
eration of different age intervals [27]. There were several 
measurement time points for each subject as a result of 
the longitudinal design. At the same time, the cohort con-
sisted of 1346 families, some of whom participated with 
several children. To ensure the independence of the meas-
uring points, as well as to be able to include all measuring 
points (and, thus, all information) in the model, a resam-
pling technique was applied. Sub-samples were assigned 
in a first step by limiting the families to 600, followed by 
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the selection of a measured value for each family. It was 
necessary to limit the number of families, because some 
families had only one measured value, and because the 
probability of factoring such a measured value into the 
calculation was to be  < 1. The sub-sample size of 600 
values proved to be an acceptable subset in this case to 
allow for a maximum number of measured values while 
maintaining an adequate sampling selection. The sam-
pling of a measured value per subject during multiple 
visits was congruent to the family sampling. The weight-
ings were chosen in such way that all measured values 
were equally probable to be obtained. This was followed 
by the calculation of the respective models, done each 
time a thousand times on the basis of the sub-sample of 
600 independent values. Figure 2 shows these calcula-
tions as gray individual curves. The average, estimated 
parameters (location, shape, scale) served as a basis for 
the calculation of the reference values, and are repre-
sented in Figure 2 as black curves. The smaller number 
of subjects in the outer age ranges made it necessary to 
limit the estimates to the age segment 3–16  years (total: 
n = 2522, boys: n = 1312, girls: n = 1210). In order to be able 
to evaluate the effect that infections had on the param-
eters ferritin and transferrin, the calculations for these 
parameters were carried out also with an adjusted dataset 
that did not contain any measurement time points with a 
simultaneously increased CRP ( ≥ 5 mg/L) (total: n = 2446, 
boys: n = 1275, girls: n = 1171). Moreover, PASW Statistics in 
Windows version 18.0 (SPSS Inc.,  Chicago, IL, USA) was 
used for further descriptive analysis.
Results
Using the adjusted statistical method (resampling) 
coupled with the GAMLSS package of the statistics R 
software, it was possible to create for the parameters 
hemoglobin, ferritin, transferrin, and reticulocytes ref-
erence intervals (percentiles 2.5 and 97.5) and smoothed 
percentile curves (percentiles 2.5, 10, 50, 90 and 97.5) 
continuously for age and separately for gender. Biannual 
base points of the respective parameters were calculated 
for the upper and lower reference limits (percentiles 2.5 
and 97.5), the median (M), the coefficient of variation (S) 
and the skew (L) (summarized in the Table included in 
the Supplementry material). As a result of the statistical 
approach, and due to the 1000 calculations of the respec-
tive models, there were just as many individual curves 
that provided an overview of the potential fluctuations in 
the individual parameters. Furthermore, an averaging of 
these individual curves made it possible to realize a stable 
curve assessment. These curves are described in the fol-
lowing for each parameter.
The hemoglobin level rose, on average, from 
7.5 mmol/L at age 3 to 8.3 mmol/L at age 11. A more pro-
nounced gender-specific distribution became apparent 
from that age forward. This was characterized by a stagna-
tion of the curves among the girls and a marked increase 
in the curves for the boys. The girls exhibited a constant 
median of 8.3 mmol/L, while the boys experienced an 
increase in the median to 9.3  mmol/L at the age of 16. 
By way of example, the reference intervals (P 2.5–P 97.5) 
ranged from 6.7 to 9.3  mmol/L for the boys and 6.8–
8.9 mmol/L for the girls aged 3, from 7.3 to 9.3 mmol/L for 
the boys and 7.2–9.2 mmol/L for the girls aged 11, all the 
way to 7.9–10.4 mmol/L for the boys and 7.0–9.1 mmol/L for 
the girls aged 16 (Supplement, Table 1). A look at the indi-
vidual hemoglobin curves revealed blurred upper limits 
(P 90, P 97.5) for children younger than 5 years, with more 
pronounced fluctuations among the boys than among the 
girls, as well as blurred lower limits (P 2.5) for the boys 
older than 15 years.
Ferritin exhibited, for the curves of percentiles 90 and 
97.5, a reduction of the concentration (P 97.5) from 88.0 ng/
mL for the boys and 87.2 ng/mL for the girls aged 3 years to 
78.9 ng/mL for the boys and 75.8 ng/mL for the girls aged 
6.5 years. Then, these curves showed a continuous increase 
up to the age of 16 years, which was more pronounced for 
boys upon reaching 128.4 ng/mL than it was for girls upon 
reaching 112.7 ng/mL. The curves for percentiles 2.5 and 10 
remained largely constant across the ages, with the girls 
showing a slight downward trend from the age of 8 years 
with levels (P 2.5) from 16.6 ng/mL to 8.2 ng/mL at age 16. 
The 50th percentile curves for the boys increased slightly 
across the ages, from 29.7 ng/mL at age 3 to 45.7 ng/mL 
at age 16. For the girls, however, they  remained largely 
unchanged between 33.81 and 35.91 ng/mL (Supplement, 
Table 2). The individual ferritin curves showed potential 
fluctuations in the upper limits (P 90, P 97.5) for both boys 
and girls across the entire age range. In addition, a sub-
group (especially among the girls) began to take form. 
What manifested itself was a single curve grouping that 
exhibited across all percentile curves, but especially from 
the 50th percentile, significantly lower concentrations at 
age 3, increasing concentrations up to the age of 11, and 
a brief drop in concentrations followed by a virtually con-
stant curve in contrast to the averaged curves. As ferritin 
is an acute-phase protein, all measurement time points 
where CRP was increased ( ≥ 5 mg/L) at the same time were 
also excluded from the calculation of percentiles. The esti-
mated reference intervals differed from the values of the 
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Figure 2: Smoothed percentile curves of age (3–16 years) based on the reference population of LIFE Child cohort.
The individual curves are gray and the averaged curves are black for the percentiles 2.5 (P 2.5), 10 (P 10), 50 (P 50), 90 (P 90), and 97.5  
(P 97.5). (A) Hemoglobin curves (mmol/L) for boys. (B) Hemoglobin curves (mmol/L) for girls. (C) Ferritin curves (ng/mL) for boys. (D) Ferritin 
curves (ng/mL) for girls. (E) Reticulocyte curves (per 1000 erythrocytes) for boys. (F) Reticulocyte curves (per 1000 erythrocytes) for girls.  
(G) Transferrin curves (g/L) for boys. (H) Transferrin curves (g/L) for girls.
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entire dataset with respect to the lower reference limit by 
a maximum of 0.7 ng/mL, and with respect to the upper 
reference limit, by a maximum of 6.5 ng/mL.
The relative reticulocyte content was constant across 
all the years of childhood and adolescence for the boys. 
The boys’ median was consistently between 9.1 and 9.2 per 
1000 erythrocytes, with the reference interval (P 2.5–P 97.5) 
ranging from 4.7 to 5.0 to 15.7 and 16.0 per 1000 erythro-
cytes. The girls exhibited greater variability overall: the 
median was between 9.8 and 10.1 per 1000 erythrocytes 
and the reference interval (P 2.5–P 97.5) between 4.9 and 
5.3–18.2 and 19.0 per 1000 erythrocytes (Supplement, 
Table 3). The upper limits (P 97.5) of the individual reticu-
locyte curves were blurred across the entire age range.
The transferrin concentrations, too, were overall 
constant across the ages. There was a slight increase in 
the curves of the percentiles 50, 90 and 97.5 for the girls. 
In total, however, the margin was minor. The median 
was between 2.7 and 3.0 g/L and the reference interval 
(P 2.5–P 97.5) between 2.2. and 2.3-3.2 and 4.0 g/L (Supple-
ment, Table 4). The individual transferrin curves exhib-
ited minor potential fluctuations in the upper (P 97.5) and 
lower limits (P 2.5) of the boys for the outer age ranges 
(under 5 years and over 13 years); for girls, this was the 
case only in the lower age ranges (under 5 years). As trans-
ferrin is an anti-acute-phase protein, all measurement 
time points where CRP was increased ( ≥ 5 mg/L) at the 
same time were also excluded from the calculation of per-
centiles. The estimated reference intervals did not differ 
from those of the entire dataset.
Discussion
The application of the LMS method according to Cole, which 
is integrated into the GAMLSS-R software package, may be 
considered an adequate method for estimating pediatric 
reference intervals. By applying the resampling method 
described, it is possible to include several measurement 
time points per subject and family, while also represent-
ing potential fluctuations as single curves, as well as stable 
curves by averaging the single curves. The curves can be 
represented in a continuous fashion across the ages, which 
is not only recommended by WHO [26], but also helps avoid 
the arbitrary division of age intervals and yields a better 
representation of physiological processes. The pediatric 
reference intervals for the parameters hemoglobin, ferritin, 
reticulocytes and transferrin were not previously worked 
out by means of the analyzers used in this context – Sysmex 
XN-9000 and Roche cobas 8000, c and e modules. This 
satisfies both the requirements of IFCC [25] to determine 
reference intervals in connection with new analytical 
methods and those of the manufacturers [34] regarding veri-
fication on the basis of one’s own reference population.
With the increase in concentrations up to the age 
of 11 years, as described, and the subsequent start of a 
gender-based progression characterized by relative con-
stant concentrations in girls and a strong increase in 
boys, hemoglobin follows a typical trend confirmed by 
previous studies [10, 12, 17, 19, 35, 36]. This can generally 
be attributed to growth during childhood development. 
With the beginning of puberty, the differences can be 
explained on the basis of gender, particularly as a result 
of hormonal factors (erythropoietin stimulation due to 
androgens, or erythropoietin inhibition due to estrogens) 
and the onset of menstruation (blood loss) in girls. The 
studies of KiGGS [16] and Zierk et al. [17] lend themselves 
to comparison due to geographic proximity, timeliness 
and the description of continuous results. When compar-
ing the reference intervals computed in this study with 
those of KiGGS (P 3–P 97), one sees mean deviations 
from the lower reference limits of 0.17 g/dL (maximum 
deviation: 0.38 g/dL) for boys and 0.07 g/dL (maximum 
deviation: 1.66 g/dL) for girls. As for the upper reference 
limits, one sees mean deviations of 0.66 g/dL (maximum 
deviation: 1.65 g/dL) for boys and 0.11 g/dL (maximum 
deviation: 1.76 g/dL) for girls. When comparing the ref-
erence intervals computed in this study with those of 
Zierk (P 2.5–P 97.5), one sees mean deviations from the 
lower reference limits of 0.34 g/dL (maximum deviation: 
0.39 g/dL) for boys and 0.25 g/dL (maximum deviation: 
0.7 g/dL) for girls. As for the upper reference limits, one 
sees mean deviations of 0.12 g/dL (maximum deviation: 
1.15 g/dL) for boys and 0.19 g/dL (maximum deviation: 
0.7 g/dL) for girls. Thus, the deviations from the studies 
mentioned are minor only. Any of the deviations are 
most likely attributable to the different analyzers used 
in the laboratory. It is virtually impossible for the gener-
ated measured values to harmonize perfectly due to the 
technical particulars of the different analyzers (different 
manufacturers, but also different models from a single 
manufacturer) [37]. As has been demonstrated, espe-
cially in the case of hemoglobin, the differences between 
various analyzers are minor compared to other hema-
tological parameters [38]. Furthermore, differences can 
also be attributed to different criteria of inclusion and 
exclusion, as well as to the different statistical methods 
employed in the various studies.
Ferritin tends to be fairly constant in the lower per-
centiles (P 2.5, P 10), while the upper percentiles (P 90, 
P 97.5) are characterized by an increase that starts at the 
age of 6.5 years. The values increased more significantly in 
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young males than in girls. Ferritin stores iron in the liver, 
bone marrow, spleen and other tissues, such as muscles. 
The increase in ferritin from the age of 6.5 years and the 
gender-specific differences are likely due to growth, organ 
maturation processes and hormonal changes, as well as 
the onset of menstruation in puberty. The calculation of 
percentiles to the exclusion of measurement time points 
with increased CRP yields virtually no deviations from the 
calculation that includes all measurement time points. 
This suggests that the statistical approach involving the 
estimate of the averaged percentile curves can compen-
sate for pathological changes to some degree. A decision, 
therefore, was taken in favor of a larger data volume, 
that is, to show the entire dataset in Tables and Figures. 
When comparing the reference intervals computed in this 
study with those of KiGGS (P 3–P 97) [16], one sees mean 
deviations from the lower reference limits of 3.07 ng/mL 
(maximum deviation: 5.39 ng/mL) for boys and 4.07 ng/
mL (maximum deviation: 6.22 ng/mL) for girls. As for the 
upper reference limits, one sees mean deviations of 25.25 
ng/mL (maximum deviation: 42.27 ng/mL) for boys and 
18.81 ng/mL (maximum deviation: 31.33 ng/mL) for girls. 
Comparability with other studies is limited because of the 
difference in the approach of continuous interval determi-
nation and the general separation by gender in this study, 
while other studies employed reference intervals mostly 
for age groups that were not consistently gender-specific. 
By contrast, however, the lower reference limits of the 
CALIPER study [14] were lower than those in the present 
study or those of the KiGGS study. One possible explana-
tion could be the recruitment of hospitalized patients, for 
whom metabolic disorders had been ruled out, but who 
did include orthopedic patients, for example. In other 
words, clinical components might play a role here. In 
a US study done in 2004 [39], ferritin levels exhibited a 
greater variability that was associated with higher upper 
reference limits than those of the present study. Our study 
shows similar variability in the percentiles 2.5–97.5 only 
for adolescents. This, too, might be attributed to the fact 
that the aforementioned study used hospitalized patients 
as reference individuals. It is highly likely that the devia-
tions mentioned can be explained by the difference in the 
recruitment of study populations. There are also indica-
tions that the use of different analyzers is instrumental 
in the discrepancy of findings also where ferritin is con-
cerned [40].
If one uses the cut-off values for hemoglobin and fer-
ritin issued by WHO [41] for diagnosing iron deficiency 
anemia as a basis for comparison, they harmonize with 
the results observed by us only partially, as they do with 
the results of the KiGGS [16] and Zierk et al. [17] studies. 
The WHO hemoglobin cut-off values are gender-specific 
only from the age of 15 years. But, as the current study 
shows, gender-specific differences manifest themselves 
already from the age of 11 years. Girls aged 12 and older 
generally remain below the WHO cut-off values accord-
ing to the lower reference limits calculated in this study. 
When it comes to ferritin, this shortfall of the WHO cut-off 
values, when compared to this study and the KiGGS study, 
is even more significant and manifests itself already in 
girls aged 11. The WHO cut-off values for iron deficiency 
anemia diagnostics should, therefore, be updated.
The reticulocyte count remains largely constant 
across the entire age range, at 5–19 per 1000 erythrocytes, 
which is thus similar to a previously described margin of 
5–15 per 1000 erythrocytes [35]. Previous data on reticulo-
cyte counts have not been uniform. They are comparable 
only to a limited degree due to different representations 
as absolute and relative values. The literature has also 
described fluctuations due to different analyzers on mul-
tiple occasions [38, 42, 43]. Sysmex GmbH has described 
decreasing trends in adulthood [37], which partially 
matches the findings of this study. But, in contrast to the 
Sysmex references, this study has found lower lower refer-
ence limits and mostly higher upper reference limits, espe-
cially in girls. One Swedish study involving children aged 
between 8 and 18 years has demonstrated gender-specific 
differences, with higher concentrations in girls [19]. In 
the present study, this has been proved particularly with 
respect to the upper percentiles (P 50, P 90, P 97.5). The 
reticulocytes constitute the last immature precursor of the 
erythrocytes and will need to be re-created permanently 
to cover the breakdown of the erythrocytes. This is why a 
consistently equal share of reticulocytes is required under 
physiological conditions.
Transferrin is characterized by an overall continu-
ous progression marked by an increase in variability 
among girls aged 12 and older. This has been confirmed 
by a large number of studies [13–15, 18, 19], while the 
subject has been controversial in a few others [39, 44]. 
However, it bears mentioning that the changes occur in 
such a small margin that one cannot assume any relevant 
gender-specific difference. In other words, the reference 
intervals of different studies harmonize well. Transferrin 
acts as a transport protein that allows for the exchange of 
iron between the intestines, iron stores and erythroblasts. 
It responds to iron deficiency by way of an increase, but 
does not appear to be influenced directly by physiological 
development processes.
The potential fluctuations described for the single 
curves in the outer percentiles and outer age ranges reflect 
a reduced stability due to a smaller number of incoming 
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measured values (only the outer 2.5%) as well as a lack 
of data points outside the outer age ranges that could act 
as reference points. But these two factors can be com-
pensated for well by way the mean estimate of the single 
curves. The grouping of ferritin single curves, which has 
also been described, suggests that there is a sub-group 
with a common characteristic. The most likely explana-
tion in this context is that this involves a genetic compo-
nent, such as the representation of a specific ferritin type 
(isoferritin) [45, 46].
The analyses can yield current reference intervals 
for hemoglobin, ferritin, reticulocytes and transferrin in 
children and adolescents, based on a primarily healthy, 
highly standardized sample population. This has been 
done for the first time for the devices used, Sysmex 
XN-9000 and Roche cobas 8000 (c and e modules). 
The statistical GAMLSS R software package has been 
confirmed as an effective means to calculate percentile 
curves and reference intervals. The progressions of the 
parameters have been represented continuously across 
the ages, for the first time for reticulocytes and transfer-
rin, rather than on the basis of age groups. This approach 
maps physiological conditions (smooth transitions 
instead of stepwise approach) and prevents the problem 
of an arbitrary classification of age intervals. Further-
more, the customized statistical method has presented 
a way in which a longitudinal design can be applied to a 
cross-sectional study. In addition, it is possible to include 
family members, without violating the independence 
necessary for the calculations. The repeated model com-
putations and averaging of the resulting single curves 
increase reliability and move the influence of confound-
ers, CRP increases in this case, to the background. The 
individual curves further allow for potential fluctuations 
or special characteristics, such as the ferritin sub-group 
described, to be evaluated. By working out agreements 
and deviations with respect to other studies, factors, 
such as analyzers, criteria of inclusion and exclusion, 
type of age (continuous or grouped) and gender analy-
sis (separated by gender or collectively), clinical aspects 
and statistical methodology, as well as the IFCC recom-
mendation on the regular revision of reference intervals 
can be substantiated. Our study draws attention particu-
larly to a possible revision of the WHO reference inter-
vals for hemoglobin and ferritin.
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Abstract The present study aims to clarify the ef-
fects of sex, age, BMI and puberty on transaminase
serum levels in children and adolescents and to provide
new age- and sex-related percentiles for alanine amino-
transferase (ALT), aspartate aminotransferase (AST)
and γ-glutamyltransferase (GGT). Venous blood and
anthropometric data were collected from 4,126 cases.
Excluded were cases of participants with potential hep-
atotoxic medication, with evidence of potential illness
at the time of blood sampling and non-normal BMI
(BMI < 10th or > 90th ). The resulting data (N =
3,131 cases) were used for the calculations of ALT,
AST, and GGT percentiles. Age- and sex-related ref-
erence intervals were established by using an LMSP-
type method. Serum levels of transaminases follow age-
specific patterns and relate to the onset of puberty. This
observation is more pronounced in girls than in boys.
The ALT percentiles showed similar shaped patterns
in both sexes. Multivariate regression confirmed signif-
icant effects of puberty and BMI-SDS (β = 2.21) on
ALT. Surprisingly, AST serum levels were negatively
influenced by age (β = −1.42) and BMI-SDS (β =
-0.15). The GGT percentiles revealed significant sex-
specific differences, correlated positively with age (β =
0.37) and showed significant association with BMI-SDS
(β = 1.16). Conclusion: Current reference values of
ALT, AST and GGT serum levels were calculated for
children between 11 months and 16.0 years, using mod-
ern analytical and statistical methods. This study ex-
tends the current knowledge about transaminases by
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1 Introduction
The high prevalence of obesity and non-alcoholic fatty
liver disease as well as the early onset of other liver
diseases, require the availability and accuracy of diag-
nostic instruments for detection of liver damage dur-
ing early life. Transaminases are usually present in the
blood at low levels and an increase in their concentra-
tions may indicate damage of liver cells (35 ). Further-
more, hepatic enzyme serum concentrations are associ-
ated with obesity, insulin resistance and type 2 diabetes
in adults (15 ). The World Health Organisation (WHO)
recommends in children the transformation of measure-
ment values into standard deviation scores as the best
way to assess their meaning in the context of age and
sex for anthropometric parameters. This approach has
been progressively applied and extended to other pa-
rameters. In the past seven years, several approaches
have been made to establish new reference intervals
or thresholds for liver enzymes in children (7 , 8 , 10 ,
11 , 24 , 31 , 39 ), particularly for alanine aminotrans-
ferase (ALT). Schwimmer et al (31 ) as well as Molle-
ston et al (22 ) were able to show that the upper limit
of ALT used in childrens hospitals varies widely and
is set too high to detect chronic liver disease reliably.
This could be due to the fact that many of the reference
values in current use have been derived from small co-
horts of healthy or hospitalized individuals or focus on
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a limited age range with arbitrary partitions (11 ). Dis-
crete age groups, however, do not adequately reflect the
continuous changes during biological development and
thus cannot always represent the exact extent and onset
of age-dependent dynamics. Partition into discrete age
groups for both males and females is commonly per-
formed to describe the age and sex dependence of lab-
oratory parameters. A continuous approach with age-
and sex-related percentiles seems to be the appropriate
method for laboratory analytes and will, therefore, be
applied in this study (39 ). Such an approach requires
a large number of samples from healthy children and
adolescents.
1.1 Objectives
We aim to provide new age- and sex-related percentiles
for ALT, aspartate aminotransferase (AST), and γ-glut-
amyltransferase (GGT) based on data from a large co-
hort of primarily healthy and normal weight children
and adolescents between 11 months and 16.0 years of
age (from the LIFE Child cohort, a representative popul-
ation-based cohort in Germany) (23 , 25 ). These per-
centiles are a condition to better evaluate pathologic
liver enzyme serum levels in order to detect children at
risk for chronic liver diseases. We aim to study poten-
tial effects of sex, age, BMI (body mass index = body
weight/(height 2 ) in kg/m2) and puberty on transam-
inase serum levels during early life.
2 Methods
This article is structured according to the STROBE
Statement checklist for cohort studies (37 ).
Study design, clinical study registration and ethnical re-
view LIFE Child is a prospective longitudinal population-
based cohort study with a life course approach to health
and disease. The Leipzig Research Centre for Civiliza-
tion Diseases (LIFE) Child study has been designed to
understand how and through which mechanisms and
mediators (epi) genetic, metabolic and environmental
factors influence health and development in children
and adolescents in modern society (23 , 25 ). The LIFE
Child study was designed pursuant to the Declaration
of Helsinki (2 ) and is registered under the clinical trial
number NCT02550236. The ethical committee of the
University of Leipzig (Reg. No. 264-10-19042010) had
no objection.
Setting Informed and written consent was obtained from
all participants and their parents. Data was pseudo-
nymized according to German data protection law. The
primary program carried out at each study centre visit
includes clinical history, clinical examination, blood col-
lection, hair and urine samples, anthropometry, and dif-
ferent age-dependent questionnaires (23 , 25 ). In this
study, we only included cases with complete datasets
of ALT, AST, GGT, age, and BMI. Samples with too
little sample material for analysis were excluded.
Participants Children residing in Leipzig or neighbour-
ing municipalities between 11 months and 16.0 years
were eligible for participation. The participants of this
study are primarily healthy (no severe diseases like ma-
lignancies, syndromal diseases or diabetes) children and
adolescents. Thus, their data are well suited to calcula-
tion of reference values.
Variables ALT, AST and GGT serum levels were de-
termined in context of sex, age, pubertal stage, and
BMI.
Data sources/measurements At the beginning of ev-
ery visit all children participating in the LIFE Child
study were asked to provide fasting, morning venous
blood. The blood was collected by venipuncture (serum
monovettes, Sarstedt AG&Co, Nmbrecht, Germany).
The analysis was done immediately in the Central Lab-
oratory of the University Hospital Leipzig. ALT and
AST (UV tests), GGT and alkaline phosphatase (colori-
metric tests) as well as high sensitive C-reactive protein
(latex-enhanced immunoturbidimetric test) were mea-
sured with cobas analyzer series (photometric measur-
ing unit, c-module, Roche Diagnostics GmbH, Mann-
heim, Germany). Platelets were measured on the Sys-
mex XN-9000 automated hematology analyzer (Sysmex
Europe, Norderstedt, Germany). Only CE-IVD-certified
laboratory tests approved for diagnostic use were ap-
plied, and all analytical procedures were performed ac-
cording to the manufacturers instruction (25 ). Height
was measured with the stadiometer (Prof. Keller, La¨n-
genmesstechnik GmbH Limbach, Limbach-Oberfrohna,
Germany) with a measurement accuracy of 0.10 cm.
The participants were weighed with the Seca 701 scale
(seca GmbH & Co. KG, Hamburg, Germany) which is
accurate to 50 g. The pubertal stage was assessed ac-
cording to Tanner stages (18 , 19 ) by specially trained
and regularly instructed investigators.
Study size 4,662 complete cases of 2,471 individuals be-
tween the ages of 0 and 18 years from 1,819 families
were available (LIFE Child cohort). To assure to work
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Figure 1 In- and exclusion criteria for the study popu-
lation. Composition of the reference population primarily
healthy and normal weight children and adolescents) from
the LIFE Child cohort. The flowchart contains information
about excluded subjects. SDS = standard deviation score,
ALT = alanine aminotransferase, AST = aspartate amino-
transferase, GGT = γ-glutamyltransferase, illness (hsCRP
> 10 mg/l), underweight (BMI-SDS < 10th percentile), nor-
mal weight (BMI-SDS 10th - 90th percentile), overweight
(BMI-SDS > 90th percentile, < 97th percentile), obese (BMI-
SDS > 97th percentile).
with a primarily healthy and normal weight cohort, we
needed to carry out several steps of exclusion (Figure
1).
1. Cases of children with highly elevated (> 3 standard
deviation score) liver enzyme serum concentrations
were identified and excluded, N = 17 cases.
2. 209 cases were excluded because of the intake of
one of 92 potentially hepatotoxic drugs at the time
of measurement (List of 92 hepatotoxic medications
available in the Supplementary Table 1). Children
with elevated high sensitive C reactive protein serum
levels (> 10 mg/l) were ruled out, N = 63 cases.
3. Due to the small numbers of very young subjects
(younger than 11 months) and older adolescents (older
than 16.0 years), the age range was reduced to 11
months to 16.0 years by the exclusion of N = 310
cases. After these exclusions, our study population
consisted of 4,126 cases (1,953 measurements of girls
and 2,173 measurements of boys) from children be-
tween 11 months and 16.0 years.
4. Due to the well described effect of the BMI on ALT
and GGT (9 , 16 ), the reference population was re-
stricted to children and adolescents with normal
weight (BMI-SDS between the 10 th and 90 th per-
centile).
The resulting data (N = 3,131 cases) were used for
the calculations of ALT, AST, and GGT percentiles.
2.1 Statistical methods
Percentile curves for ALT, AST and GGT were esti-
mated as functions of the covariate age stratified by
sex using a LMS-type method (LMSP) implemented in
the package gamlss (29 ). Assuming a Box- Cox Power
Exponential (BCPE) distribution the LMSP method
of Cole (28 ) models four parameters µ, σ, ν and τ
as a function of age by using a log link. These may
be interpreted as relating to location (median), scale
(centile-based coefficient of variation), skewness (power
transformation to symmetry) and kurtosis (degrees of
freedom) (28 ). Estimation of parameters as continu-
ous functions of age seems to be a more appropriate
approach to reflect the physiological development of
laboratory analytes (27 , 39 ). Since LIFE Child has a
longitudinal study design and recruits families partici-
pated with more than one child, our sampled data con-
tains multiple measurements per child as well as mea-
surements of siblings. Therefore, percentile calculations
had to follow an adapted approach. To maintain the in-
dependence of all measurements, but also consider all
measurements for the calculation, we calculated each
model 1000 times on distinct subsamples of 600 inde-
pendent values (one per family). The weighting was de-
fined to maintain the same probability for each value
to be chosen (36 ). The mean estimated parameter (lo-
cation, scale, shape and kurtosis) built the basis for
the calculation of the reference values. The process was
carried out twice: after the first iteration, all measure-
ment values were transformed into standard deviation
scores, and the exclusion criteria were applied as de-
scribed above. After that, the process was repeated on
the cleaned data set. Finally, percentile curves for the
3rd (P3), 10th (P10), 50th (P50), 90th (P90) and 97th
(P97) centile were calculated. The 3rd and 97th per-
centiles were defined as lower and upper limit of the
reference interval. To determine the strength of the re-
lationship of the different parameters, a hierarchical
linear regression analysis was performed. All regres-
sion analyses were carried out using multivariate linear
mixed models with sex, age, BMI-SDS and pubertal
stage as predictors (Table 1). By adding random effects
on the intercept for the individual nested within its fam-
ily, we accounted for possible correlations between mea-
surements and, therefore, for multiple measurements
per person/family. The Tanner stages (18 , 19 ) were
separated into three groups (Tanner stage 1, stages
2 4 and stage 5 reflecting prepubertal, pubertal and
post-pubertal stages) to emphasize on puberty-specific
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changes in the transaminases serum levels. Analyses
were performed using the package lme4 (3 ) (version
1.1.10) in R version 3.2.3, which accounts for multiple
measurements (R Foundation for Statistical Comput-
ing, Vienna, Austria) (26 )
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Table 1 Sex, age, BMI-SDS, and pubertal stage influence transaminase levels [transaminase SDS levels] in boys and girls. Multivariate linear mixed model regression in
primarily healthy children and adolescent between 11 months and 16 years (N = 3,325 cases from LIFE child study cohort).
Intercept 20.15 [-0.03] 19.32; 20.98 [-0.16;0.09] 46.27 [-0.05] 45.46; 47.08 [-0.18; 0.08] 9.83 [0.02] 9.37; 10.29 [-0.10; 0.14]
Sex (Female)1 -1.65 [-0.05] -2.21; -1.09 [-0.14;0.03] -1.77 [-0.03] -2.32; -1.21 [-0.12; 0.06] -1.17 [-0.00] -1.50; -0.83 [-0.09; 0.08]
Age (years) -0.02 [0.02] -0.13; 0.08 [0.00;0.03] -1.42 [0.01] -1.52; -1.31 [-0.01; 0.03] 0.37 [0.01] 0.32; 0.43 [-0.01; 0.03]
BMI-SDS 2.21 [0.28] 1.85; 2.56 [0.22; 0.33] -0.15 [-0.07] -0.50; 0.20 [-0.13; -0.02] 1.16 [0.26] 0.96; 1.36 [0.21; 0.32]
Pubertal stage2
Pubertal 6.29 [0.41] 3.36; 9.22 [-0.04; 0.87] -1.28 [-0.14] -4.10; 1.54 [-0.62; 0.35] 4.36 [0.51] 2.94; 5.79 [0.10; 0.92]
Post-pubertal -20.67 [-4.34] -31.80; -9.55 [-6.12; -2.57] -20.97 [-3.14] -31.59; -10.36 [-5.06; -1.23] -11.83 [-2.87] -16.84; -6.82 [-4.40; -1.35]
Interactions
BMI-SDS:sex (Female)3 -1.10 [-0.08] -1.50; -0.58 [-0.16; -0.01] -0.51 [-0.07] -0.98; -0.05 [-0.14; 0.01] -0.43 [-0.01] -0.70; -0.16 [-0.08; 0.06]
Pubertal:Age4 -0.53 [-0.03] -0.78; -0.28 [-0.08; 0.00] 0.16 [0.01] -0.08; 0.41 [-0.04; 0.05] -0.41 [-0.05] -0.54; -0.29 [-0.08; -0.01]
Post-pubertal:Age5 1.25 [0.29] 0.48; 2.03 [0.16; 0.41] 1.48 [0.21] 0.75; 2.22 [0.07; 0.34] 0.69 [0.18] 0.34; 1.04 [0.08; 0.29]
Adjuste R2 0.85 [0.64] 0.91 [0.91] 0.87 [0.69]
1 reference: male;
2 pubertal stages using Tanner stages, reference: prepubertal (Tanner stage 1), pubertal (Tanner stages 2 4), post-pubertal (Tanner stage 5);
3 interaction between BMI SDS and sex with male as reference;
4 interaction between pubertal (Tanner stages 2 - 4) and age in years increase/decrease of transaminases serum levels per year;
5 interaction between post-pubertal (Tanner stage 5) and age in years increase/decrease of transaminases serum levels per year;
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3 Results
Description of the study population The reference pop-
ulation used to calculate percentiles is composed of 3,131
cases (53.1% male cases) from 1,746 individuals out
of 1,308 families. Excluded were cases of participants
with potential hepatotoxic medication, potential illness
at the time of measurement and cases of children with
underweight, overweight or obesity. Underweight, over-
weight and obesity were defined by using the 10 th , 90
th and 97 th percentile of the BMI-SDS (BMI standard
deviation score) as cut-offs (38 ). For regression analy-
ses we used the LIFE Child study population including
cases from underweight (7.6%), normal weight (75.9%),
overweight (7.4%) and obese (9.1%) children and ado-
lescents. The mean BMI-SDS of this population was
0.20 for girls and 0.13 for boys; this slightly elevated
mean can be explained by the rising number of over-
weight and obese children and especially adolescents in
Germany over the past decades (14 ). Characteristics of
both populations are represented as mean ( s.d.) and
median values in Supplementary Table 2.
Percentiles of liver enzyme serum levels derived from a
primarily healthy and normal weight pediatric cohort
The smoothed percentile curves (Figures 2, 3, 4) for
ALT, AST and GGT are presented for boys and girls.
The corresponding reference values are represented as
P3, P10, P50 (median), P90 and P97 and tabulated the
coefficient of variation (sigma), the skewness (nu), and
the kurtosis (tau) in half-year age groups and separated
for boys and girls (Supplementary Tables 3-5).
The ALT percentiles show similar shaped pattern
in boys and girls and starting with a peak in infancy,
followed by a drop of the median until the age of 4.0
in girls and 6.5 years in boys. After that decline we
found rising values, which resulted in an earlier ALT
peak in girls (17.7 U/l between 7.5 and 9.5 years) and a
later peak in boys (18.5 U/l at 11.5 years). During early
adolescence, the median ALT serum concentrations fall
continuously in boys and in girls. While this decline was
found in all depicted percentiles in girls, the 90 th and
97 th percentiles in boys remained stable, even slightly
increased. The median ALT serum concentration varies
between 14.0 U/l and 20.3 U/l in girls and between 17.1
U/l and 21.1 U/l in boys. The 97 th percentile, which is
commonly used as cut-off, spans from 24.2 U/l to 31.7
U/l in girls and from 29.9 U/l to 38.0 U/l in boys. The
range between the 3 rd and the 97 th percentile is more
apparent in boys during preschool and adolescence and
more pronounced in girls during puberty.
Both, female and male AST percentiles follow a con-
tinuous downwards trend with increasing age, which
differs considerably from the patterns shown by ALT
and GGT serum levels. Before the age of 11, no signif-
icant sex-specific differences can be found for P50, but
after that age, AST serum concentrations stronger de-
crease in girls. Boys present decreasing medium serum
concentrations, whereas the female percentiles appear
to reach a plateau at 23.1 U/l. The median spans from
23.1 U/l to 46.1 U/L in girls and from 25.7 U/l to 47.6
U/l in boys. The upper limit (97 th percentile) ranges
from 35.2 U/l to 62.9 U/l in females and from 41.5 U/l
to 68.7 U/l in males. All female percentiles curves follow
parallel courses, while enlarging ranges between P3 and
P97 were apparent in boys, especially with the onset of
puberty.
The GGT pattern revealed sex-specific differences.
While there is a continuous increase of P50 in boys
over the whole age span, girls GGT serum levels rise
until they reach a maximum of 12.0 U/l at the age of
9.5 years. After that peak, the serum concentrations
slightly fall to reach a plateau of 11.0 U/l at 13.5 years.
The median serum concentrations vary from 9.5 U/l to
12.0 U/l in girls and from 9.4 U/l to 14.8 U/l in boys.
The upper limit (97 th percentile) ranges from 14.5 U/l
to 18.1 U/l in girls and 14.1 U/l to 27.4 U/l in boys.
The parameter tables for each of the parameters
are provided as part of an R package including conve-
nient functions to transform measurement values into
SDS values. It is openly available from CRAN (http://
CRAN.R-project.org/package=childsds). Practically,
it would so either be possible to calculate the centile/SDS
of a patients value and provide this in addition to the
absolute levels (or the patients level could be plotted
into the curves). This would even provide the opportu-
nity to track the laboratory values longitudinally. Alter-
natively, the normal range could be given in age specific
reference intervals.
Influencing factors on liver enzyme serum levels: Ef-
fects of age, sex, puberty, and BMI All cases between
11 months and 16 years (including all BMI s) with
complete data regarding modelling were considered for
the multivariate regression analysis. Regression analy-
ses were performed twice with the raw- and the SDS-
values of the depended variables to account for age- and
sex-specific effects. Detailed results are summarized in
Table 1.
Influence of age AST and GGT serum concentrations
are significantly associated with age. While AST serum
levels significantly decrease with increasing age (β =
−1.4), GGT serum levels significantly rise with age
(β = 0.37). However, there is no significant effect of
age on ALT serum levels found beyond the effect al-
ready conveyed by puberty.
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Figure 2 Smoothed percentile curves for alanine aminotransferase (ALT) (U/l, y-axis: log scale) in females/males over the
age (11 months to 16.0 years) based on a normal weight reference population from a LIFE Child study sample: N = 3,131,
Nfemale = 1,467, NMale = 1,664. The 3rd (P3), 10th (P10), 50th (P50, median), 90th (P90) and 97th (P97)
Influence of sex All three liver enzymes are significantly
associated with sex. Boys present higher mean serum
levels of ALT, AST and GGT compared to girls. This
effect is strongest for AST (β = −1.77), medium for
ALT (β = −1.65) and weakest for GGT (β = −1.17).
Influence of puberty Puberty has significant effects on
all three investigated transaminases independently of
age. During puberty (Tanner stage 2 4) children ex-
hibit significantly higher ALT (β = 6.29) and GGT
(β = 4.36) serum levels compared to prepubertal chil-
dren (Tanner stage 1). These effects are stronger than
the associations with age. In contrast, AST serum con-
centrations are negatively associated with puberty (β =
−1.28). Post-pubertal adolescents (Tanner stage 5) re-
vealed significantly lower transaminases serum levels
compared to prepubertal children (β = −20.67 for ALT,
−20.97 for AST and −11.83 for GGT).
Influence of BMI A significant positive correlation was
found between BMI-SDS and ALT serum concentra-
tions (β = 2.21), a similar, but slightly weaker associa-
tion was found between GGT and BMI-SDS (β = 1.16).
The depicted associations are weaker in girls. While a
rise of the BMI-SDS about +1 results in an ALT serum
level increase about 2.21 U/l in boys, it only results in a
rise about 1.11 U/l in girls. This applies accordingly to
associations with GGT serum levels. Surprisingly, anal-
ysis revealed a weak negative association between AST
serum concentrations and BMI-SDS (β = −0.15). This
effect is stronger in girls (β = −0.66) compared to boys
(β = −0.15).
Elevated ALT serum levels are associated with a higher
pediatric NAFLD score Liver biopsy remains the gold
standard for assessing non-alcoholic fatty liver disease
(NAFLD) severity and staging of fibrosis, however, per-
forming a liver biopsy for screening purpose is neither
practical nor ethical and therefore cannot be part of a
cohort study. For this reason, Alkhouri et al (1 ) have
developed a non-invasive test to identify children with
advanced fibrosis (Fibrosis score 3): The Pediatric NAFLD
Fibrosis Score (PNFS), which was defined as:
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Figure 3 Smoothed percentile curves for aspartate aminotransferase (AST) (U/l, y-axis: log scale) in females/males over the
age (11 months to 16.0 years) based on a normal weight reference population from a LIFE Child study sample: (N = 3,131,
Nfemale = 1,467, NMale = 1,664. The 3rd (P3), 10th (P10), 50th (P50, median), 90th (P90) and 97th (P97) percentiles are
shown.
z = 1.1 + (0.34 ·
√
ALT)
+ 0.002 · alkaline phosphatase
− 1.1 · log(platelets)
− 0.02 ·GGT
This value was converted into a probability distribu-
tion. We applied the recommended cut-off of 8% which
would provide sensitivity and specificity values of 97%
and 33% to detected children with advanced liver fibro-
sis (1 ). However, this new score was not validated in
further studies.
We found that increasing liver enzyme SDS values
are accompanied by a higher PNFS. This influence is
higher than the mathematical influence of the respec-
tive term in the formula. In addition, Figure 5 revealed
that children with ALT serum concentrations above the
97 th percentile present significantly higher (p < 0.001)
PNFS values compared to children with lower ALT
serum levels (< 97 th percentile).
Furthermore, we found that 7.9% of the overweight/
obese children show PNFS values above 8%. By looking
at the group of children with overweight/obesity and
ALT serum levels > 97 th percentile this percentage
even represents 39.5%. However, also 29.0% of children
with normal weight and elevated ALT serum concentra-
tions (> 97 th percentile) present PNFS values above
8% possibly indicating a high risk for advanced liver
fibrosis.
4 Discussion
Our study presented age- and sex-specific percentiles of
ALT, AST and GGT derived from the LIFE Child co-
hort in Germany, which consists of 3,131 cases of normal
weight children and adolescents between 11 months and
16.0 years. This study is the first to present percentiles
for all three transaminases derived from normal weight
children and adolescents, carried out within a standard-
ised protocol of a cohort study and is one of the largest
cohort studies on this topic. In the past seven years,
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Figure 4 Smoothed percentile curves for γ-glutamyltransferase (GGT) (U/l, y-axis: log scale in females/males over the age
(11 months to 16.0 years) based on a normal weight reference population from a LIFE Child study sample: (N = 3,131, Nfemale
= 1,467, NMale = 1,664. The 3rd (P3), 10th (P10), 50th (P50, median), 90th (P90) and 97th (P97) percentiles are shown.
Figure 5 Elevated alanine aminotransferase serum levels
(ALT) and overweight/obesity influence the risk for advanced
liver fibrosis. ALT serum concentrations (U/l) ¿ 97th per-
centiles are associated with higher PNFS (Pediatric NAFLD
Fibrosis Score) (%) values and present significantly (p-value
¡ 0.001) higher PNFS values compared to cases with ALT
serum levels ¡ 97th percentile. PNFS is a non- invasive screen-
ing tool to detect children with advanced fibrosis (Fibrosis
score 3). A cut-off at 8% provides sensitivity and specificity
values of 97% and 33%. Overweight/obese children present
higher PNFS values. NALT ¡ 97th percentile = 3,580 cases
(3,010 normal weight, 567 overweight/obese), NALT ¿ 97th
percentile = 221 (107 normal weight, 114 overweight/obese).
various studies have been conducted to examine ALT in
children and adolescents, while far fewer have been per-
formed for AST or GGT. Characteristics of studies that
published reference intervals or percentiles for transam-
inases are available in Supplementary Table 6. The pri-
mary studies are KiGGS (8 ) (nationwide health survey
in children and adolescents carried out by the Robert
Koch Institute, Germany), Estey et al (11 ) (results
from the CALIPER cohort study, Canada), Zierk et
al (39 ), Schwimmer et al (31 ) (SAFETY study, USA),
England et al (10 ), Poustchi et al (24 ) and Dehghani
et al (7 ).
Comparison of our new percentiles with previous cut-
offs and reference intervals The aforementioned stud-
ies differ markedly regarding the country of origin, the
ethnical structure of the reference populations, the age
groups applied, inclusion and exclusion criteria, sam-
ple size, laboratory devices, statistical methods, and
the serum levels proposed as the cut-off. While most
of the studies used P95 as upper limit, Zierk et al (39 ),
KiGGS (8 ) and LIFE Child propose P97/P97.5 as a
threshold. Only KiGGS (8 ) and England et al (10 ) es-
timated percentiles, Zierk et al (39 ) applied a mixture
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of healthy and pathologic samples and a complex sta-
tistical approach to calculate percentiles. Dehghani et
al (7 ) presented reference values for three distinct age
intervals. This explains substantial differences in the
serum levels proposed as cut-off values.
The initial decrease in ALT has also been described
by England et al (10 ) and apart from the missing ALT
peak in early puberty in boys, Zierk et al (39 ) pre-
sented similar patterns for boys and girls. Their ref-
erence values are only slightly higher than our 97 th
percentile values, especially during infancy. Estey et al
(11 ), Schwimmer et al (31 ), Poustchi et al (24 ), and
Dehghani et al (7 ) published reference values that are
markedly below ours. Looking at the trends shown by
reference intervals of distinct age groups, we found no-
ticeable changes during the onset of puberty. According
to Siest et al (33 ) the most commonly used cut-off val-
ues for ALT and AST in adults are 40 U/l (30 50 U/l
) . Kim et al (13 ) recently estimated male thresholds
of 30 U/l for ALT and 31 U/l for AST to be best cut-
offs for the prediction of liver disease. These cut-offs
show good accordance for our ALT P97, but are signif-
icantly below our AST upper limit. Our AST thresh-
old exceeds 31 U/l throughout the observed age span.
Apart from Kim et al (13 ), only a few studies exist
that examined AST. Estey et al (11 ) and Zierk et al
(39 ) both found similar dynamics to our percentiles for
boys and girls, whereas Dehghani et al (7 ) presented
increasing reference values over age for both sexes. The
proposed cut-off values from Estey et al (11 ) and De-
hghani et al (7 ) are below our 97 th percentiles, but
those published by Zierk et al (39 ) are in good ac-
cordance. GGT percentiles were published by KiGGS
(8 ) in 2009 and by Zierk et al (39 ) in 2015. Their
percentiles correspond quite well with ours. The LIFE
Child percentiles slightly exceed KiGGS (8 ) serum lev-
els during adolescence. Compared to Zierk et al (39 ),
our reference values are slightly higher in girls during
adolescence. Comparing all mentioned reference values,
we found differences in the described trends, particu-
larly during the onset of puberty. The previously pub-
lished patterns showed varying changes during that pe-
riod, such as dips or rises. However, variations have
also been found within our percentiles. Most studies
described sex-specific differences in serum level concen-
trations (8 , 10 , 31 , 39 ). In addition, we showed that
gender disparity with regard to transaminases appears
to increase with age. Boys exceed girls with their serum
concentration regarding all three transaminases. Obvi-
ously, age and more significantly puberty influence the
level of transaminases. Differences as described above
may be partly caused by an increasing liver size or
rising muscle mass with age as well as changing fat-
muscle distribution especially during puberty (17 , 30 ).
Interactions between sex hormones and metabolic pro-
cesses (e.g. insulin resistance) may contribute to sex-
and puberty-specific alterations (12 , 21 , 34 ).
Potential NAFLD in overweight children with elevated
ALT NAFLD is the most common form of hepatic dis-
ease during childhood (20 ). Its overall prevalence in
children has reached approximately 10%, including up
to 17% in teenagers and 40%-70% among obese children
(4 ). It appears twice as often in boys than in girls and
has its onset mainly peripubertal (20 , 32 ). NAFLD en-
compasses a large spectrum of conditions ranging from
simple hepatic steatosis, which is reversible, to steato-
hepatitis with or without fibrosis and to hepatic cirrho-
sis and its complications (20 ). We found that 39% of
the overweight/obese children with elevated ALT serum
levels presented PNFS values above 8%, possibly indi-
cating an increased risk for advanced liver fibrosis. How-
ever, it is well known that new scoring systems need to
be evaluated externally by further (comparing) studies.
The PNFS is a new tool and its utility and transfer-
ability from one study cohort to another cohort needs
to be assessed, addressing also possible bias due to het-
erogeneity in pediatric NAFLD in different countries.
Early diagnosis and therapy are essential to prevent
further progression. For that reason, it is important to
have access to reliable reference values derived from pri-
marily healthy and normal weight children, especially
during critical phases like puberty.
Strengths and limitations The main strengths of our
study are the composition and large sample size of the
reference population, the standardised assessment, and
the usage of novel statistical and laboratory methods.
LIFE Child is one of the largest cohorts of primarily
healthy and normal weight children and adolescents in
Europe and therefore very well suited for the calculation
of reference values. This study provides an openly avail-
able R package including convenient functions to trans-
form measurement values into SDS values for ALT,
AST and GGT. Regarding limitations, others have al-
ready reported that the composition of the LIFE Child
cohort differs from the general distribution in the city
of Leipzig, especially regarding the social background
of the participants (6 ). Children from socially disad-
vantaged families were underrepresented in the LIFE
Child study, possibly due to a less pronounced health
awareness (5 ). Due to the ethnic composition of the city
of Leipzig and underrepresentation of Non-Caucasians,
this study does not describe the potential influence of
ethnicity on transaminases. Therefore, the suitability
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and/or comparability of these reference values for other
ethnicities needs to be investigated.
The usage of the PNFS scoring system is a further
limitation of this study. This score has been developed
recently, therefore its superior performance has not yet
been confirmed by studies other than Alkhouri et al
(1 ). However, this non-invasive scoring system could be
a useful screening tool to select children with NAFLD
who are at risk for advanced disease to undergo further
investigations and more aggressive monitoring.
5 Conclusion
Current reference values of ALT, AST and GGT serum
concentrations from primarily healthy and normal weight
children and adolescents between 11 months and 16.0
years were proposed. A new methodological approach
permitted a more detailed description of the age-depend-
ency than in former studies. We found that age, sex,
BMI, and puberty status influence the patterns of the
three transaminases considered here and highlight the
need for sex- and age-specific reference values. The util-
ity of these current reference values in children and
adolescents has to be evaluated by further studies. We
hope that this study will contribute to daily practice in
healthcare for children and adolescents.
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R PA C K A G E CHILDSDS
To provide the functions to a broader audience they were pub-
lished as part of the R package childsds [76]. The package
is released under the GNU General Public License version 3
(GPL-3) and freely available for download from the The Compre-
hensive R Archive Network (CRAN), https://cran.r-project. website
org/package=childsds. In the following chapter, the core func-
tions are described. For the full documentation and examples
I refer to the documentation available at the aforementioned
website and to the belonging git repository at https://github. git & wiki
com/mvogel78/childsds.
7.1 the example data
The NHANES is a survey research program conducted by the NHANES
National Center for Health Statistics to assess the health and
nutritional status of adults and children in the United States.
The program has started in the early ’60s. Every year, about
5000 persons are sampled. The data is available from https:// data for download
wwwn.cdc.gov/nchs/nhanes/. Here, data on body height from
the survey years 1999–2012 is used (Listing 1). As example data
only data from subjects aged 0 to 18 years were used. Note that
the examples included in this chapter only show the techni-
qual abilities of the R package. The actual creation of reference
values needs more diagnostics and adjustments of modeling
parameters.
Listing 1: Example data
> head(data)
year seqn riagendr bmxht age
1 19992000 1 female 91.6 2.416667
2 19992000 10 male 190.1 43.166667
3 19992000 100 female 152.8 14.500000
4 19992000 1000 male 179.9 53.083333
5 19992000 1001 male 164.4 53.000000
6 19992000 1002 male 163.5 40.000000
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7.2 the fitting functions
7.2.1 prepare_data()
The prepare_data() function prepares the data for the estima-
tion process. The first argument is the data set. Subsequently,
the important columns subject id, sex, age, and value are de-
fined. In general, the function results in a list of two data sets,
one for each sex. If the sex variable contains more or less than
two levels, the number of resulting data frames changes ac-
cordingly. In the following paragraphs, two levels of sex are
assumed. If there is some grouping or clustering in the data
like families, the grouping variable can be defined as well.
Listing 2: prepare_data()
> data <- prepare_data(data,
subject = "seqn",
sex = "riagendr",
age ="age",
value = "bmxbmi")
> data
$male
group subject value age sex
2 NA 10 30.94 43.16667 male
4 NA 1000 30.34 53.08333 male
5 NA 1001 25.64 53.00000 male
6 NA 1002 27.27 40.00000 male
7 NA 1003 27.40 78.50000 male
8 NA 1004 22.45 18.41667 male
$female
group subject value age sex
1 NA 1 14.90 2.416667 female
3 NA 100 28.44 14.500000 female
9 NA 1005 26.71 14.583333 female
11 NA 1007 15.99 4.083333 female
12 NA 1008 15.12 11.333333 female
13 NA 1009 33.32 39.000000 female
7.2.2 do_iterations()
The function do_iterations() takes a list of data frames (result
of the function prepare_data() as input. It repeats the fitting
process n times. The result consists of two lists: one containsparameters
the models and the other one the parameter tables called lms
table list. The fitting distribution is stored as attribute to the
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lms table list. The lms table list itself consists of two lists of
parameter tables1, one for each sex. Each list contains as many
parameter tables as iterations were done.
Additional parameters are listed in Table 7. The age.min and
age.max arguments define the age range of fitting. To avoid ex-
trapolation, age.min is set to the minimum age contained in the
data if the given age.min argument is lower than the minimum
age in the given data. The same is true if age.max is greater than
the maximum age contained in the data. Via the age.int argu-
ment the density of grid points is specified, the default value is
1/12 (monthly grid points). Most of the remaining arguments
are arguments to the lms() function and concern smoothing,
see [72, 71].
argument description
n number of desired fits
max.it maximum number of iterations that will be
run
prop.fam proportion of families or groups to be sam-
pled
prop.subject proportion of subject to be sampled
age.min lower bound of age
age.max upper bound of age
age.int step width of the age variable
keep.models indicator whether or not models in each
iteration should be kept
dist distribution used for the fitting process,
preferable one of these three: BCCGo,
BCPEo, BCTo (works with any other dis-
tribution accepted by lms())
mu.df degree of freedom location parameter
sigma.df degree of freedom spread parameter
nu.df degree of freedom skewness parameter
tau.df degree of freedom kurtosis parameter
trans.x indicator whether or not the age variable
should be transformed (power transforma-
tion)
continue next page
1 in the BCCG case the three paramters λ (but here ν), µ, and σ, hence the
name lms table
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argument description
lim.trans the limits for the search of the optimum
power parameter for age
verbose whether or not information about sam-
pling will be printed while iterate
Table 7: Arguments of the do_iterations() function.
Listing 3: do_iteration()
> res <- do_iterations(data.list = data.l,
n = 1000,
max.it = 1500,
prop.subject = 0.7,
min.age = 2,
max.age = 18)
> res
List of 2
$ male :List of 1000
..$ : ’data . frame ’: 193 obs. of 4 variables:
.. ..$ age : num [1:193] 2 2.08 2.17 2.25 2.33 ...
.. ..$ mu : num [1:193] 89 89.6 90.1 90.7 91.3 ...
.. ..$ sigma: num [1:193] 0.0393 0.0394 0.0395 0.0397 ...
.. ..$ nu : num [1:193] 0.715 0.702 0.69 0.677 0.665 ...
..$ : ’data . frame ’: 193 obs. of 4 variables:
.. ..$ age : num [1:193] 2 2.08 2.17 2.25 2.33 ...
.. ..$ mu : num [1:193] 89 89.6 90.1 90.7 91.3 ...
.. ..$ sigma: num [1:193] 0.0393 0.0394 0.0395 0.0397 ...
.. ..$ nu : num [1:193] 0.715 0.702 0.69 0.677 0.665 ...
...
$ female:List of 1000
..$ : ’data . frame ’: 193 obs. of 4 variables:
.. ..$ age : num [1:193] 2 2.08 2.17 2.25 2.33 ...
.. ..$ mu : num [1:193] 87.7 88.3 88.9 89.4 90 ...
.. ..$ sigma: num [1:193] 0.0384 0.0385 0.0386 0.0387 ...
.. ..$ nu : num [1:193] -0.26 -0.262 -0.264 -0.266 ...
..$ : ’data . frame ’: 193 obs. of 4 variables:
.. ..$ age : num [1:193] 2 2.08 2.17 2.25 2.33 ...
.. ..$ mu : num [1:193] 87.7 88.3 88.9 89.4 90 ...
.. ..$ sigma: num [1:193] 0.0384 0.0385 0.0386 0.0387 ...
.. ..$ nu : num [1:193] -0.26 -0.262 -0.264 -0.266 ...
...
- attr(*, " distribution ")= chr "BCCGo"
The resulting lms table list can be aggregated using the func-
tion aggregate_lms(). In addition, the confidence bands can be
calculated.
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7.2.3 aggregate_lms()
The aggregate_lms() function has only one argument. It takes
the lms table list from the do_iterations() as input and calcu-
lates the mean parameters for all ages and both sexes simulta- mean parameters
neously. The result are two data frames, each containing an age
variable and, dependent on the fitting distributions, the distri-
bution parameters. The fitting distribution is stored as attribute
to the list of the two tables.
Listing 4: aggregate_lms()
> lmstable <- aggregate_lms(res$lms)
> str(lmstable)
List of 2
$ male : ’data . frame ’: 193 obs. of 4 variables:
..$ age : num [1:193] 2 2.08 2.17 2.25 2.33 ...
..$ mu : num [1:193] 89 89.6 90.1 90.7 91.3 ...
..$ sigma: num [1:193] 0.0393 0.0394 0.0395 0.0396 0.0398 ...
..$ nu : num [1:193] 0.727 0.714 0.701 0.688 0.675 ...
$ female: ’data . frame ’: 193 obs. of 4 variables:
..$ age : num [1:193] 2 2.08 2.17 2.25 2.33 ...
..$ mu : num [1:193] 87.7 88.3 88.9 89.4 90 ...
..$ sigma: num [1:193] 0.0384 0.0385 0.0386 0.0388 0.0389 ...
..$ nu : num [1:193] -0.248 -0.25 -0.252 -0.254 -0.256 ...
- attr(*, " distribution ")= chr "BCCGo"
7.2.4 calc_confints()
The function calc_confints() calculates the confidence bands
of a defined set of percentile curves as quantiles of the repli-
cates at each point. Therefore, there should be a sufficient large
number of replicates. The function envelope() included in the
R package boot [12] is used [21]. The confidence bands are cal- confidence bands
cualted as pointwise confidence envelopes for the curves based
on the n replicates at the grid points defined by the age vari-
able.
The first argument to the function is also the ”long ‘’ lms table
list. The desired centile curves can be specified via the perc
argument. The confidence level α is set via the level argument.
The result is a list containing the respective lower and upper
confidence levels
Listing 5: calc_confints()
> confbands <- calc_confints(res$lms)
> str(confbands)
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List of 2
$ :List of 5
..$ perc_02_5: ’data . frame ’: 193 obs. of 2 variables:
.. ..$ upper: num [1:193] 82.5 83 83.5 84 84.5 ...
.. ..$ lower: num [1:193] 82 82.5 83 83.5 84 ...
..$ perc_05_0: ’data . frame ’: 193 obs. of 2 variables:
.. ..$ upper: num [1:193] 83.5 84 84.6 85.1 85.6 ...
.. ..$ lower: num [1:193] 83.1 83.6 84.1 84.7 85.2 ...
..$ perc_50_0: ’data . frame ’: 193 obs. of 2 variables:
.. ..$ upper: num [1:193] 89.2 89.7 90.3 90.9 91.4 ...
.. ..$ lower: num [1:193] 88.8 89.4 90 90.5 91.1 ...
..$ perc_95_0: ’data . frame ’: 193 obs. of 2 variables:
.. ..$ upper: num [1:193] 95.1 95.7 96.3 96.9 97.6 ...
.. ..$ lower: num [1:193] 94.5 95.1 95.7 96.4 97 ...
..$ perc_97_5: ’data . frame ’: 193 obs. of 2 variables:
.. ..$ upper: num [1:193] 96.2 96.9 97.5 98.1 98.8 ...
.. ..$ lower: num [1:193] 95.5 96.2 96.8 97.5 98.1 ...
$ :List of 5
..$ perc_02_5: ’data . frame ’: 193 obs. of 2 variables:
.. ..$ upper: num [1:193] 81.7 82.2 82.7 83.2 83.7 ...
.. ..$ lower: num [1:193] 81.2 81.7 82.2 82.7 83.2 ...
..$ perc_05_0: ’data . frame ’: 193 obs. of 2 variables:
.. ..$ upper: num [1:193] 82.6 83.1 83.6 84.2 84.7 ...
.. ..$ lower: num [1:193] 82.2 82.7 83.2 83.8 84.3 ...
..$ perc_50_0: ’data . frame ’: 193 obs. of 2 variables:
.. ..$ upper: num [1:193] 87.9 88.5 89 89.6 90.2 ...
.. ..$ lower: num [1:193] 87.6 88.1 88.7 89.3 89.9 ...
..$ perc_95_0: ’data . frame ’: 193 obs. of 2 variables:
.. ..$ upper: num [1:193] 93.8 94.4 95 95.6 96.3 ...
.. ..$ lower: num [1:193] 93.2 93.8 94.4 95.1 95.7 ...
..$ perc_97_5: ’data . frame ’: 193 obs. of 2 variables:
.. ..$ upper: num [1:193] 95 95.6 96.2 96.9 97.5 ...
.. ..$ lower: num [1:193] 94.3 94.9 95.6 96.2 96.9 ...
> confbands <- calc_confints(res$lms,
+ perc = c(10,90),
+ level = .99)
> str(confbands)
List of 2
$ :List of 2
..$ perc_10_0: ’data . frame ’: 193 obs. of 2 variables:
.. ..$ upper: num [1:193] 84.7 85.3 85.8 86.3 86.8 ...
.. ..$ lower: num [1:193] 84.4 84.9 85.4 86 86.5 ...
..$ perc_90_0: ’data . frame ’: 193 obs. of 2 variables:
.. ..$ upper: num [1:193] 93.7 94.3 95 95.6 96.2 ...
.. ..$ lower: num [1:193] 93.2 93.9 94.5 95.1 95.7 ...
$ :List of 2
..$ perc_10_0: ’data . frame ’: 193 obs. of 2 variables:
.. ..$ upper: num [1:193] 83.7 84.2 84.8 85.3 85.8 ...
.. ..$ lower: num [1:193] 83.4 83.9 84.4 85 85.5 ...
..$ perc_90_0: ’data . frame ’: 193 obs. of 2 variables:
.. ..$ upper: num [1:193] 92.4 93 93.6 94.2 94.9 ...
.. ..$ lower: num [1:193] 91.9 92.5 93.2 93.8 94.4 ...
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7.3 the classes
In addition, two classes are defined: The ParTab class and the
RefGroup class. The ParTab defines a structure holding the name
of the item, the parameter tables, and the information about the
fitting distribution. The RefGroup class provides a structure to
collect and communicate ParTab objects.
7.3.1 The ParTab class
The ParTab class is defined as S3 class. Every ParTab object has
three slots:
• a slot item containing the name of the respective item (in
Listing 6, for example, height).
• a slot dist containing a named list holding the informa-
tion about the fitting distribution (one entry per sex)
• a slot params containing a named list holding the parame-
ter tables themselves (as produced by the aggregate_lms()
function, one for each sex)
Listing 6: Structure of the ParTab class
Formal class ’ParTab ’ [package "childsds"] with 3 slots
..@ item : chr "height"
..@ dist :List of 2
.. ..$ male : chr "BCCG"
.. ..$ female: chr "BCCG"
..@ params:List of 2
.. ..$ female: ’data . frame ’: 248 obs. of 4 variables:
.. .. ..$ age : num [1:248] -0.326 -0.307 -0.287 -0.268 ...
.. .. ..$ nu : num [1:248] 1 1 1 1 1 1 1 1.83 1.6 1.31 ...
.. .. ..$ mu : num [1:248] 30.9 32 33.2 34.5 35.9 ...
.. .. ..$ sigma: num [1:248] 0.071 0.071 0.075 0.077 0.08 ...
.. ..$ male : ’data . frame ’: 248 obs. of 4 variables:
.. .. ..$ age : num [1:248] -0.326 -0.307 -0.287 -0.268 ...
.. .. ..$ nu : num [1:248] 1 1 1 1.45 1.28 1.63 1.96 2.1 ...
.. .. ..$ mu : num [1:248] 31 32.2 33.5 34.7 36.2 ...
.. .. ..$ sigma: num [1:248] 0.07 0.073 0.076 0.074 0.079 ...
The corresponding show() method prints out the keystone
information: the name, the fitting distributions, and a table with
minimal and maximal age per sex.
Listing 7: show() method of the ParTab class
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> height
*** Table of Reference Values ***
[1] "height fit ted with : male BCCG, female BCCG"
sex minage maxage
female female -0.326 92.5
male male -0.326 92.5
7.3.2 The RefGroup class
The RefGroup class provides a structure to collect and commu-
nicate ParTab objects and the respective references. It is also
defined as S3 class. There are four slots:
• a slot name containing the name of the reference group (in
Listing 8 Kromeyer-Hauschild)
• a slot refs containing a list of ParTab objects
• a slot citations containing a list of one or more refer-
ences
• a slot info containing additional information
Listing 8: Structure of the RefGroup class
> str(kro.ref)
Formal class ’RefGroup’ [package "childsds"] with 4 slots
..@ name : chr "Kromeyer−Hauschild"
..@ refs :List of 4
.. ..$ bmi :Formal class ’ParTab ’ with 3 slots
.. .. .. ..@ item : chr "bmi"
.. .. .. ..@ dist :List of 2
.. .. .. .. ..$ male : chr "BCCG"
.. .. .. .. ..$ female: chr "BCCG"
.. .. .. ..@ params:List of 2
.. .. .. .. ..$ female: ’data . frame ’: 231 obs. of 4 variables:
.. .. .. .. .. ..$ age : num [1:231] 0 0.083 0.167 0.25 ...
.. .. .. .. .. ..$ nu : num [1:231] 1.339 0.664 0.452 ...
.. .. .. .. .. ..$ mu : num [1:231] 12.6 14.3 14.9 15.4 ...
.. .. .. .. .. ..$ sigma: num [1:231] 0.0969 0.088 0.0858 ...
.. .. .. .. ..$ male : ’data . frame ’: 231 obs. of 4 variables:
.. .. .. .. .. ..$ age : num [1:231] 0 0.083 0.167 0.25 ...
.. .. .. .. .. ..$ nu : num [1:231] 1.306 0.114 -0.149 ...
.. .. .. .. .. ..$ mu : num [1:231] 12.7 14.7 15.5 16 ...
.. .. .. .. .. ..$ sigma: num [1:231] 0.1005 0.0925 0.0897 ...
.. ..$ height:Formal class ’ParTab ’ with 3 slots
...
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.. ..$ waist :Formal class ’ParTab ’ with 3 slots
.. .. .. ..@ item : chr "waist"
.. .. .. ..@ dist :List of 2
.. .. .. .. ..$ male : chr "BCCG"
.. .. .. .. ..$ female: chr "BCCG"
.. .. .. ..@ params:List of 2
.. .. .. .. ..$ female: ’data . frame ’: 145 obs. of 4 variables:
.. .. .. .. .. ..$ age : num [1:145] 6 6.08 6.17 6.25 6.33 ...
.. .. .. .. .. ..$ nu : num [1:145] -2.52 -2.52 -2.52 ...
.. .. .. .. .. ..$ mu : num [1:145] 50.6 50.7 50.9 51 ...
.. .. .. .. .. ..$ sigma: num [1:145] 0.0653 0.066 0.0666 ...
.. .. .. .. ..$ male : ’data . frame ’: 145 obs. of 4 variables:
.. .. .. .. .. ..$ age : num [1:145] 6 6.08 6.17 6.25 6.33 ...
.. .. .. .. .. ..$ nu : num [1:145] -2.66 -2.66 -2.66 ...
.. .. .. .. .. ..$ mu : num [1:145] 52.5 52.6 52.8 52.9 ...
.. .. .. .. .. ..$ sigma: num [1:145] 0.0629 0.0635 0.0641 ...
..@ citations:List of 1
.. ..$ : chr "Kromeyer−Hauschild et al . Percentiles of body . . .
. .@ info : List of 3
. . . . $ : chr "Reference values 0-18 years of age Kromeyer-..."
. . . . $ : chr "18-92.5 Mikrozensus"
. . . . $ : chr "Correction for gestational age: Voigt"
There is also a show() method defined for RefGroup objects.
It prints out a summary of the object: the number of ParTab ob-
jects contained in the RefGroup, the summary of each RefGroup,
the references, and the additional information. The last line
of the output contains a list of valid items. As an example,
in Listing 9 a RefGroup object kro.ref containing four refer-
ences of the German reference values by Kromeyer-Hauschild
are printed.
Listing 9: show() method of the RefGroup class
> kro.ref
*** Group of Reference Tables ***
[1] "Kromeyer−Hauschild containing 4 reference tables "
*** Table of Reference Values ***
[1] "bmi fitted with : male BCCG, female BCCG"
sex minage maxage
female female 0 92.5
male male 0 92.5
*** Table of Reference Values ***
[1] "height fit ted with : male BCCG, female BCCG"
sex minage maxage
female female -0.326 92.5
male male -0.326 92.5
*** Table of Reference Values ***
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[1] "weight fit ted with : male BCCG, female BCCG"
sex minage maxage
female female -0.326 92.5
male male -0.326 92.5
*** Table of Reference Values ***
[1] "waist f i t ted with : male BCCG, female BCCG"
sex minage maxage
female female 6 18
male male 6 18
[1] "Kromeyer−Hauschild et al . Percentiles of . . .
[1] "Reference values 0-18 years of age Kromeyer-Hausschild"
[1] "18-92.5 Mikrozensus"
[1] "Correction for gestational age: Voigt"
[1] "use one of the following keys:bmi - height - weight - waist"
7.3.3 The Example
The under section 7.2.3 generated parameter table can easily
be transformed into a ParTab object. Note that the information
about the fitting transformation which is essential for the back-
transformation is contained within the dist slot.
Listing 10: Creating a ParTab object
> height <- new("ParTab",
+ item = "height",
+ dist = list(male = "BCCGo", female = "BCCGo"),
+ params = lmstable
+ )
> height
*** Table of Reference Values ***
[1] "height fit ted with : male BCCGo, female BCCGo"
sex minage maxage
male male 2 18
female female 2 18
In the next step, a RefGroup object is created. In general, more
than one parameter table is contained in a RefGroup. Respective
information are added via the citations and info slots.
Listing 11: Creating a RefGroup
> nhanes.ref <- new("RefGroup",
+ name = "NHANES",
+ refs = list(
+ height = height
+ ),
+ citations = list(
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+ "Author1 , Author2 . Publication"),
+ info = list(" Info 1"," Info 2"))
> nhanes.ref
*** Group of Reference Tables ***
[1] "NHANES containing 1 reference tables "
*** Table of Reference Values ***
[1] "height fit ted with : male BCCGo, female BCCGo"
sex minage maxage
male male 2 18
female female 2 18
[1] "Author1 , Author2 . Publication"
[1] " Info 1"
[1] " Info 2"
[1] "use one of the following keys : height"
7.4 the back-transformation function
The ability of back-transformation was one of the main criteria
for choosing a estimation method [6]. The back-transformation
algorithm is, at its core, identical to the calculation of the nor-
malized quantile residuals. In the childsds package, the sds()
function provides a convenient way to calculate SDS or Z-scores.
The arguments of the function shown in Table 8. The function
is vectorized and can, therefore, applied to whole tables.
argument description
value vector of measurement values
age vector of age values
sex vector of sex
item name of the item e.g. "height"
ref RefGroup object
type "SDS" or "perc"
male coding of sex for male
female coding of sex for female
Table 8: Arguments of the sds() function.
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7.4.1 The Example
Adding the SDS values to the original data set data is straight-
forward.
Listing 12: Calculation of SDSs 1
> head(data)
year seqn riagendr age bmxht
1 19992000 1 female 2.416667 91.6
2 19992000 100 female 14.500000 152.8
3 19992000 1004 male 18.416667 168.7
4 19992000 1005 female 14.583333 164.0
5 19992000 1006 male 6.666667 116.3
6 19992000 1007 female 4.083333 105.5
> data$height_sds <- sds(value = data$bmxht,
+ age = data$age,
+ sex = data$riagendr,
+ item = "height",
+ ref = nhanes.ref)
> head(data)
year seqn riagendr age bmxht height_sds
1 19992000 1 female 2.416667 91.6 0.2833311
2 19992000 100 female 14.500000 152.8 -1.1365274
3 19992000 1004 male 18.416667 168.7 NA
4 19992000 1005 female 14.583333 164.0 0.4822191
5 19992000 1006 male 6.666667 116.3 -0.9252072
6 19992000 1007 female 4.083333 105.5 0.6734540
Note the missing value in the third row. The parameter ta-
ble only provides parameters in the age range 2–18 years. No
extrapolation is done. In comparison SDS, Listing 13 shows an
additional column containing the transformed values using the
German reference data (Listing 9) [45]. Here, the available age
ranges from -0.3 to 90 years.
Listing 13: Calculation of SDSs 2
> data$height_sds_kr <- sds(value = data$bmxht,
+ age = data$age,
+ sex = data$riagendr,
+ item = "height",
+ ref = kro.ref)
> head(data)
year seqn riagendr age bmxht height_sds height_sds_kr
1 19992000 1 female 2.416667 91.6 0.2833311 0.35240121
2 19992000 100 female 14.500000 152.8 -1.1365274 -1.67083815
3 19992000 1004 male 18.416667 168.7 NA -1.77307406
4 19992000 1005 female 14.583333 164.0 0.0482219 -0.05322527
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5 19992000 1006 male 6.666667 116.3 -0.9252072 -1.20993408
6 19992000 1007 female 4.083333 105.5 0.6734540 0.29032377
7.5 convenience functions
7.5.1 make_percentile_tab()
The function creates a table containing parameter values and
percentiles at particular ages (determined via the age argument).
The table of the percentile table can also be returned in a stacked
version for easy creation of graphics (Listing 15).
Listing 14: Creating a percentile table
> make_percentile_tab(ref = kro.ref,
+ item = "height",
+ perc = c(3,50,97),
+ age = c(1,5,10))
sex age perc_03_0 perc_50_0 perc_97_0 nu mu sigma
1 male 1 70.9495 76.7215 82.4936 1 76.7215 0.0400
2 male 5 102.6654 111.6785 120.6916 1 111.6785 0.0429
3 male 10 128.9590 141.6236 154.2882 1 141.6236 0.0475
4 female 1 69.9333 75.3961 80.8588 1 75.3961 0.0385
5 female 5 101.9324 110.9692 120.0060 1 110.9692 0.0433
6 female 10 128.6176 141.3379 154.0582 1 141.3379 0.0479
> make_percentile_tab(ref = kro.ref,
+ item = "height",
+ perc = c(3,50,97),
+ age = c(1,5,10),
+ include.pars = F)
sex age perc_03_0 perc_50_0 perc_97_0
1 male 1 70.9495 76.7215 82.4936
2 male 5 102.6654 111.6785 120.6916
3 male 10 128.9590 141.6236 154.2882
4 female 1 69.9333 75.3961 80.8588
5 female 5 101.9324 110.9692 120.0060
6 female 10 128.6176 141.3379 154.0582
Listing 15: Creating a stacked percentile table
> head(ptab <- make_percentile_tab(ref = kro.ref,
+ item = "height",
+ perc = c(3,50,97),
+ age = seq(0,10,l = 500),
+ stack = T))
age sex variable value
1 0.00000000 male perc_03_0 47.0198
2 0.02004008 male perc_03_0 47.6993
3 0.04008016 male perc_03_0 48.3793
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4 0.06012024 male perc_03_0 49.0595
5 0.08016032 male perc_03_0 49.7402
6 0.10020040 male perc_03_0 50.4192
> ggplot(ptab, aes(x = age, y = value, group = variable)) +
+ geom_line() +
+ facet_wrap( ~ sex)
Figure 31: Percentile curves created using the two functions
make_perc_tab().and ggplot()
7.5.2 wormplot_gg()
The wormplot_gg() function creates worm plots as described
in section 4.2.5. In contrast to the original version wp() from
the gamlss package, it also can handle models resulting from
an iteration process as described in the originial article [78]. Its
return value is a ggplot object. Therefore, the resulting figure
can be manipulated after creation.
Listing 16: Creating of a worm plot
> wormplot_gg(residuals = data$height_sds)
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Figure 32: Worm plot for the resulting reference values from Listing
3
Listing 17: Worm plots per age interval
> wormplot_gg(residuals = data$height_sds,
+ age = data$age,
+ n.inter = 16)
Figure 33: Worm plot for the resulting reference values from Listing
3 for 16 age intervals
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7.6 collection of reference values
RefGroup objects are a convenient way to store and communi-
cate reference values and parameter tables. In combination with
the sds() and make_perc_tab() functions the transformation
of raw measurement values into SDSs is easy to achieve (within
R). The childsds package contains a collection of published
German and international reference values. A list of available
reference tables is given in Table 9.
item ref object age range year comments
height cdc.ref 0 – 3 US
cdc.ref 2 – 20 US
zong13.ref 0 – 18 2013 China
saudi.ref 0 – 5 2016 Saudi Arabia
saudi.ref 5 – 18 2016 Saudi Arabia
portug.ref 7 – 17 Portugal
kiggs.ref 0.3 – 18 03-06 Germany
kro.ref -0.3 – 92 Germany
ukwho.ref -0.3 – 20 UK/Intern.
uk1990.ref -0.1 – 23 UK
belgium.ref 0 – 21 Belgium
italian.ref 2 – 20 2006 North Italy
italian.ref 2 – 20 2006 South Italy
italian.ref 2 – 20 2006 Italy
nl4.ref 0 – 21 1997 NL Dutch
nl4.ref 0 – 20 1997 NL Turkish
nl4.ref 0 – 20 1997 NL Moroccon
who.ref 0 – 5 Intern.
who2007.ref 5 – 19 2007 Intern.
preterm.ref -0.3 – 0 98-06 US
turkish.ref 6 – 18 2006 Turkey
weight belgium.ref 0 – 21 Belgium
cdc.ref 0 – 3 US
cdc.ref 2 – 20 US
italian.ref 2 – 20 2006 North Italy
italian.ref 2 – 20 2006 South Italy
italian.ref 2 – 20 2006 Italy
kiggs.ref 0.3 – 18 03-06 Germany
kro.ref -0.3 – 92 Germany
portug.ref 7 – 17 Portugal
continue next page
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item ref object age range year comments
ukwho.ref -0.3 – 20 UK/Intern.
uk1990.ref -0.3 – 23 UK
who.ref 0 – 5 Intern.
who2007.ref 5 – 19 2007 Intern.
zong13.ref 0 – 18 2013 China
saudi.ref 5 – 13 2016 Saudi Arabia
saudi.ref 0 – 5 2016 Saudi Arabia
nl4.ref 0 – 21 1997 NL Dutch
nl4.ref 0 – 20 1997 NL Turkish
nl4.ref 0 – 20 1997 NL Moroccon
preterm.ref -0.3 – 0 98-06 US
turkish.ref 6 – 18 2006 Turkey
BMI cdc.ref 2 – 20 US
zong13.ref 0 – 18 2013 China
saudi.ref 5 – 18 2016 Saudi Arabia
saudi.ref 0 – 5 2016 Saudi Arabia
portug.ref 7 – 17 Portugal
turkish.ref 6 – 18 Turkey
kiggs.ref 0.3 – 18 03-06 Germany
kro.ref 0 – 92 Germany
ukwho.ref 0 – 20 UK/Intern.
uk1990.ref -0.1 – 23 UK
belgium.ref 2 – 21 Belgium
nl4.ref 0 – 21 1997 NL Dutch
nl4.ref 0 – 20 1997 NL Turkish
nl4.ref 0 – 20 1997 NL Moroccon
nl3.ref 0 – 20 1980 NL
italian.ref 2 – 20 2006 North Italy
italian.ref 2 – 20 2006 South Italy
italian.ref 2 – 20 2006 Italy
who.ref 0 – 5 Intern.
who2007.ref 5 – 19 2007 Intern.
preterm.ref -0.3 – 0 98-06 US
sitting nl4.ref 0 – 21 1997 NL Dutch
height nl4.ref 0 – 20 1997 NL Turkish
nl4.ref 0 – 20 1997 NL Moroccan
uk1990.ref 0 – 23 UK
leg length fredriks05.ref 0.3 – 21 1996/7 NL
uk1990.ref 0 – 23 UK
waist nl4.ref 0 – 21 1997 NL Dutch
continue next page
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item ref object age range year comments
circumference nl4.ref 0 – 20 1997 NL Turkish
nl4.ref 0 – 20 1997 NL Moroccan
us.ref 5 – 19 US
uk1990.ref 3 – 17 UK
(max narrowing) japan.ref 6 – 18 2007 Japan
(top iliac crest) japan.ref 6 – 18 2007 Japan
kro.ref 11 – 18 Germany
kiggs.ref 11 – 18 03-06 Germany
portug.ref 7 – 17 Portugal
turkish.ref 7 – 17 Turkey
hip nl4.ref 0 – 21 1997 NL Dutch
circumference nl4.ref 0 – 20 1997 NL Turkish
nl4.ref 0 – 20 1997 NL Moroccan
kiggs.ref 11 – 18 03-06 Germany
head nl4.ref 0 – 21 1997 NL Dutch
circumference nl4.ref 0 – 20 1997 NL Turkish
nl4.ref 0 – 20 1997 NL Moroccan
cdc.ref 0 – 3 US
who.ref 0 – 5 Intern.
uk1990.ref -0.3 – 23 UK
zong13.ref 0 – 18 2013 China
saudi.ref 0 – 5 2016 Saudi Arabia
belgium.ref 0 – 20 1997 Belgium
kiggs.ref 0.3 – 18 03-06 Germany
ethiop.ref 0 – 2 2015 Ethiopian
preterm.ref -0.3 – 0 98-06 US
sitting height nl4.ref 0 – 21 1997 NL Dutch
to height ratio nl4.ref 0 – 20 1997 NL Turkish
nl4.ref 0 – 20 1997 NL Moroccan
waist to nl4.ref 0 – 21 1997 NL Dutch
hip ratio nl4.ref 0 – 20 1997 NL Turkish
nl4.ref 0 – 20 1997 NL Moroccan
kiggs.ref 11 – 18 03-06 Germany
subscapular who.ref 0.3 – 5 Intern.
skin fold kiggs.ref 0.3 – 18 03-06 Germany
colombia_sf.ref 9 – 18 2016 Colombia
triceps who.ref 0.25 – 5 Intern.
skin fold kiggs.ref 0.3 – 18 03-06 Germany
colombia_sf.ref 9 – 18 2016 Colombia
skin fold sum kiggs.ref 0.3 – 18 03-06 Germany
continue next page
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item ref object age range year comments
colombia_sf.ref 9 – 18 2016 Colombia
body fat uk1990.ref 4.8 – 20 1990 UK
portug.ref 7 – 17 Portugal
kiggs.ref 8 – 18 03-06 Germany
IGF-1 japan_lab.ref 0 – 77 2012 Japan
intnat_lab.ref 0 – 94 2014 US, Canada, EU
intnat_lab.ref 0 – 94 2014 US, Canada, EU
IGF-BP3 intnat_lab.ref 0 – 90 2014 US, Canada, EU
IGF1/IGF-BP3 intnat_lab.ref 0 – 90 2014 US, Canada, EU
HDL lipids.ref 0.2 – 18 2016 Germany
LDL lipids.ref 0.2 – 18 2016 Germany
total Chol. lipids.ref 0.2 – 18 2016 Germany
triglycerides lipids.ref 0.2 – 18 2016 Germany
ApoA1 lipids.ref 0.2 – 18 2016 Germany
ApoB lipids.ref 0.2 – 18 2016 Germany
ferritin iron.ref 4 – 18 2016 Germany
hemoglobin iron.ref 4 – 18 2016 Germany
reticulocytes iron.ref 4 – 18 2016 Germany
transferrin iron.ref 4 – 18 2016 Germany
Table 9: Reference tables available in the childsds package. Due to
lack of space international_int_lab.ref is abbreviated as int-
nat_lab.ref.
In addition, there exist a 2-dimensional reference kiggs_bp.ref
and a function sds_2d() for handling 2-dimensional reference
tables (here dependent on age and height). However, these are
still under development (alpha version).

8
S U M M A RY A N D O U T L O O K
8.1 summary
The comparison of a measurement value to its respective ex-
pected value is a convenient way to assess its meaning. The
value may depend on several conditions like age, sex, or health
status. Flexible methods like GAMLSS facilitate the estimation of
statistical reference ranges dependent on one or more covari-
ates. This current thesis presents a way to combine the estima-
tion of age-dependent distribution parameters using GAMLSS
with resampling to handle dependency structures within the
data. The necessary work steps are provided as set of R func-
tions within an R package freely available from the CRAN.
In the LIFE Child study [52], the method is applied to sev-
eral laboratory measurements. Three works have been already
published or accepted:
• Dathan-Stumpf et al. “Pediatric reference data of serum
lipids and prevalence of dyslipidemia” [20]
• Rieger et al. “Reference intervals for iron-related blood
parameters” [57]
• Bussler et al. “New pediatric percentiles of liver enzyme
serum levels (ALT, AST, GGT): effects of age, sex, BMI and
pubertal stage” [10]
Further publications on parameters of bone metabolism, and
kidney function are in preparation. In addition, we work on
a publication on reference intervals for different skin folds in
lean children (triceps, subscapular, suprailiac, sum) and on a
publication on voice ranges in boys and girls.
8.2 sds values and quality control
Within the context of LIFE Child, the SDS transformation of raw
values is also used in data quality control. It is combined with
a two-stage clustering (on variable and subject level). The dis-
tance between the observed value and a mean (expected) value
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within the cluster is a measure of the peculiarity of measure-
ment value [77]. The method is particularly useful if a large
number of variables and observations is available,e.g., in a large-
scale studies using the 3D body scanner technology. An exam-
ple is visualized in Figure 34.
Figure 34: SDS transformed values of torso-near circumference mea-
sures resulting from two 3D scanning (3D body scanner)
processes visualized as polar plots: On the left, measure-
ments of a child having relative high SDS values around
1.9 for all of the measures. On the right, the majority of
transformed values ranges between -0.5 and -0.9. The two
values outside this range are very likely to be measurement
errors.
8.3 the r package
The package is still under development. The iteration functions
rely heavily on the lms() function from the gamlss package
[72]. This function itself is a wrapper function around the orig-
inal gamlss() function. I plan to implement the alternative use
of gamlss() directly because it is more flexible. The functional-
ity will be extended to handle 2-dimensional reference values
(first tests already implemented). There will also be efforts to
improve the performance of the iterations as well as the sds()
function.
The contained library of international reference values (Table
9) and the documentation at https://github.com/mvogel78/
childsds/wiki will continuously be complemented.
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Especially in pediatrics, the availability of age-dependent ref-
erence values or reference ranges is essential in the decision
whether or not a value is likely to be pathological. The compar-
ison of a measurement value to its respective expected value
is a convenient way to assess its meaning. The expected value
may depend on several conditions like age, sex, or health status.
Therefore, the transformation of a measurement value into anSDS transformation
age- and sex-adjusted standardized value (a standard deviation
score) is recommended for anthropometric as well as laboratory
measurement values by the WHO [22]1.
Flexible regression methods like generalized additive models
for location, shape, and scale (GAMLSS) facilitate the estimationGAMLSS
of statistical reference ranges dependent on one or more co-
variates. GAMLSS is also recommended by the World Health Or-
ganization and can, therefore, be seen as a standard method in
estimating age-dependent reference values [6]. It has been used
to establish a wide range of reference values in children as well
as adults. In the last two decades, a large number of articles has
been published, e.g., [39, 33, 56, 44, 38, 64, 3, 15, 9, 19, 5, 4, 13,
69, 2]. This current thesis presents a way to combine the estima-
tion of age-dependent distribution parameters using GAMLSS
with resampling to handle dependency structures within the
data. This means that the estimation process is repeated over
and over (> 1000) on random subsamples of measurement val-
ues meeting the modeling assumption of independence. There-
fore, multiple measurements per subject (follow-up or sequen-
tial measures) or multiple measurements per family can be in-
cluded without violation of the independent assumption. The
final estimates are calculated as the mean estimates.
In the LIFE Child study [52], the method is applied to sev-
eral laboratory measurements. Three works have already been
published or are in press:
• Dathan-Stumpf et al. “Pediatric reference data of serum
lipids and prevalence of dyslipidemia” [20]
• Rieger et al. “Reference intervals for iron-related blood
parameters” [57]
• Bussler et al. “New pediatric percentiles of liver enzyme
serum levels (ALT, AST, GGT): effects of age, sex, BMI and
pubertal stage” [10]
Further publications on parameters of bone metabolism and further publications
1 all references refer to the bibliography in the thesis
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kidney function are in preparation. In addition, we work on
a publication on reference intervals for different skin folds in
lean children (triceps, subscapular, suprailiac, sum) and on a
publication on voice ranges in boys and girls.
Within the context of LIFE Child, the SDS transformation of
raw values is also used in data quality control. It is combined
with a two-stage clustering (on variable and subject level). The
distance between the observed value and a mean (expected)
value within the cluster is a measure of the peculiarity of a
measurement value [77]. The method is particularly useful if a
large number of variables and observations is available, e.g., in
large-scale studies using the 3D body scanner technology.
To provide the algorithm to a broader audience it was imple- R package
mented and published as part of the R package childsds [76].
The package is released under the GPL-3 and freely available
for download from CRAN2,. For the full documentation and ex- website
amples I refer to the documentation available at the aforemen-
tioned website and to the belonging git repository at https: git & wiki
//github.com/mvogel78/childsds. The package also provides
a library of international reference values. A detailed list of
available reference tables is provided as public wiki3.
childsds is still under development. The functionality will be
extended to handle 2-dimensional reference values (e.g. blood
pressure which depends on age and height, first tests already
implemented). There will also be efforts to improve the perfor-
mance of the iterations as well as the transformation function
(sds()). The included library of reference tables and the docu-
mentation will continuously be complemented.
2 https://cran.r-project.org/package=childsds
3 https://github.com/mvogel78/childsds/wiki
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